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Abstract 
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) derived from large 
mammals reproduce few characteristics displayed by rodent or human counterparts. This is 
complicated by the inherent plasticity of mammalian ESC/iPSC cultures that resemble a 
variety of developmental stages including the naïve and primed pluripotent states. Defining 
the extrinsic signals that modulate the developmental identity of canine ESC/iPSC (i.e. 
primed versus naïve) will improve knowledge integration with more sophisticated rodent and 
primate research. In this thesis, I sought to determine if manipulation of the culture 
environment can promote nuclear and metabolic reprogramming of canine cell lines towards 
a more primitive state of pluripotency. Using growth factors and kinase inhibitors to 
modulate pluripotency of canine ESCs (cESCs), I demonstrated that cESCs exhibit the 
plasticity to adopt multiple developmental identities. I observed that lineage-specific 
differentiation of cESCs is influenced by pluripotent state modulation, coincident with 
changes to colony architecture, transcriptional and epigenetic markers of developmental 
maturity. I found that primed- and naïve-like cESCs exhibit pluripotent-state specific 
mitochondrial structure and function, including differential reliance on glucose oxidation 
pathways for steady-state proliferation in vitro. Lastly, using comparative sequence analysis 
and biochemical assays, I observed that evolutionary differences in genomic CpG density at 
pluripotency-associated promoters correlate with functionally relevant cytosine modifications 
to the induction and maintenance of pluripotency. I showed the utility of physiological 
metabolites that regulate 5-methylcytosine oxidation in promoting cellular and transcriptional 
features associated with early nuclear reprogramming of canine fibroblasts (e.g. 
mesenchymal-to-epithelial transition). Taken together, my work establishes a binary cESC 
model of primed- and naïve-pluripotent states, providing insight into shared and divergent 
features of pluripotency progression and acquisition in placental mammals.  
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Chapter 1  
1 Introduction 
1.1 Overview 
1.1.1 Stem Cells, Fate Decisions and Cellular Plasticity 
Ontogenesis broadly refers to the formation of an entire multicellular organism, which 
includes a vast increase in cell number by means of replication and spatially patterned 
differentiation into functionally mature cell types (Longo et al., 2015). A population of 
undifferentiated cells, referred to as stem cells, exist at many developmental stages and 
are defined by two fundamental cellular processes: self-renewal and differentiation 
(Evans and Kaufman, 1981; Till and McCulloch, 1961). Self-renewal describes the 
replication of undifferentiated cells without age-related deterioration or transformation, 
thereby maintaining the stem cell reserve (Zeng and Rao, 2007). Whereas differentiation 
describes the commitment to a more specialized cell type by the coordinated expression 
of gene products critical for that lineage (Bruno et al., 2004). These observable traits 
comprise the stem cell phenotype, however stem cells are further classified by the niche 
they reside in and their latent capacity to derive one or more lineages (Barker et al., 2010; 
De Los Angeles et al., 2015). The ex vivo culture of a variety of stem cells and 
knowledge of external stimuli that regulate self-renewal and differentiation, hold exciting 
promise in regenerative medicine and drug discovery (Hanna et al., 2007; Kondo et al., 
2013). 
Cell fate decisions are partially determined by the range of commitment opportunities 
available to a cell (i.e. potency) (Mitalipov and Wolf, 2009). Pluripotent stem cells 
(PSCs) can differentiate into all cell types found in postnatal tissues (Nagy et al., 1993) 
and are conventionally derived from the inner cell mass or epiblast of mammalian 
preimplantation embryos (Martin, 1981; Thomson et al., 1998). Embryonic stem cells 
(ESCs) are authenticated by prolonged self-renewal in vitro and differentiation into 
progenitor cells from all three primary lineages (i.e. endoderm, mesoderm, ectoderm) 
(Huang et al., 2011). Cell potency is subject to varying degrees of restriction or 
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broadening (i.e. plasticity) in response to environmental and experimental perturbations 
(Lakshmipathy and Verfaillie, 2005). This notion that cell fate is progressively and 
irreversibly restricted was famously conceptualized as an epigenetic landscape by Conrad 
Waddington (Waddington, 1957). It is now understood that epigenetic modification of 
chromatin regulates the developmental competence of PSCs to respond to environmental 
cues and enables the maintenance of acquired information in their derivatives (Mohn and 
Schübeler, 2009). However, persistent disruption of signal transduction pathways or gene 
regulatory networks can ectopically induce or prevent the formation of a lineage 
(Ladewig et al., 2013).  
The extent of cellular plasticity is exemplified by direct reprogramming of somatic cells 
to an ESC-like phenotype, known as induced pluripotent stem cells (iPSCs) (Takahashi 
and Yamanaka, 2006). These reprogramming technologies progressively reconfigure the 
cytoskeleton, organelles, active signaling pathways and modifications to chromatin to 
attain a self-perpetuating pluripotency gene regulatory network (Jaenisch and Young, 
2008; Sakurai et al., 2014). Interestingly, cellular reprogramming to a pluripotent state is 
associated with changes in cellular metabolism (Folmes et al., 2011; Panopoulos et al., 
2012). Functional studies interrogating metabolic pathway activity and metabolite 
availability perceive metabolism as a determinant in cellular reprogramming and 
differentiation (Moussaieff et al., 2015; Sone et al., 2017). In this metabolic-epigenomic 
axis, metabolites regulate cell fate by functioning as rate-limiting reactants or cofactors 
for post-translational modifying enzymes that target chromatin (Carey et al., 2014; 
Sperber et al., 2015). 
The variation among developmental gene expression and range of differentiation 
potentials exhibited by different PSC lines and their embryonic correlates in vivo 
(Beddington and Robertson, 1989; Gardner et al., 1985; Huang et al., 2012) are currently 
observed and modeled as pluripotency comprising multiple discrete phases rather than a 
unitary state (Ghimire et al., 2018; Yachie-Kinoshita et al., 2018). Developmental 
progression through pluripotency may be conditionally paused or reversed by modulating 
activities of protein kinases through cytokines, growth factors and selective inhibitors 
(Morgani et al., 2017; Weinberger et al., 2016). Alterations to mitochondrial dynamics or 
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the metabolites produced and/or consumed by mitochondria appear to regulate these 
pluripotent state transitions (Bahat et al., 2018; Tischler et al., 2019). Present findings 
support the notion that pluripotency progression is conserved in placental mammals 
(Bernardo et al., 2018). However, identifying the species-specific requirements for 
culture, molecular and functional attributes remains an ongoing challenge (Roberts et al., 
2016). 
1.2 Mammalian Development and Embryo-derived 
Pluripotent Stem Cells 
1.2.1 Overview of Early Mammalian Development 
Embryonic development begins with the fertilization of the oocyte and later continues as 
fetal development during gestation. Progression through mammalian embryonic 
development is best understood in murine embryogenesis, where lineage-tracing and 
transplantation studies have resolved the spatiotemporal variations of embryonic cell 
potency (Lokken and Ralston, 2016). Fertilization of the oocyte initiates a series of fixed 
mitotic divisions (i.e. cleavage) followed by a gradual strengthening of basolateral cell-
cell interactions resulting in compaction of blastomeres (White et al., 2016). Successful 
completion of cleavage is dependent on activation of zygotic transcriptional programs by 
maternal factors that decondense chromatin and erase much of the epigenetic 
modifications to the genome (Evsikov et al., 2006; Svoboda et al., 2015). The zygote and 
blastomeres of two-to-eight cell murine embryos are generally considered totipotent with 
the capacity to contribute to either embryonic or extra-embryonic lineages and develop 
into viable offspring under appropriate conditions (Cockburn and Rossant, 2010). 
Totipotency is lost in the sixteen-cell embryo, known as the morulae, as the apical-basal 
polarity established by compaction initiates positional and mechanical cues essential to 
the first lineage specification event (Leung et al., 2016; Suwińska et al., 2008; Tarkowski 
et al., 2010).  
The innermost cells of morulae embryos give rise apolar cluster of pluripotent cells called 
the inner cell mass (ICM) enveloped by an epithelial layer known as trophectoderm (TE) 
(Rossant, 1987). The TE contains only the multipotent cells that derive placental tissues 
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for implantation, whereas the ICM will give rise to all embryonic tissues including some 
extraembryonic membranes (Rossant, 1987). Cell restriction to either lineage is mediated 
by signaling pathways and gene regulatory mechanisms that reinforce differential 
expression of transcription factors (TFs) associated with TE identity (e.g. CDX2, 
EOMES) versus ICM identity (e.g. POU5F1/OCT4, SOX2 and NANOG) (Strumpf et al., 
2005; Wicklow et al., 2014). Formation of a fluid-filled space (i.e. blastocoele) after 
ICM-TE lineage segregation is an indication successful progression to the early 
blastocyst stage (Madan et al., 2007).  
ICM proliferation and enhanced integrin-mediated interactions with the extracellular 
matrix (ECM) are associated with a second differentiation event that generates the early 
epiblast and primitive endoderm (Copp, 1978; Sakai et al., 2003). The early epiblast 
retains the pluripotent cell population, but transitions from spherical morphology to a 
radially symmetric monolayer (Beddington and Robertson, 1999). Epiblast 
morphogenesis creates a cylinder-like shape in rodents, as opposed to the disc-like 
morphology adopted by the primate epiblast (Bedzhov and Zernicka-Goetz, 2014). It is 
believed that probabilistic variation in fibroblast growth factor (FGF) ligand and receptor 
expression among ICM cells randomly restricts either NANOG or GATA6 to the epiblast 
or primitive endoderm (PE), respectively (Guo et al., 2010; Kang et al., 2017). Cells 
differentiating into PE upregulate several TFs (e.g. GATA4, SOX17), migrate towards 
the blastocoele-facing surface of the early epiblast and give rise to the extraembryonic 
endoderm portions of the yolk sac (Chazaud and Yamanaka, 2016; Gardner and Rossant, 
1979).  
At gastrulation, a subpopulation of the epiblast undergoes epithelial-to-mesenchymal 
transition (EMT), resulting in a loss of epithelial adhesive junctions and increased cell 
motility (Shook and Keller, 2003; Thiery et al., 2009). Migration of epiblast cells 
undergoing EMT through a dorsal structure known as the primitive streak establishes the 
definitive mesoderm (Ciruna and Rossant, 2001; Sun and Stathopoulos, 2018). Whereas 
the cells within the anterior third of the primitive streak form definitive endoderm (Ang et 
al., 1993). Continued cellular migration elongates the whole embryo and rearranges the 
late epiblast into an asymmetric structure known as the anterior to posterior epiblast 
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(Brennan et al., 2001; Lawson et al., 1991). Late epiblast cells continue to proliferate and 
expand, becoming spatially restricted, yet remaining pluripotent until the onset of 
somitogenesis (DeVeale et al., 2013; Osorno et al., 2012). Epiblast-derived primordial 
germ cells (PGCs) are induced during gastrulation and actively migrate to genital ridge 
via the posterior endoderm (Ginsburg et al., 1990). PGCs represent a form of unipotent 
stem cell in vivo which do not continue specification into gametes until gonad 
development (Ginsburg et al., 1990). Migrating PGCs undergo programmed epigenetic 
erasure and may be isolated and expanded in vitro with defined extracellular factors as 
pluripotent embryonic germ cells (Resnick et al., 1992; Stewart et al., 1994). Marked 
differences in the timing of transcriptional events, the wiring of regulatory circuits, and 
epiblast morphogenesis are observed when embryonic development of the mouse is 
compared to other mammals (Rossant and Tam, 2017). However, the functional 
relevance of these evolutionarily divergent features to the establishment or resolution of 
embryonic pluripotency remains less clear. 
1.2.2 Mouse Pluripotent Stem Cells from Peri-implantation 
Embryos 
Although pluripotent cells exist only transiently in vivo, it is possible to research stem 
cell lines that are paused in a stable pluripotent identity within a defined milieu. 
Pluripotent stem cells (PSCs) maintain the ability to differentiate into the all somatic and 
germline cell types of the ectoderm, mesoderm and endoderm (Doetschman et al., 1985; 
Leahy et al., 1999). In contrast to pluripotent cells within early embryos, PSCs in culture 
acquire the distinct ability to undergo prolonged self-renewal (Evans and Kaufman, 1981; 
Thomson et al., 1998). The precise molecular alterations that conditionally adapt 
embryonic cells to an ex vivo environment remain unclear (Buehr et al., 2003). Mouse 
embryonic stem cells (mESCs) are routinely established from the epiblast outgrowths of 
preimplantation embryos explanted on a mouse embryonic fibroblast (MEF) layer (Brook 
and Gardner, 1997; Evans and Kaufman, 1981; Martin, 1981). When embryos retrieved 
at an earlier developmental time point, embryos progress to the blastocyst stage under 
derivation conditions before mESCs arise (Boroviak et al., 2014).  
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Among the supportive factors secreted by MEFs or present in serum, leukemia inhibitory 
factor (LIF) was identified as the component with anti-differentiation activity (Smith et 
al., 1988). Exogenous LIF preparations have enabled the feeder-free propagation of 
mESCs (Makino et al., 2004). Supplementation with LIF promotes mESC self-renewal 
and expression of pluripotency-associated TFs through the LIF receptor-gp130 complex 
and activation of Janus kinase (JAK)-signal transducer and activator of transcription 3 
(STAT3) signaling (Matsuda et al., 1999; Niwa et al., 1998). LIF-STAT3 signaling can 
synergize with the bone morphogenetic protein 4 (BMP4)-SMAD1 signaling to support 
the maintenance of undifferentiated mESC (Ying et al., 2003a). The observation that 
BMP4 bioactivity is partly mediated by repression of mitogen-activated protein kinase 
(MAPK) pathways was followed by the identification of two kinase inhibitors (2i) that 
negate pro-differentiation stimuli in mESCs and established a minimal input so-called 
ground state of pluripotency (Qi et al., 2004; Ying et al., 2008).  
Cell lines equivalent to mESC cannot be derived from the murine post-implantation 
epiblast in serum and LIF (S/L) conditions. However, culture with Activin A and FGF2 
(A/F) mimics the signaling within the peri-gastrulation niche and enables the 
establishment of cell lines known as mouse epiblast stem cells (mEpiSC) (Brons et al., 
2007; Tesar et al., 2007). mEpiSC meet the self-renewal and tri-lineage differentiation 
criteria of a PSC population (Brons et al., 2007; Tesar et al., 2007). In contrast to mESC, 
mEpiSC cannot autonomously produce the ECM components needed to maintain their 
undifferentiated state, and therefore are propagated on a layer of MEFs or synthetic ECM 
(Hunt et al., 2012; Veluscek et al., 2016). Activin A supports mEpiSC pluripotency via 
SMAD2/3 transactivation of NANOG expression, which operates in a negative feedback 
loop to repress SMAD2/3. In this delicately balanced mechanism, Activin A signaling 
opposes neuroectoderm differentiation by maintaining NANOG, while NANOG prevents 
mesendoderm cell fate by limiting the transcriptional activity of SMAD2/3 (Vallier et al., 
2009). FGF2-MAPK kinase (MEK) signaling does not appear to directly promote 
pluripotency-associated TFs, but rather dually suppresses regulators of neuroectoderm 
fate and krüppel-like factor 2 (KLF2) (Greber et al., 2010). 
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1.2.3 Naïve and Primed Pluripotent States 
Given that pluripotent cells can be isolated from different compartments of developing 
embryos with different requirements for self-renewal, it was proposed that mESC and 
mEpiSC represent different temporal iterations of pluripotency in vitro (Tesar et al., 
2007). Importantly, the divergent features of mESC and mEpiSC were not explained by 
the mouse strain of origin (Brons et al., 2007). The observation that mEpiSC exhibit 
transcriptional signatures and signaling requirements similar to human ESC (hESC) 
suggests that PSC subtypes are conserved in mammals (Rossant, 2008; Tesar et al., 
2007). A combination of evolutionary variation among pluripotency regulatory 
mechanisms and developmental maturity of human blastocysts donated from fertility 
clinics to derive conventional hESCs, likely contribute to their homology to mEpiSCs 
(Hanna et al., 2010, 2009a). The generic terminology naïve or primed pluripotent state 
were adopted to describe the pan-mammalian existence of two discrete phases of 
pluripotency exemplified by mESC (S/L and 2i conditions) or mEpiSC and hESC, 
respectively (Nichols and Smith, 2009).  
Primed and naïve PSC exhibit similar ultrastructural features including a large nucleus, 
scant cytoplasm, perinuclear mitochondria and intercellular junctional complexes (i.e. 
desmosomes) (Baharvand and Matthaei, 2003; Sathananthan et al., 2002). A notable 
exception is the mitochondria of mESC are oval in shape, whereas tubular mitochondria 
are observed in mEpiSC and hESC (Zhou et al., 2012). Obvious differences exist in the 
morphological appearance of multicellular colonies formed by naïve or primed PSC. 
mESCs proliferate in multi-layer, hemispherical colonies of compacted cells which are 
difficult to distinguish by light microscopy (Baharvand and Matthaei, 2003). In contrast, 
mEpiSC/hESC form planar, disc-shaped colonies with compacted interior cells with a 
“cobblestone” appearance, surrounded by distended columnar cells at the margins 
(Sathananthan et al., 2002). The colony-forming ability (i.e. clonogenicity) of PSC is 
influenced by the pluripotent state, which impacts culture protocols and the efficiency of 
cell selection. mESC are routinely passaged by enzymatic dissociation into single cells. 
However, primed PSC are intrinsically hypersensitive to apoptotic stimuli and 
mechanical fragmentation often improves viability and self-renewal of mEpiSC or hESC 
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(Hartung et al., 2010; Pernaute et al., 2014). Clonogenicity of hESC can be improved 
with Rho-associated kinase (ROCK) inhibition or epithelial-type cadherin (CDH1) 
overexpression, suggesting that cytoskeletal and cell adhesion dynamics regulate PSC 
clonality (L. Li et al., 2010; Watanabe et al., 2007).  
Mouse naïve or primed PSC contribute to chimeric embryos within a defined range of 
development following orthotopic transplantation, suggesting that intrinsic properties to 
either pluripotent state influences differentiation capabilities in vivo. Whereas mESCs 
readily differentiate to somatic tissues and the germ line upon reintroduction into the 
preimplantation blastocyst, mEpiSC do not contribute to the embryo proper at this 
developmental time point (Bradley et al., 1984; Guo et al., 2009; Tesar et al., 2007). 
Identification of the variables that influence cellular competence for embryonic 
integration have greatly improved the efficiency and reproducibility of chimeric embryo 
generation including matched developmental timing, reducing competition with host cells 
or dampening cell responsiveness to pro-apoptotic stimuli (Masaki and Nakauchi, 2017; 
Wu et al., 2016). The in vivo pluripotency of mEpiSC was demonstrated by functional 
engraftment into the anterior-mid primitive streak of post-implantation host embryos 
(Huang et al., 2012; Kojima et al., 2014; Tsakiridis et al., 2014). The use of chimeric 
blastocyst functional assays to unambiguously dichotomize PSC as naïve or primed, 
generally excludes primate PSC lines in many jurisdictions for technical, legal and ethical 
reasons (Streiffer, 2007). However, the conceptual barriers to interspecies embryonic 
chimerism are receding with improved cell fate-mapping, developmental stage-matching 
and a softening international stance on procedures which include early termination 
policies (Mascetti and Pedersen, 2016; Wu et al., 2016). The development of teratomas 
upon PSC engraftment into somatic tissues of immune-deficient mice is a shared feature 
among mESC, mEpiSC or hESC (Brons et al., 2007; Reubinoff et al., 2000; Tesar et al., 
2007). Therefore, teratoma formation assays are not useful in discriminating between 
naïve or primed PSC.   
Collections of molecular genome annotations and transcriptional output associated with 
those regions have generated integrated global signatures of any given cell type 
(Roadmap Epigenomics Consortium et al., 2015). Transcriptional profiling studies 
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indicate that mESC transcriptomes resemble the ICM or preimplantation epiblast, 
depending on the culture conditions (Boroviak et al., 2014; Martin Gonzalez et al., 2016; 
Tang et al., 2010). Debate and imprecision with regards to the precise developmental 
correlate of mESC likely stem from variables that influence the transcriptome such as the 
inclusion of serum, application of 2i, use of MEF feeders or different substratum 
(Kolodziejczyk et al., 2015; Marks et al., 2012). Conversely, mEpiSC exhibit 
transcriptomic features of primitive streak cells found within gastrulating embryos rather 
than the post-implantation epiblast from which they are derived (Kojima et al., 2014; 
Tsakiridis et al., 2014). Therefore, mESC and mEpiSC exhibit both molecular and 
functional equivalence to temporally distinct stages of embryonic development (Morgani 
et al., 2017). Both pluripotent states represent generalizable phenotypes among PSC 
derived from mice, humans and likely other mammals (Theunissen et al., 2016; 
Weinberger et al., 2016). Recently, ectopic stabilization of naïve pluripotency in 
developing mouse and human embryos was shown to disrupt amniotic cavity formation, 
thereby demonstrating a conserved physiological relevance of pluripotent state 
progression in tissue morphogenesis (Shahbazi et al., 2017). 
1.2.4 Generation of Transient Embryonic States in vitro 
Cells resembling mEpiSC can be generated from mESC in A/F conditions, but this 
appears to be a prolonged and inefficient transition that features a strong negative 
selection (Turco et al., 2012). This suggests that the naïve-to-primed pluripotent state 
transition is not a single-step, but rather a dynamical process that is poorly recapitulated 
in vitro (Kalkan and Smith, 2014). Access and characterization of this embryonic stage 
has not been possible due to the methodological difficulty of isolating these transient 
cells in mouse preimplantation development (Bedzhov et al., 2014). These mouse 
epiblast-like cells (mEpiLC) can generate PGCs in response to BMP4, recapitulating the 
developmental potential exhibited by a subpopulation of the native epiblast in vivo 
(Hayashi et al., 2011; Lawson et al., 1999). If an intermediate PSC population were to be 
purified, a theoretical “formative” pluripotent state is proposed to relinquish aspects of 
naïve pluripotency before upregulating gastrulation-stage lineage markers observed in the 
primed pluripotent state (Smith, 2017). Because mEpiLC are a heterogeneous mixture, 
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moderate expression levels of both naïve and primed pluripotency markers are not 
considered to be strong evidence of formative pluripotency. 
1.3 Characteristics of Mammalian Pluripotent Stem Cells 
1.3.1 Techniques to Study Self-Renewal and Differentiation 
The clonogenicity, self-renewal, broad differentiation abilities of PSC lines make feasible 
large-scale functional genomics and high-throughput screening approaches, compared to 
embryo models where limitations cell numbers and embryo availability exist (Boiani and 
Schöler, 2005; Desbordes and Studer, 2013). Despite the existence of cell culture-related 
artifacts, both naïve and primed PSC are viewed as complementary in vitro systems to 
animal models of preimplantation development to dissect the molecular basis of 
pluripotency and lineage specification (Niwa, 2010). PSCs are typically studied under 
self-renewing conditions in vitro (i.e. steady-state) and static comparisons may be made 
to an independent culture of differentiated PSC progeny (Reubinoff et al., 2000). When 
higher temporal resolution is desirable, reporter genes (e.g. fluorescent proteins) are 
introduced under the genetic control of either pluripotency or differentiation affiliated 
regulatory elements to dynamically track changes in gene expression (Gossler et al., 
1989).  
In the absence of essential self-renewal factors (i.e. S/L or 2i for mESC, A/F for 
mEpiSC/hESC), PSCs will spontaneously differentiate into an assortment of stem or 
progenitor cell types from the ectoderm, mesoderm and endoderm lineages (Spencer et 
al., 2011). Spontaneous differentiation of PSC in low adherence conditions yields 
spherical aggregates of committed progeny (i.e. embryoid bodies), which crudely mimics 
postimplantation development to achieve an even distribution of the primary embryonic 
lineages compared to adherent culture (Doetschman et al., 1985; Martin and Evans, 
1975). A basic understanding of the soluble or matrix-dependent signals for lineage 
specification, permits the use of selective differentiation protocols, which can be 
advantageous for PSC lines with skewed lineage bias (Murry and Keller, 2008). Stepwise 
application of specific differentiation stimuli to differentiating PSC over multiple weeks 
can guide the maturation of cell types formed later in gestation (Ying et al., 2003b). 
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1.3.2 Gene Regulatory Networks in Pluripotency 
Gene regulatory networks (GRNs) are critical for the integrity of pluripotent states and 
for stable commitment to a given lineage upon differentiation. The architecture of GRNs 
include few “master” TFs, many “collaborating” TFs, regulatory non-coding RNA and 
chromatin modifying enzymes, which act in auto- and cross-regulatory circuits to exert 
combinatorial control on cis-regulatory modules (CRMs) of target genes (Hackett et al., 
2014; Peter and Davidson, 2016). GRNs frequently act upstream of pluripotency and 
lineage related genes such that cell fate decisions are executed only when pre-existing 
cell state and differentiation stimulus is appropriate (Martín et al., 2016). The 
transcription factors OCT4, SOX2 and NANOG (O-S-N) are central to naïve mouse 
pluripotency GRNs both in vivo and in vitro (Mitsui et al., 2003; Nichols et al., 1998). 
Strong imbalances in O-S-N expression leads to extraembryonic or germ lineage 
differentiation, rather than reinforcing a stable pluripotent state (Niwa et al., 2000; 
Thomson et al., 2011). However, minute fluctuations in the core GRN factors are 
effectively buffered by dense regulatory interconnectivity and redundant CRM 
occupancy with collaborating TFs (MacArthur et al., 2009). Under steady-state 
conditions the pluripotency GRN collectively antagonizes lineage-specific GRNs, while 
simultaneously remaining sensitive to differentiation cues (Jaenisch and Young, 2008). In 
this model, variations in pluripotency GRN membership (i.e. TFs expressed) and 
wiring/topology (i.e. available CRMs in genome) would account for the different 
properties of spatiotemporal or evolutionary iterations of PSCs (Li and Belmonte, 2017).   
Input from several developmentally regulated signaling pathways can be finely tuned to 
either support or destabilize the pluripotency GRN. In many cases, small molecule 
inhibition of protein kinases or knockdown of epigenetic modifiers are titrated to levels 
of partial antagonism or depletion (Cheloufi et al., 2015; Mor et al., 2018). Dual 
inhibition of glycogen synthase kinase 3β (GSK3β) and MEK in the 2i condition 
synergistically reinforces the naïve pluripotency GRN in mice (Ying et al., 2008). 
Stimulation of WNT signaling induces nuclear localization of β-catenin, which de-
represses OCT4-SOX2 targeted genes (Cole et al., 2008; Qiu et al., 2015; Wray et al., 
2011). Partial blockade of FGF–ERK signaling elevates KLF2/4 and NANOG 
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accumulation by transcriptional and post-translational mechanisms (Kim et al., 2014; Yeo 
et al., 2014). Beyond the direct impact on NANOG and KLF2, several collaborating TFs 
associated with naïve pluripotency are reinforced by 2i such as TBX3, ZFP42/REX1, 
GBX2 or ESRRB (De Los Angeles et al., 2015). By these mechanisms, the 2i condition 
is proposed to reduce spontaneous differentiation and increase mESC derivation 
efficiency from refractory strains by optimally stabilizing the naïve pluripotency GRN 
(Hanna et al., 2009a; Wray et al., 2011).  
Whereas hESCs also exhibit an O-S-N centric GRN, mEpiSCs operate with Zic family 
member 2 (ZIC2) and orthodenticle homeobox 2 (OTX2) in place of NANOG (Boyer et 
al., 2005; Iwafuchi-Doi et al., 2012; Matsuda et al., 2017). NANOG is required for 
acquisition of naïve pluripotency during ICM development in vivo but is dispensable for 
transactivation of target pluripotency genes and overall mESC maintenance (Chambers et 
al., 2007; Silva and Smith, 2008). Several collaborative TFs associated with naïve 
pluripotency are direct targets of NANOG and downregulated in mEpiSCs (Festuccia et 
al., 2012; Osorno and Chambers, 2011). Therefore, primed PSC appear to possess a less 
densely interconnected GRN owing to fewer collaborating TFs that directly support the 
undifferentiated state (Iwafuchi-Doi et al., 2012). Rather, hESC/mEpiSCs exhibit 
sporadic expression of early lineage specification genes from each germ layer including 
FGF5, SOX17 and brachyury (T/BRA) (Tsakiridis et al., 2014). The combination of 
variably co-expressed lineage-specific genes and a less insulated GRN may explain the 
considerable heterogeneity and propensity for spontaneous differentiation in the primed 
pluripotent state (Ghimire et al., 2018; Hough et al., 2009). 
1.3.3 Transcriptional and Epigenetic Crosstalk at 
Developmentally-Regulated Genes  
The basic unit of genomic DNA (gDNA) organization is the nucleosome, an octamer of 
histone proteins each surrounded by roughly 147 bp of the gDNA string (Kaplan et al., 
2009). CRMs contained within nucleosomal gDNA are generally inaccessible to TFs and 
RNA polymerase (Lee et al., 2004; Lorch et al., 1987). The active (i.e. euchromatin) and 
inactive (i.e. heterochromatin) portions of the genome are physically segregated through 
interactions with architectural chromatin proteins to presumably facilitate chromosomal 
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interactions pertinent to cell identity (Novo and Rugg-Gunn, 2016). Euchromatin 
domains are enriched for interactions with the transcriptional coactivators, whereas 
heterochromatin is associated with laminin B that tethers transcriptionally inert regions to 
the inner nuclear membrane (Handoko et al., 2011). TFs, RNA polymerase and 
architectural proteins compete with histones for occupancy of CRMs in order liberate 
segments of gDNA from the nucleosome (Gilchrist et al., 2010; Krebs et al., 2017). 
Epigenetic modifications affecting local chromatin accessibility regulate the influence of 
pluripotency or lineage GRNs by modulating the ability of TFs to physically engage with 
target CRMs (John et al., 2011; Mao et al., 2011).  
Targeted and reversible covalent modifications on gDNA or histones control the 
accessibility of a given CRM by changing the steric properties of the chromatin interface 
and alter the affinity of DNA or chromatin binding proteins (Keshet et al., 1986; Yin et 
al., 2017). DNA methylation involves transfer of a methyl group to the 5-position of 
cytosine base (5-mC), which occurs predominantly in the context of cytosine-phosphate-
guanine (CpG) dinucleotides (Gruenbaum et al., 1982). Whereas, histone proteins can 
undergo a variety of post-translational modifications (PTM) at the histone tail domain 
that protrudes from the nucleosome (Jenuwein and Allis, 2001). Specific histone tail 
modifications may be either correlated or anti-correlated with overlapping DNA 
methylation, implying extensive crosstalk between these enzyme families.  
The variety of distinct PTM and/or DNA methylation patterns introduces different levels 
of epigenetic resistance and non-uniform regulatory control over transcriptional activity 
dependent on the genomic context (Cedar and Bergman, 2009). Constitutive 
heterochromatin is marked by co-occurrence DNA methylation and histone H3 lysine 9 
di/tri-methylation (H3K9me2/3), which is believed to encourage chromatin compaction 
and a non-permissive transcriptionally state (Sarraf and Stancheva, 2004; Smallwood et 
al., 2007). Large repressive domains of constitutive heterochromatin are characteristic of 
repetitive sequences, mobile elements and subsets lineage-specific genes needed for 
stable differentiated cell fates (Becker et al., 2016; Saksouk et al., 2015). Conversely, 
facultative heterochromatin involves H3 lysine 27 trimethylation (H3K27me3) and the 
absence of DNA methylation, that promotes transcriptional repression yet maintains 
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accessibility to general transcriptional machinery (Dellino et al., 2004; Jermann et al., 
2014; Reddington et al., 2013). H3K27me3 offers a reversible mode of silencing for 
CRMs of lineage-associated genes that are dynamically expressed during development 
(Margueron and Reinberg, 2011; Trojer and Reinberg, 2007).  
Several mechanisms exist to grant certain TFs access to gDNA within a fully constituted 
nucleosome and initiate local epigenome remodeling. Certain TFs have affinity for partial 
binding sites in nucleosomal gDNA or histone proteins themselves, granting these TFs 
“pioneer activity” to engage previously inaccessible chromatin (Cirillo et al., 2002; 
Sekiya et al., 2009). Pioneer TFs can provide a platform for sequence-independent 
recruitment of histone modifying and/or chromatin remodeling enzymes, which can 
destabilize, reposition or remove histones to generate nucleosome depleted regions 
(Klemm et al., 2019). Transcriptionally active CRMs are associated with acetylation of 
histone H3 and H4 proteins, which is proposed to accumulate in regions with frequent 
nucleosome destabilization (Henikoff, 2008; Müller and Leutz, 2001). 
1.3.4 Hyperdynamic and Poised Features of the Pluripotent 
Regulatory Epigenome 
The nuclei of PSC contain smaller, more diffuse H3K9me3 domains that is suggestive of 
a lower prevalence of heterochromatin genome-wide, compared to lineage restricted cells 
(Ahmed et al., 2010; Fussner et al., 2011; Park et al., 2004). PSCs also exhibit 
hyperdynamic chromatin compared to committed progenitor cells, which is exemplified 
by rapid turnover of architectural chromatin proteins (Meshorer et al., 2006). As a likely 
consequence of a permissive chromatin state, PSCs are transcriptionally hyperactive and 
feature greater histone acetylation levels (Efroni et al., 2008; Meshorer et al., 2006). 
Chromatin plasticity in PSCs manifests as frequent non-specific chromosomal 
interactions and less prominent insulator boundaries (i.e. topologically associating 
domains) (De Wit et al., 2013; Pękowska et al., 2018). Differentiation of PSCs is 
associated with greater chromosomal interaction specificity and enhanced 
compartmentalization of the genome by chromatin architectural proteins (Melcer et al., 
2012; Pękowska et al., 2018).  
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One mechanism employed by PSCs to transcriptionally repress the euchromatic portions 
of the genome, while remaining poised for lineage specifying cues is the maintenance of 
bivalent chromatin (Azuara et al., 2006; Bernstein et al., 2006; Mikkelsen et al., 2007). 
Bivalent domains are characterized by the co-occurrence of H3K27me3 at H3K4me3-
marked promoters on different histone tail domains within the same nucleosome (Shema 
et al., 2016). Resolution of bivalent domains to single activating or silencing marks could 
be theoretically mediated by the selective recruitment of the appropriate lysine 
demethylase enzyme (Pasini et al., 2008). However, bivalent domain partitioning is 
representative of only a minority of developmentally-regulated promoters and epigenetic 
remodeling during differentiation occurs principally at distal CRMs bearing the enhancer-
associated H3 lysine 4 monomethylation (H3K4me1) mark (Hawkins et al., 2011). Distal 
CRMs marked solely by H3K4me1 are considered poised enhancers, which are 
discriminated from actively-used enhancers with H3K4me1 and acetylated histone H3 
(H3Ac) (Creyghton et al., 2010). Core pluripotency GRN TFs preferentially interact with 
poised enhancers, which is believed to maintain or bookmark a repertoire of distal CRMs 
available to be activated when a lineage if specified (Creyghton et al., 2010; Hawkins et 
al., 2011). 
1.3.5 Dynamic Heterogeneity and Epigenetic Barriers to 
Pluripotent State Transitions 
The permissive chromatin landscape of PSCs allows dynamic fluctuations between 
closely-related pluripotency GRNs and introduces variation among individual cells, 
known as dynamic heterogeneity (Rompolas et al., 2013; Singer et al., 2014). Initially, 
single-cell analyses demonstrated at least two molecularly and functionally distinct sub-
populations exist interchangeably among S/L mESCs (Hayashi et al., 2008). Promoting 
hyper-acetylation of nucleosomes can skew the sub-populations in dynamic equilibrium, 
therefore highlighting the contribution of epigenetic plasticity to this phenomenon 
(Hayashi et al., 2008). External input from the microenvironment, such as paracrine 
signals or exogenously supplemented molecules, stabilize different cell identities without 
differentiation so long that perturbations do not exceed the buffering capacity of 
pluripotency GRNs (Davey and Zandstra, 2006; Yachie-Kinoshita et al., 2018). The 
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notion that extrinsic signals dictate the predominant phenotype adopted among available 
cell identities is loosely referred to as metastability (Hanna et al., 2009a). Cell intrinsic 
sources of variation also contribute to dynamic heterogeneity of pluripotent cell 
populations both in vitro and in vivo such as transcriptional noise and cell cycle stage 
(Navarro et al., 2012; Singh et al., 2013).   
Changes in cell fate that follow a developmental progression are relatively efficient by 
making use of epigenomic plasticity and poised GRNs. In contrast, experimental 
manipulations that force the rejuvenation of a mature nuclear environment (i.e. nuclear 
reprogramming) must overcome epigenetic barriers established during development 
leading to inefficiency (Morgani et al., 2017; Weinberger et al., 2016). Switching the 
mESC media containing S/L to a composition with F/A will promote a naïve-to-primed 
transition and generate mEpiSCs (Guo et al., 2009; Onishi et al., 2012). Overexpression 
of NANOG in mESC resists naïve-to-primed transition despite prolonged exposure to 
F/A conditions (Osorno and Chambers, 2011). The mESC-to-mEpiSC conversion is 
dependent on FGF2-mediated induction of OTX2, which is co-expressed in low NANOG 
expressing cells among the originating S/L mESC population (Acampora et al., 2012). 
Naïve-to-primed transition involves the decommissioning of naïve-specific enhancers 
through gains in DNA methylation (Buecker et al., 2014; Factor et al., 2014).  
The reversion of mEpiSC to mESC is infrequent yet reproducibly observed when F/A 
conditions are replaced with S/L media (Bao et al., 2009). Forced expression of NANOG, 
KLF2/4, ESRRB or STAT3 can induce nuclear reprogramming of mEpiSC to reset 
mESCs when F/A is replaced with S/L (Guo et al., 2009; Hall et al., 2009; Silva et al., 
2009; Yang et al., 2010). mEpiSC are also considered to be in dynamic equilibrium with 
sub-states exhibiting low levels of naïve pluripotency TF expression (Han et al., 2010). 
The mEpiSC subpopulation that is poised to transition towards naïve pluripotency can 
spontaneously transition to the mESC phenotype with greater (~15-fold) efficiency (Han 
et al., 2010). The addition of 2i to either growth factor or transgene mediated 
reprogramming of mEpiSC to mESC promotes NANOG expression and reactivation of 
naïve pluripotency-specific enhancers (Adachi et al., 2018). Reset mESC exhibit 
transcriptomic, epigenomic and morphological similarity to steady state mESC as well as 
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competency to repopulate the germline in chimeras (Bao et al., 2009; Lai and Bu, 2016; 
Zhang et al., 2016b). These outcomes suggest that a subset of mEpiSCs are poised to 
adopt a naïve pluripotency GRN and overcome the epigenetic barriers established during 
lineage priming in a LIF/STAT3 signaling environment, which can be augmented by 
reintroduction of naïve pluripotency TFs (Fig. 1-1).   
Global comparisons of DNA methylation show that S/L mESC have a less methylated 
genome compared to mEpiSC (Habibi et al., 2013; von Meyenn et al., 2016). Moreover, 
2i mESC display even greater DNA hypomethylation, in part by repression of DNA 
methyltransferase expression (DNMT) (Hackett et al., 2013; Leitch et al., 2013; Yagi et 
al., 2017). Additionally, mEpiSCs show more frequent facultative heterochromatin 
indicated by greater numbers of H3K27me3 domains, whereas gains in H3K9me3 
heterochromatin are disputed as cell culture artifacts (Joshi et al., 2015; Marks et al., 
2012). Genetically female mEpiSCs exhibit inactivation of one X-chromosome, a form of 
dosage compensation that occurs late in embryogenesis, that is mediated by the non-
coding RNA Xist and H3K27me3 deposition (Augui et al., 2011; Plath et al., 2003). 
Erasure of genome-wide DNA methylation and reactivation of the silent X-chromosome 
are both reproducible features of steady state and reset mESC (Bao et al., 2009; Guo et 
al., 2009). DNA methylation exhibits a strong correspondence with restricted 
developmental potential and is associated with stronger interactions between histones and 
nucleosomal DNA (Choy et al., 2010; Smith and Meissner, 2013). Accordingly, the 
chromatin of primed PSC is comparatively less hyperdynamic than naïve mESCs but 
remain more plastic than differentiated cells (Pękowska et al., 2018). In addition to 
nuclear determinants of pluripotency, nutrient-sensing and mitochondrial crosstalk 
pathways are emerging as coordinators self-renewal and cell fate decisions in embryos 
and PSCs.     
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1.4 Metabolism in Pluripotent Stem Cells 
1.4.1 Overview of Cell Metabolism 
Metabolism broadly describes the collection of enzyme-catalyzed reactions organized 
parallel and sequential pathways that provide molecular energy, substrates or cofactors 
necessary for cell viability, division and function. Eukaryotic cells produce chemical 
energy in the form of adenosine triphosphate (ATP) molecules through the breakdown of 
carbohydrates, amino acids and lipids (i.e. catabolism). The major ATP-producing 
pathways are segregated into oxygen-independent cytosolic reactions (glycolysis) and 
oxygen-dependent mitochondrial processes, known as oxidative phosphorylation 
(OXPHOS). However, most molecules are never completely consumed by bioenergetic 
pathways, and instead diverted at a variety of branch points to alternative metabolic 
pathways (i.e. shunts) that produce essential substrates for biosynthetic reactions (i.e. 
anabolism) (Folmes et al., 2011). Otherwise, metabolic intermediates with cofactor or co-
substrate functions can be made available to non-metabolic reactions through redirection 
to a different subcellular compartment such as the nucleus (DeBerardinis et al., 2008). 
The relative activity of glycolysis, mitochondrial metabolism and intermediary metabolic 
pathways depends on the functional demands of a cell type and the physicochemical 
composition of the extracellular environment (Gardner, 1998). Glycolysis involves a 
series of phosphorylation, isomerization and oxidoreduction (redox) reactions that 
converts glucose to pyruvate. Metabolite turnover through glycolysis reactions (i.e. flux) 
regulates the availability of glycolytic intermediates to alternative biosynthetic pathways 
such as the pentose phosphate pathway or the hexosamine biosynthetic pathway (Reitzer 
et al., 1980; Wellen et al., 2010). Glycolysis-derived pyruvate is shunted away from 
mitochondrial metabolism in a metabolic configuration known as aerobic glycolysis. 
Lactate dehydrogenase (LDH) is central to this mode of metabolism by regenerating 
electron acceptor NAD+ for the GAPDH enzyme, thereby sustaining glycolysis 
independent of OXPHOS (Brand and Hermfisse, 1997; Ochocki and Simon, 2013). 
Reduced electron transport chain (ETC) activity limits the efficiency of ATP synthesis by 
OXPHOS but offers a rapid source of anabolic substrates and decreases cell exposure to 
reactive oxygen species (ROS) produced by mitochondria (Lunt and Vander Heiden, 
20 
 
2011). Therefore, aerobic glycolysis may be selectively beneficial for cell types that 
rapidly proliferate or reside in hypoxic niches. 
1.4.2 Metabolic Regulation of Self-Renewal and Differentiation 
Mouse preimplantation embryos show elevated glucose consumption at the blastocyst 
stage, suggesting that pluripotent cells of the epiblast exhibit high glycolytic flux 
(Houghton et al., 1996; Leese and Barton, 2004). Indeed, mESCs display high glycolytic 
activity in self-renewing conditions but upregulate genes involved in mitochondrial 
biogenesis and OXPHOS upon differentiation into specialized lineages (Cho et al., 2006; 
Chung et al., 2007; Kondoh et al., 2007). The rapid pace of cell division set by glycolytic 
flux in PSC likely promotes self-renewal by desensitizing PSC to pro-differentiation 
stimuli. PSCs continuously transit through the cell cycle due to an abbreviated G1 
checkpoint, spending most of the cell cycle in S-phase where PSCs are refractory to 
developmental cues (Becker et al., 2006; Neganova et al., 2009; Pauklin and Vallier, 
2013). High glycolytic flux in mESC or hESC drives pentose phosphate pathway activity 
which is important to maintain the cytosolic NADPH pool and a reducing redox 
environment in vitro (Filosa et al., 2003; Zhang et al., 2016a). Manipulating the cellular 
redox state by the addition of pro-oxidative metabolites encourages germ layer 
differentiation from PSCs (Yanes et al., 2010). Endogenous levels of ROS appear to be 
regulated by multiple developmental stimuli and likely has signal transduction 
functionality to coordinate early lineage specification (Sharifpanah et al., 2008). The 
observation that OCT4 DNA-binding ability is negatively affected in oxidizing 
conditions suggests that the redox environment can induce functionally-relevant 
biochemical changes to pluripotency TFs (Marsboom et al., 2016).  
Both mESC and hESC possess structurally immature mitochondria compared to 
differentiated cells and express several isoenzymes limiting the availability of pyruvate to 
oxidative metabolic pathways in the mitochondria (Prigione and Adjaye, 2010; Varum et 
al., 2011, 2009; Zhang et al., 2011). Coupling of glycolysis to reactions within the 
mitochondria offers efficient ATP generation for energy-consuming processes in 
specialized cells. Inhibition of the ETC does not impair PSC self-renewal, suggesting that 
glycolysis alone is sufficient to meet energy demands (Varum et al., 2009). Mitochondria 
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also produces a variety of metabolites such as tricarboxylic acid (TCA) cycle 
intermediates, which may be used in anabolism or participate in non-metabolic processes 
(Nagaraj et al., 2017; Wellen et al., 2009) (Fig. 1-2A). Beyond conventionally recognized 
retrograde signals (e.g. ROS, ATP), fluctuations in nucleo-cytosolic levels of metabolites 
are sensed by chromatin modifying enzymes (Shi and Tu, 2015).  
Histone acetylation and chromatin remodeling in mammalian cells is regulated by the 
conversion of TCA intermediate citrate to acetyl-coenzyme A (CoA), the universal acetyl 
group donor, by the ATP citrate lyase enzyme (Wellen et al., 2009). Acetyl-CoA level is 
also dependent on the upstream provision of pyruvate by glycolysis. High glycolytic flux 
maintains histone acetylation and pluripotent gene expression signatures in naïve mESC, 
primed mEpiSC and hESC (Moussaieff et al., 2015). Depletion of cytosolic acetyl-CoA 
with mechanistically distinct pathway inhibitors promotes PSC differentiation, whereas 
acetate supplementation supports the undifferentiated state (Moussaieff et al., 2015). 
Similarly, histone and DNA methyltransferase enzymes primarily use the methyl donor 
S-adenosylmethionine (SAM), an intermediate of the one-carbon metabolism pathway 
(Finkelstein, 1990; Locasale, 2013). Physiological variations in threonine or methionine, 
the amino acids upstream of SAM synthesis in mice or humans respectively, have been 
shown to affect histone methylation patterns in mammalian cells (Mentch et al., 2015; 
Ulrey et al., 2005). Supplementation of threonine/methionine is necessary for the self-
renewal of both mESCs and hESCs, whereas depletion of these respective molecules 
selectively decreases the promoter-associated H3K4me3 modification and augments 
differentiation (Shiraki et al., 2014; Shyh-Chang et al., 2013). These observations shed 
light on an emerging metabolo-epigenetic axis and suggest that the variations in the 
metabolic state of PSCs contribute to differention into a variety of lineages and cell types 
(Fig 1-2B). 
1.4.3 Metabolic Reprogramming in Pluripotent State Transitions 
Redistribution and local dynamics of certain epigenetic modifications (e.g. DNA 
methylation, H3K27me3) are recognized to facilitate stable naïve-to-primed transitions 
without complete exit from the pluripotent state (Joshi et al., 2015; Tosolini et al., 2018). 
LIF-STAT3 signaling in mESC synergistically promotes mitochondrial respiration  
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Figure 1-2. Metabolic regulation of self-renewal and pluripotency. 
(A) Glucose uptake fuels the pentose cycle and provides subtrates for intermediary 
metabolism. Glutamine metabolism replenishes the tricarboxylic acid (TCA) cycle at the 
level of alpha-ketoglutarate (αKG). Metabolic intermediates are diverted to anabolic 
pathways such as lipid synthesis. (B) The relative balance of glycolytic and 
mitochondrial metabolism and the one carbon cycle (1C) are implicated in regulating 
epigenetic cofactors acetyl-coenzyme A (Ac-CoA) and s-adenosylmethionine (SAM) to 
facilitate epigenetic events during pluripotent state transitions. Implicated epigenome 
modifiers are histone acetyltransferase (HAT), histone methyltransferase (HMT) and 
ATP-dependent chromatin remodelers (BAF). 
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alongside accessory naïve GRN members such as ESRRB (Carbognin et al., 2016; Sone 
et al., 2017). As a result, naïve mESC maintain greater steady-state ATP levels than 
primed mEpiSC or hESC through glucose and lipid oxidation (Sperber et al., 2015). 
Interestingly, mESC are metabolically flexible and tolerate pharmacological blockade of 
glycolysis or ETC activity without loss of pluripotency (Vlaski-Lafarge et al., 2019). The 
functional relevance of emphasizing ATP generation by oxidative phosphorylation is still 
unclear. However, it has recently been proposed that efficient ATP generation is 
necessary to maintain ATP-dependent chromatin remodeling, histone acetyltransferase 
activity and hyperdynamic chromatin characteristic of the naïve pluripotent state (Zhang 
et al., 2018).   
Activation of SMAD2 signaling in F/A conditions used to maintain and derive primed 
mEpiSC or hESC suppresses the expression of cytochrome c oxidase subunits (Zhou et 
al., 2012). Hypoxia inducible factor 1α (HIF1α) is necessary for naïve-to-primed 
transition and reinforces the SMAD2-driven transcriptional program (Sperber et al., 
2015). Although primed PSC display a relative suppression of ETC activity and 
glycolytic bias, they exhibit mature tubular-shaped mitochondria compared to naïve PSC 
(Zhou et al., 2012). Primed PSC contain mitochondria with an active, albeit truncated 
TCA cycle that siphons and replaces different intermediate metabolites found in the 
mitochondrial matrix (Tohyama et al., 2016). These studies posit that a switch from a 
balanced glycolysis/OXPHOS metabolic state to a preferentially glycolytic mode is 
reinforced by the extrinsic signals and GRNs associated with each pluripotent state. The 
knowledge that cell metabolism can influence both specific TF activity and higher levels 
of genome organization, has informed culture media preparations to enhance 
reprogramming from a relatively constrained somatic nuclear environment. 
1.5 Induced Pluripotent Stem Cells 
1.5.1 Overview of Induced Pluripotent Stem Cell Generation 
Nuclear reprogramming of somatic cells directly to a pluripotent state with similar 
attributes to ESCs has been a widely adopted technique to study mechanisms in 
development, model a variety of diseases or establish a renewable cell source for 
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regenerative medicine (Robinton and Daley, 2012). The original induced pluripotent stem 
cell (iPSC) generation protocol involved the forced expression of exogenous TFs namely 
OCT4, KLF4, SOX2 and c-MYC (O-K-S-M) (Takahashi et al., 2007; Takahashi and 
Yamanaka, 2006). Ectopic expression of O-K-S-M can reprogram donor cells to either 
naïve or primed pluripotent state depending on the derivation environment (Han et al., 
2011). Nucleic acid constructs encoding O-K-S-M are typically delivered to cells by 
integrative DNA, non-integrative DNA or RNA-based systems (Hussein and Nagy, 
2012). Regardless of delivery method, O-K-S-M overabundance initiates widespread 
interactions between reprogramming factors with pioneer activity and somatic chromatin 
(Soufi et al., 2012). The selection of donor cell type affects the route to induced 
pluripotency, but most data are collected in dermal fibroblast to date (Nefzger et al., 
2017). In a fraction of the reprogramming cell population, O-K-S factors outcompete the 
somatic GRN to allow de novo silencing of lineage-related CRMs antagonizing 
pluripotency induction (Hanna et al., 2008; Shao et al., 2016). Transfactors recruit 
endogenous transcriptional coactivators to previously silent CRMs to facilitate local 
epigenetic remodeling and reactivation of the endogenous pluripotency GRN (Ho et al., 
2009; Singhal et al., 2010).  
Somatic cell reprogramming is associated with a stepwise progression of few cells 
through intermediate cell states, which is reflected in measurable changes in cell 
phenotype over a period of days to weeks (Polo et al., 2012; Stadtfeld et al., 2008). The 
fluctuant latency involved in putative iPSCs emergence is partially attributed to 
experimental variables such as O-K-S-M stoichiometry, cell cycle stage or the existence 
of privileged cell subpopulations within a heterogeneous culture (Carey et al., 2011; Chen 
et al., 2012; Guo et al., 2014). However, even when the aforementioned variables are 
controlled, successful reprogramming remains inefficient (<1%) due to the ordered, 
probabilistic mechanisms associated with overcoming somatic epigenetic constraints and 
acquiring pluripotency (David and Polo, 2014). Complicating the study of 
reprogramming intermediates is that many observed changes to bulk reprogramming cells 
are not specific to those undergoing successful reprogramming (i.e. productive trajectory) 
compared to bulk intermediates that adopt alternative cell fates (Koche et al., 2011). 
Many O-K-S-M expressing cells undergo alternative trajectories (e.g. senescence, 
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apoptosis) because reprogramming factor binding is largely non-specific and capable of 
inadvertently activating antagonistic processes that restrict the frequency of pluripotency 
acquisition (Lujan et al., 2015; Polo et al., 2012). 
1.5.2 Phase-Dependent Obstacles to Somatic Cell 
Reprogramming  
Two major reconfiguration events of the transcriptome and proteome occur during 
reprogramming, which broadly segment reprogramming into early, mid and late phases 
(Hansson et al., 2012; Polo et al., 2012; Samavarchi-Tehrani et al., 2010). The early 
phase (i.e. initiation) occurs within the first few days of reprogramming and is 
characterized by a loss of somatic identity, acquisition of glycolytic metabolism and a 
hyperproliferative state (Hansson et al., 2012; Mikkelsen et al., 2008; Polo et al., 2012). 
Changes to cell phenotype in early reprogramming are dependent on persistent O-K-S-M 
expression and reprogramming factor engagement with pre-existing accessible regions on 
somatic chromatin (Chen et al., 2016; Smith et al., 2010; Stadtfeld et al., 2008). Immune 
and DNA damage responses to ectopic TF expression are barriers to early reprogramming 
by inducing cell cycle arrest and apoptosis (González et al., 2013; Kawamura et al., 2009; 
Li et al., 2009). Experimental manipulations that promote cell evasion of apoptosis, 
increase proliferation or high glycolytic flux reproducibly facilitate early reprogramming 
progression (Folmes et al., 2011; Hanna et al., 2009b). Repression of somatic identity 
genes by reprogramming factors elicits a variable response dependent on the donor cell 
population but manifests as mesenchymal-to-epithelial transition (MET) in 
reprogramming dermal fibroblasts (R. Li et al., 2010; Samavarchi-Tehrani et al., 2010). 
The mid phase (i.e. maturation) occurs after the first week of reprogramming and 
involves gradual and probabilistic transactivation of a theoretical endogenous gene 
subset, called pluripotency-initiating or maturation factors (Chung et al., 2014). 
Expression of these early maturation markers is reversible, dependent on the exogenous 
transgenes and therefore does not guarantee complete reprogramming (Teshigawara et 
al., 2016). Maturation is characterized by a high rate of reprogramming failure, accounts 
for most of the latency in reprogramming and may be further subdivided at a single-cell 
resolution (Natarajan et al., 2017; Tanabe et al., 2013). Transcriptome analysis of 
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reprogramming intermediates showed the maturation phase exhibits the greatest 
transcriptional variability, likely due to a combination of clonal dominance of highly 
proliferative cells and activation of competing transcriptional responses (Kuno et al., 
2018; Tanabe et al., 2013). Chromatin modifying complexes with negative rheostatic 
functions such as polycomb repressive complex 2 (PRC2) and nucleosome remodeling 
deacetylase (NuRD) are implicated in the maturation phase (Khazaie et al., 2016; Rais et 
al., 2013). PRC2 and NuRD are necessary for de novo silencing of lineage-related genes 
during maturation but may be inadvertently recruited to critical pluripotency regions and 
oppose reactivation (Dos Santos et al., 2014; Pereira et al., 2010; Rais et al., 2013). 
Integrated analysis of reprogramming factor binding, and epigenetic modifications show 
a gradual enrichment of TF binding at previously silent pluripotency enhancers during 
iPSC maturation. Subsequent epigenetic remodeling at targeted pluripotency loci is 
followed by promoter reactivation and pluripotency gene expression, marking the 
transition to the final phase of reprogramming (Chen et al., 2016). 
The late phase (i.e. stabilization) occurs after two or three weeks and is characterized by 
transgene independent (through depletion or epigenetic silencing) self-renewal and stable 
expression of endogenous pluripotency GRN (David and Polo, 2014; Golipour et al., 
2012). Concurrently, a small set of pluripotency-associated genes appear to elicit 
deterministic completion of reprogramming by a coordinated and hierarchical 
transcriptional program (Buganim et al., 2012). The factors at the top of the deterministic 
hierarchy are considered refractory to O-K-S-M binding because they are spanned by 
large constitutive heterochromatin domains (Soufi and Zaret, 2013). Provided that 
stabilized iPSC intermediates are in a permissive signaling environment for pluripotency 
GRN maintenance, they will adopt transcriptional and epigenetic signatures as well as 
differentiation capabilities equivalent to ESC (Hanna et al., 2008; Wang et al., 2018; 
Wernig et al., 2007) (Fig. 3-1). 
1.5.3 Modifiers of DNA Methylation to Facilitate Reprogramming 
Reprogramming progress is constrained by repressive chromatin modifications at 
pluripotency-specific CRMs, and a lack thereof at lineage-associated CRMs (Chen et al., 
2013; Wang et al., 2011). Therefore, the extent of epigenetic remodeling that must occur  
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at both pluripotency and lineage-specific genes can play a role in the relative efficiency 
of reprogramming (i.e. colony yield) or reprogramming kinetics (i.e. time interval to 
iPSC establishment) (Chen et al., 2011). For instance, variations in reprogramming 
efficiency between somatic cell types shows a strong positive correspondence with the 
number shared hypermethylated CRMs for tissue-related genes that are shared with ESCs 
(Barrero et al., 2012). Furthermore, incomplete DNA methylation of lineage-related 
CRMs during reprogramming can propagate a transcriptional memory, which affects the 
differentiation potential of the resultant iPSC (Kim et al., 2011; Ohi et al., 2011). 
Understanding the network of proteins that evoke targeted remodeling of genome-wide 
methylation with desirable reprogramming outcomes are important to the development of 
experimental manipulations that improve reprogramming efficiency, kinetics and quality 
of iPSC lines. 
Genes related to pluripotency or the germline tend to be regulated by CpG-rich promoter 
and/or enhancer sequences, which are stably silenced in differentiated cells by DNA 
methylation (Li et al., 2007; Smith and Meissner, 2013). Transfer of the methyl group 
from the co-substrate SAM to CpG dinucleotides are catalyzed by the DNMT family of 
enzymes (Robertson and Jones, 2000). The DNMT1 enzyme, known as the maintenance 
methyltransferase, has a distinguishable preference for hemi-methylated CpG 
palindromes established by semi-conservative DNA replication (Sharif et al., 2007; 
Yoder et al., 1997). Small molecule inhibitors of DNMTs, such as the cytidine analogue 
5-azacytidine (5azaC), induce genome-wide demethylation largely by disrupting 
maintenance DNMT1 from re-establishing DNA methylation on the daughter strand 
leading to progressive dilution of methylated cytosine with each cell division (i.e. passive 
DNA demethylation) (Christman, 2002; Wu and Zhang, 2010). Non-specific DNMT 
inhibitors can modestly increase reprogramming efficiency, particularly when applied 
late in reprogramming such that lineage-related CRMs are appropriately silenced 
(Mikkelsen et al., 2008). 5azaC treatment has also been shown to promote the 
stabilization of partially reprogrammed cells (i.e. intermediates stuck in maturation 
phase) or erasing residual epigenomic memory (Bilic and Izpisua Belmonte, 2012; 
Mikkelsen et al., 2008). However, prolonged DNMT inhibition exposure is not desirable 
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due to elevated transposable element motility and loss of genomic imprints (Eden et al., 
2003; Walsh et al., 1998). 
The TET dioxygenase family of enzymes catalyze the iterative oxidation of 5-
methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC) and less stable derivatives 
5-formylcytosine and 5-carboxycytosine (Ito et al., 2011; Tahiliani et al., 2009). 
Subsequently, thymine DNA glycosylase (TDG) may excise of the oxidized derivatives 
and return the non-modified cytosine independent of cell replication (i.e. active 
demethylation) via the base-excision repair pathway. Therefore, TET catalyzes the rate-
limiting step in the most widely-accepted and biochemically validated mechanism of 
DNA demethylation in mammals (Inoue et al., 2011; Zhang et al., 2012). TET family 
members (TET1-3) exhibit partial functional redundancy with regards to genomic 
affinities but differ in protein-protein interaction partners and substrate preferences (Putiri 
et al., 2014; Xu et al., 2011; Zhang et al., 2010). TET enzymes have catalysis-
independent functions in protecting CpG-rich regions from de novo methylation, however 
these are poorly understood (Williams et al., 2011; Wu et al., 2011). Expression and 
activity of TET1 and TET2 are highly correlated with differential methylation, epigenetic 
remodeling and pluripotency factor expression (Di Stefano et al., 2014; Gao et al., 2013). 
The knockdown or deletion of either paralog negatively affects pluripotency TF binding 
and reprogramming success rates (Costa et al., 2013; Doege et al., 2012).  
Somatic fibroblasts and early reprogramming intermediates (days 3-6) have similar 
genome-wide DNA methylation levels (Schwarz et al., 2018). After the initiation phase, 
roughly 25% of 5mC-enriched regions and 10% of 5hmC-enriched regions are 
redistributed compared to the initial somatic environment (Sardina et al., 2018). Gains in 
5hmC negatively correlate with 5mC level dynamics, suggesting that active, rather than 
passive DNA demethylation occurs during early reprogramming (Sardina et al., 2018). 
The role of TET-mediated active DNA methylation is substantiated by the inability of 
TET triple knockout or thymidine DNA glycosylase knockout MEFs to reprogram (Hu et 
al., 2014). Hypomethylated CRMs are established in two distinct waves of demethylation 
during that correlate with the progression to maturation and stabilization phases (Schwarz 
et al., 2018). Reprogramming transfactors with pioneer activity can bind nucleosomal 
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DNA and recruit TET enzymes for active demethylation (Koche et al., 2011; Sardina et 
al., 2018; Soufi et al., 2015). After focal DNA demethylation, TET enzymes can recruit 
histone modifying enzymes (e.g. SET1-COMPASS, EP300) to gene regulatory regions to 
create a more permissive environment for pluripotency TF occupancy (Chen et al., 2016; 
Deplus et al., 2013; Wei et al., 2015). 
1.6 Pluripotent Stem Cells from Domesticated Large 
Mammals 
1.6.1 Livestock and Companion Animals in Regenerative Medicine 
The establishment of human ESCs and eventually iPSCs has spurred a new generation of 
cell-based therapies seeking to replace or repair human tissues (Tsuji et al., 2019). 
Dozens of therapeutically desirable cell types can be differentiated from human 
ESC/iPSC, each with specific cell maturation and purification strategies (Rodrigues et al., 
2015). Specialized cell types derived from human ESC/iPSC perform reasonably well in 
functional assays in vitro (Schwartzentruber et al., 2018). Xenotransplantation 
experiments have demonstrated proof-of-concept that therapeutic cells expanded and 
manipulated ex vivo are efficacious in a variety of rodent disease models (Nagamoto et 
al., 2016). First-in-human trials still pose considerable risk for volunteer participants 
because therapeutic cells derived from ESC/iPSC may elicit an immune reaction or 
harbor potentially tumorigenic cells (Heslop et al., 2015). Occasionally, mice carrying 
disease-relevant mutations do not recapitulate the pathogenic features observed in 
humans (Carvalho-Oliveira et al., 2007; Li and Li, 2012). PSCs derived from 
domesticated farm or companion animals would offer preclinical mammalian models of 
inherited or acquired disease to complement existing transgenic murine systems (Ezashi 
et al., 2015). Evidence from preclinical studies in mammals with greater longevity should 
affirm the safety, viability and functionality of ex vivo manufactured cell products for the 
anticipated duration of therapeutic efficacy in vivo (Trounson and DeWitt, 2016). 
Furthermore, the development of dosing and delivery procedures in domesticated 
mammals better emulates the organ size and immune system physiology encountered in 
human patients (Casal and Haskins, 2006; Harding et al., 2013). 
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In livestock species (e.g. porcine, bovine), embryological studies have yielded insights 
into evolutionarily conserved or divergent features of embryonic pluripotency (Liu et al., 
2014). Data from both in vivo or in vitro matured preimplantation embryos provide a 
comparative reference to scrutinize the specificity of orthologous pluripotency-related 
gene products (Bernardo et al., 2018). Consequently, PSCs derived from farm species 
have performed more consistently in teratoma assays and have generated a larger 
repertoire of functional differentiated cell types (Ezashi et al., 2015). In contrast, 
challenges facing the procurement and culture of embryos from companion and work 
animals (e.g. canine, equine) have deferred similar embryo characterization studies 
causing uncertainty regarding molecular signature of embryonic pluripotency in these 
species (Paris et al., 2010; Wilcox et al., 2009).  
Among companion animals, the domestic dog (Canis lupus familiaris) shares a variety of 
inherited diseases exhibiting complex genetic and environmental interactions including 
cancer, respiratory, endocrine, neurological and age-related disorders (Head et al., 2002; 
Schneider et al., 2008; Shearin and Ostrander, 2010). In this regard, exposure to common 
mutagenic agents throughout human-canine co-evolutionary history and high percentage 
(94%) of conserved ancestral DNA is proposed to favor analogous defects in gene 
products and similarity in disease presentation (Breen and Modiano, 2008). Given the 
high degree of genomic sequence similarity, the research community was initially 
optimistic that stem cells derived from dogs would be more representative of stem cell 
biology in humans than rodents (Tecirlioglu and Trounson, 2007). However, PSC from 
companion species do not maintain their pluripotency characteristics with prolonged 
culture (Roberts et al., 2016). The broad availability reprogramming vectors and well-
conserved ability of O-K-S-M factors to promote ESC-like state indicates that derivation 
of iPSC from large mammals is attainable. Regardless of source, PSC derivation in 
domestic mammals will be hindered by an incomplete understanding of species-
dependent variation in pluripotency GRN hierarchies and the unique signaling inputs 
needed to stabilize a self-sustaining pluripotent state. 
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1.6.2 Regulative Implications of Evolutionary Variation to 
Pluripotency 
Our knowledge of the signaling pathways and GRNs involved in steady-state 
pluripotency, pluripotent state transitions, acquired pluripotency and early lineage 
restriction is derived from rodents and primates (Boyer et al., 2005; Loh et al., 2006). 
Core pluripotency TFs are well conserved in vertebrates with respect to protein structure 
and role in developmental plasticity (Dixon et al., 2010; Morrison, 2006). Comparisons 
of gene expression and core pluripotency TF binding sites among mammals has revealed 
extensive rewiring of the regulatory interactions (Kunarso et al., 2010; Xie et al., 2010). 
Regulatory variation between mammals appears to be driven by single base-pair 
mutations that create and destroy individual TF binding sites, or the insertion of entire 
CRMs by mobile elements that constitute approximately 40% of mammalian genomes 
(Waterston et al., 2002; Xie et al., 2010). Only about 5% of OCT4 and NANOG binding 
events occur in homologous sequences between mouse and human ESCs, with the 
remaining species-specific regulatory elements harbored in transposable sequences 
(Kunarso et al., 2010). Pluripotency TF binding sites within transposable sequence are 
co-opted as distal CRMs (Feschotte, 2008) and targeted by DNMT or TET to control 
transcriptional output by differential DNA methylation (de la Rica et al., 2016; Muramoto 
et al., 2010). The introduction of new TFs or alterations to hierarchical relationships 
between existing TFs have driven divergence in orthologous gene expression patterns and 
contribute to species-specific phenotypes in development and pluripotency (Barakat et 
al., 2018; Glinsky, 2015; Kojima et al., 2017).  
CpG islands (CGIs) are regions of CpG dinucleotide overrepresentation spanning a 
region of 0.5-1 kilobase on average (Han and Zhao, 2009a). CGIs are hallmarks of 
regulatory elements that are silenced by DNA methylation and either situated adjacent to 
the 5’ end (i.e. promoter) of a subset of mammalian genes or at distal CRMs (i.e. 
enhancer) (Antequera et al., 1990; Bell and Vertino, 2017; Mendizabal and Yi, 2016). 
Interestingly, CGI density is the highest in the canine assembly among completely 
sequenced placental mammals (2-3 fold greater than mouse or human), despite no 
marked difference in overall guanine and cytosine prevalence (Han et al., 2008). The 
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dramatic increase in CGI density in dogs is thought to be a consequence of a bias in 
meiotic recombination, rather than mobile elements/repeats or differential rates of 
cytosine deamination (Han and Zhao, 2009b).  
Dogs and all ancestral canids sequenced to date carry a frameshift mutation in PR domain 
containing 9 (PRDM9) (Muñoz-Fuentes et al., 2011). PRDM9 is a H3K4 trimethylase 
that regulates the distribution of highly recombining regions during meiosis in mammals 
(Baudat et al., 2010). Mouse PRDM9 knockouts are infertile in both males and females 
(Oliver et al., 2009). It is proposed that meiotic recombination hotspots have remained 
the same in canines due to the loss of PRDM9, thereby increasing local CG content 
through GC-biased gene conversion (gBGC) (Axelsson et al., 2012). gBGC is a form of 
base substitution where AT/CG sites in heteroduplex DNA preferentially include the CG 
allele (Dreszer et al., 2007; Mugal et al., 2015). These features may have driven genome 
instability, chromosomal rearrangements, altered the local properties of distal CRMs and 
decreased the overall euchromatic portion of the dog genome throughout canid evolution 
(Auton et al., 2013; Berglund et al., 2015; Lindblad-Toh et al., 2005; Webber and 
Ponting, 2005). 
1.6.3 Canine Embryogenesis and Embryonic Stem Cells 
Embryogenesis in placental mammals is dependent on intricate intercellular 
communication mechanisms between the embryo proper and TE. Numerous differences 
exist between mammals during early embryogenesis, including divergent responses to 
trophic signals or pathway inhibitors (Kuijk et al., 2012; Roode et al., 2012), differences 
in the pattern of developmental gene expression (Petropoulos et al., 2015; Xie et al., 
2010), and timing and mechanistic variation in epigenetic events (e.g. X-chromosome 
inactivation, zygotic genome activation) (Okamoto et al., 2011). The peculiarities of 
canine embryonic development begin at ovulation, where the oocyte is released at the 
germinal vesicle stage. Meiosis resumes after 48-72 hours in the oviduct becoming 
competent for fertilization soon afterward (Reynaud et al., 2005). Zygotic genome 
activation is believed to occur at the eight-cell stage (Hyttel et al., 2010). Canine morulae 
and blastocysts can be found in the uterine horn starting 8-10 days after ovulation (Bysted 
et al., 2001). Gastrulation and uterine attachment occur around 15-16 days after a period 
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of free-floating embryo migration (Renton et al., 1991; Reynaud et al., 2006). Canine 
blastocysts exhibit positive immunostaining for OCT4 within the ICM, but the existence 
of naïve or primed pluripotency signatures has not been investigated in the embryo 
(Wilcox et al., 2009).  
Canines have a comparatively short gestation compared to similarly-sized mammals 
(Pretzer, 2008) and differ from rodents and primates by their placental architecture. 
Primate or rodent embryos invade the uterine epithelium, remaining completely encircled 
by TE and directly eroding maternal vasculature (i.e. discoid hemochorial placenta) 
(Carter and Enders, 2004). Whereas canine embryo implantation is distinguishable by the 
proliferation and invasion of only the middle third of trophoblast forming a single banded 
point of attachment which approximates but does not dissolve the maternal endothelial 
barrier (i.e. zonary endotheliochorial placenta) (Carter and Enders, 2004). The differences 
in both the duration preimplantation embryo migration and fetal membrane organization 
may have yet unknown consequences on the nutritional environment and metabolism of 
any remaining pluripotent cells within canine peri-implantation embryos.  
Attempts to derive ESCs from canine blastocyst embryos have established heterogeneous 
cultures exhibiting some of the molecular hallmarks of PSCs from mice or humans. For 
instance, various cESC lines show reactivity to cell surface glycoprotein epitopes specific 
to mESC (Hatoya et al., 2006; Schneider et al., 2008) or hESC (Vaags et al., 2009; 
Wilcox et al., 2009). Loss of pluripotency marker expression and compact colony 
morphology upon LIF withdrawal, suggests that exogenous LIF is required for the self-
renewal of cESC (Vaags et al., 2009; Wilcox et al., 2009). The co-supplementation of 
LIF and FGF (L/F) appears to promote longer-term maintenance of cESCs (Vaags et al., 
2009; Wilcox et al., 2009). However, these canine ESCs (cESCs) cells tend to 
spontaneously differentiate and are tedious to maintain in prolonged culture despite 
intensive efforts (Gonçalves et al., 2014; Hayes et al., 2008). Only two groups attempted 
different derivation procedures from canine preimplantation embryos (Vaags et al., 2009; 
Wilcox et al., 2009), therefore the challenges facing long-term culture of cESCs could 
relate to the narrow subset of culture conditions investigated.  
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1.6.4 Canine Induced Pluripotent Stem Cells 
A variety of donor cell populations from the mesodermal lineage have been used to 
produce canine iPSC (ciPSC) including embryonic and adult fibroblast, mesenchymal 
cells from testes or adipose tissue. Integrating viral vectors (i.e. retrovirus, lentivirus) 
have been the predominant strategy to deliver human O-K-S-M orthologs, with some 
exceptions (Menon et al., 2019). Co-transduction of O-K-S-M with LIN28 and NANOG 
also supports ciPSC generation (Whitworth et al., 2012), as does the delivery of murine 
O-K-S-M orthologs (Gonçalves et al., 2017; Koh et al., 2013). Similar to cESCs, ciPSCs 
form heterogeneous cultures and exhibit inherent variability in pluripotency-associated 
marker expression, which cannot be resolved with fluorescence activated cell sorting 
(FACS) (Koh et al., 2013; Luo et al., 2011). Incomplete silencing and maintained 
expression of exogenous O-K-S-M factors is a persistent issue and likely contributes to 
the heterogeneous features of ciPSC (Koh et al., 2013; Luo et al., 2011).  
L/F conditions appear to be best suited for ciPSC derivation, but lines dependent solely 
on either LIF or FGF2 have been reported (Chow et al., 2017; Gonçalves et al., 2017; 
Koh et al., 2013; Luo et al., 2011; Nishimura et al., 2013; Whitworth et al., 2012). The 
requirement of L/F conditions is peculiar because these signaling pathways have 
opposing influences on murine pluripotency (Nichols and Smith, 2009). It is believed that 
LIF signaling is mediated by STAT3 similar to mESCs (Luo et al., 2011). Whereas, FGF 
signaling is believed to resemble the mechanisms characterized in hESCs, involving 
paracrine TGFβ ligand secretion from MEF feeders and SMAD2 induction of NANOG in 
ciPSC (Luo and Cibelli, 2016).  
The establishment of transgene-dependent, partially reprogrammed ciPSC clones appears 
to be reproducible in multiple labs and donor cell populations. However, there is 
diminishing value in continuing to characterize transgene-dependent cell populations 
stuck within an ill-defined alternative reprogramming trajectory. Recent efforts have 
navigated towards commercially available RNA-based sendai virus reprogramming 
vectors, which do not integrate into host genomes (Chow et al., 2017). Previous studies 
have stressed the importance of studying genomic stability and the epigenetic state of 
ciPSC, as aberrations in these attributes may confer selective growth advantages and lead 
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to genetic drift in cultures (Koh et al., 2013). Investigations focusing on the precise 
nature of signaling networks and GRNs associated with the induction and maintenance of 
pluripotency, should build the foundational knowledge required for reproducible 
derivation of stable cESC and ciPSC.   
1.7 Rationale and Study Aims 
PSC represent a tractable system to probe the molecular mechanisms underlying the 
acquisition, maintenance and loss of pluripotency (Morgani et al., 2017; Rossant and 
Tam, 2017). Once the regulative character and clonogenic attributes of PSC can be 
exploited with precision, PSC offer a scalable source of healthy cells for regenerative 
medicine or to assess the molecular basis and drug responsiveness of disease states (Ilic 
and Ogilvie, 2016; Robinton and Daley, 2012). Evolutionary rewiring of pluripotency 
associated regulatory elements and contrasting embryological features will likely drive 
the emergence of species-specific phenotypes and culture requirements among 
mammalian PSC (Greber et al., 2010; Xie et al., 2010). Although early mammalian 
embryos share morphological similarities, there is a lack of clarity regarding the defining 
molecular characteristics of pluripotent cells within canine peri-implantation blastocysts. 
The derivation and maintenance of PSC analogous to mESC or mEpiSC in canines would 
contribute to our understanding of the evolutionary variations in regulatory mechanisms 
impacting pluripotency induction or maintenance across mammals. A growing 
appreciation of the interdependent epigenetic, transcriptional and metabolic mechanisms 
in pluripotent state transitions and nuclear reprogramming, suggests that specific 
manipulations to the culture environment can influence the plasticity of mammalian cells.    
For my thesis work, I used canine embryonic stem cells (cESCs) as a model system to 
evaluate discriminatory markers and functional assays to decipher the developmental 
approximate of cESCs in different microenvironments. Additionally, I used transcription 
factor-mediated de-differentiation of canine fibroblasts to study the early stages of 
nuclear reprogramming. cESC established from in vivo-derived blastocyst explants 
exhibit requirements of exogenous LIF and FGF2, clump passaging techniques and MEF 
co-culture, neural lineage default in minimal media that are indicative of the primed 
pluripotent state (Wilcox et al., 2011, 2009). Furthermore, partial antagonism of MEK1/2 
37 
 
and activation of WNT signaling in mouse or human PSC appears to have an essential 
role in stabilizing a naïve-like pluripotency stage (Weinberger et al., 2016).  
Given these observations, I predict that direct manipulation of the culture conditions can 
facilitate nuclear reprogramming of canine cells. The overall hypothesis of my thesis is 
that the culture environment can promote nuclear and metabolic reprogramming of 
canine cell lines towards a more primitive state of pluripotency. First, I will determine if 
LIF-FGF2 cESCs exhibit molecular and functional characteristics of primed pluripotency 
typified by mEpiSCs, and if manipulation of FGF2-MEK and WNT signaling pathways 
can support a less mature state of pluripotency (Chapter Two). Secondly, I aim to 
determine the influence of cESC pluripotent state on mitochondrial structure and activity 
of relevant bioenergetic pathways to cell proliferation (Chapter Three). Lastly, I aim to 
determine if metabolites influencing DNA methylation can promote transcriptional 
responses associated with the initiation of canine reprogramming (Chapter Four). These 
studies further our understanding of conditions suitable for canine pluripotent stem cell 
expansion and establish a framework for cESCs as a model to assess the molecular events 
in canine developmental progression. Collectively, these investigations substantiate the 
role of extrinsic factors regulating pluripotent states and pose fundamental questions 
regarding evolutionarily conserved features of mammalian pluripotency. 
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Chapter 2  
2 Manipulation of developmental signaling pathways 
alters the pluripotency characteristics of canine 
embryonic stem cells 
A version of this chapter has been published: 
Tobias, I.C., Brooks, C.R., Teichroeb, J.H., Villagómez, D.A, Hess, D.A., Séguin, C.A., 
and Betts, D.H. (2016). Small-molecule induction of canine embryonic stem cells toward 
naive pluripotency. Stem Cells and Development 25 (16), 1208-1222.  
Reproduced here with permission from Mary Ann Liebert, Inc., New Rochelle, NY 
(Appendix B). 
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2.1 Introduction 
Canine reproduction and early embryonic development exhibit peculiar features that have 
limited the progress of assisted reproduction technologies and embryo maturation 
protocols in this species (Nagashima et al., 2015; Van Soom et al., 2014). Briefly, canids 
release oocytes at the immature germinal vesicle-stage and trophoectoderm 
differentiation does not occur until ten days post-ovulation (Renton et al., 1991; Reynaud 
et al., 2006). In vivo matured canine blastocyst embryos have been collected from the 
reproductive tracts of artificially inseminated dams after slightly less than two weeks 
after ovulation (Reynaud et al., 2006). A number of canine embryonic stem cell (cESC) 
have been established from the outgrowths of spontaneously or mechanically hatched 
blastocysts (Hatoya et al., 2006; Hayes et al., 2008; Schneider et al., 2007; Vaags et al., 
2009). However, there is no clear consensus regarding the appropriate embryonic stage 
for cESC derivation or which extrinsic signals are required for self-renewal of cESCs 
(Betts and Tobias, 2015). As such, most presumptive cESCs rapidly lose in vitro 
characteristics of pluripotency before detailed molecular characterizations can be 
performed (Koh and Piedrahita, 2014).  
We have previously shown that cESCs exhibiting core pluripotency TF expression (e.g. 
OCT4, SOX2) and hESC-like cell surface epitopes (e.g. SSEA4, TRA-1-81) can be 
reproducibly derived on mouse embryonic fibroblast (MEF) feeders when cultured in 
media containing both LIF and FGF (L/F) (Wilcox et al., 2009). Whereas LIF supports 
the naïve pluripotent state in mice, primed mEpiSC or hESCs depend on FGF2 and 
Activin A-SMAD2/3 signaling (Brons et al., 2007; Dahéron et al., 2004; Tesar et al., 
2007; Vallier et al., 2009). The dual requirement of L/F indicate that cESCs may reflect a 
mixture of naïve or primed pluripotency characteristics. Canine iPSCs have been shown 
to quickly re-establish variable surface marker abundances after fluorescence-activated 
cell sorting (FACS), indicating that the canine pluripotent state is metastable (Hayashi et 
al., 2008; Koh et al., 2013).  
Similar to primed mEpiSCs, explant-derived cESCs in L/F undergo apoptosis unless 
propagated with clump passaging techniques and exhibit a neural lineage default in 
minimal media (Greber et al., 2010; Wilcox et al., 2011). These observations indicate that 
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L/F cESCs may represent the canine-equivalent of primed pluripotency, despite the 
requirement of LIF for prolonged self-renewal. The application of two inhibitors (i.e. 
PD0325901 and CHIR99021, known as 2i) that partially suppress MEK and GSK3β 
kinase activity maintains mESCs in a naïve pluripotent state (Qi et al., 2004; Ying et al., 
2008). 2i and LIF (2iL) has been shown to overcome intrinsic determinants that promote 
an unstable pluripotent state in mouse strains that were previously considered refractory 
(Hanna et al., 2009). Supplementation with 2iL also appears to be important to stabilizing 
a naïve pluripotent state in primates, although several additional kinase inhibitors are 
usually included (Gafni et al., 2013; Hanna et al., 2010; Theunissen et al., 2014). We and 
others have reported considerable morphological heterogeneity among the outgrowths of 
canine blastocysts in the early derivation process, but there is no direct molecular 
evidence that multiple pluripotent states can be adopted by cESC (Vaags et al., 2009; 
Wilcox et al., 2009).  
Given the partially conserved role of 2iL molecules to stabilize rodent and primate ESCs 
in a naïve-like pluripotent state in the absence of ectopic transgene expression, we 
explored the possibility that altering the culture conditions may induce an earlier 
development state in cESCs. We report the induction of a distinct state of canine 
pluripotency through modulation of environmental cues and intracellular signal 
transduction using 2iL. Our results demonstrate that the 2iL-enriched canine pluripotent 
state correlates with increased expression of genes associated with the preimplantation 
mammalian blastocyst, augmented STAT3 signaling, improved clonogenic potential, and 
decreased global repressive epigenetic modifications. 
2.2 Materials and Methods 
2.2.1 Feeder layer and Embryonic Stem Cell Culture 
DR4 strain MEF feeders were mitotically arrested with γ-irradiation (8,000 rad) and 
maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS) and 1X GlutaMAX. For co-cultures with cESCs, MEFs were 
seeded at a density of 2 x 104 cells/cm2 and allowed to adhere overnight in MEF medium. 
cESCs were derived at the Ontario Veterinary College (OVC, University of Guelph, 
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Ontario) from explanted blastocysts (OVC.EX) and characterized in an earlier report 
(Wilcox et al., 2009). cESCs were seeded onto growth-arrested MEFs and cultured in 
basal media: KnockOut DMEM/Ham’s F12, 15% KnockOut Serum Replacement 
(KOSR), 1X GlutaMAX, 1X nonessential amino acids, 10 ng/mL recombinant insulin-
like growth factor (R3IGF1; Sigma-Aldrich), and 0.1 mM 2-mercaptoethanol. Basal 
medium was supplemented with 10 ng/mL human recombinant LIF and 4 ng/mL 
recombinant human FGF2 (L/F) for maintenance of control cESCs; or 10 ng/mL human 
recombinant LIF, 0.5 µM MEK inhibitor PD0325901 (Selleck Chemicals), and 3 µM 
GSK3β inhibitor CHIR99021 (BioVision) for establishment and culture of 2iL cESCs. 
LIF-FGF2 cESC colonies were mechanically isolated, dissected into small clumps, and 
transferred onto fresh MEFs every 4–6 days. 2iL cESC colonies were picked from 
culture, dissociated enzymatically with TrypLE Express, and split onto new feeder layers. 
For feeder-free cESC cultures, dishes were covered in dilute Geltrex (1:100) solution and 
incubated at 37 °C for one or more hours. cESCs transferred to Geltrex-coated dishes 
were cultured with 70% MEF-conditioned medium balanced with nonconditioned basal 
media. Culture medium was exchanged daily and incubators were maintained at 37 °C, 
5% CO2, and ambient oxygen tensions. Unless otherwise stated, all reagents for cell 
culture were from Thermo Fisher Scientific.  
2.2.2 Metaphase Spread Preparation and Karyotyping 
Cells were seeded into Geltrex-coated T75 flasks and grown to 60% confluency before 
metaphase spread preparation. Approximately 16 hours before spread preparations, 
dividing cells were synchronized with 100 nM Methotrexate in fresh media. Cells were 
released from replication block with 10 mM thymidine and incubated for 3 hours at 37 
°C. Cells were treated with 1.25 mM Ethidium Bromide for 50 minutes to prevent 
excessive chromosome compaction and 10 µg/mL Colcemid for 30 minutes to induce 
metaphase arrest. Cells were then dissociated, suspended in hypotonic solution (75 mM 
Potassium Chloride), and incubated at 37 °C for 15 minutes. A few drops of ice-cold 
Carnoy’s fixative (3:1 methanol: acetic acid) were added and mixed by gentle agitation. 
The cells were pelleted and resuspended in the fixative twice before dropping the cells 
onto fixative-soaked microscope slides to prepare metaphase spreads. At least 30 
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metaphase cells were examined for each treatment group. Karyotypes were assembled 
according to ideograms using SmartType (Digital Scientific UK Ltd). 
2.2.3 Reverse Transcription and Quantitative PCR 
Cells were rinsed once with PBS and harvested directly into TRIzol Reagent. After 
phenol-chloroform extraction, the RNA was purified using the PureLinkTotal RNA 
Purification Kit. Quality and quantity of RNA samples were determined through 
spectrometry using a NanoDrop ND-2000. Genomic DNA was removed using RQ1 
RNase-free DNase (Promega). Approximately 300 ng of total RNA was reverse 
transcribed using the SuperScript III First Strand cDNA synthesis kit (Thermo Fisher 
Scientific) with a random hexamer and oligo (dT)15 primers (Promega). Primer pairs for 
each target gene were designed using NCBI Primer BLAST software, spanning an exon–
exon junction where possible. Specificity of each primer set was determined if a single 
amplicon of the correct size was detected on a 2% agarose gel following electrophoresis. 
For primer sequences and amplicon sizes, see Table 2-1. Quantitative polymerase chain 
reaction (qPCR) was performed using the CFX384 detection system (BIO-RAD 
Technologies). To each reaction 5 µL Power SYBR Green, 1 µL custom oligonucleotide 
primers (250 nM final), 1 µL water and 3 µL template cDNA were added. Thermocycling 
conditions are as follows: 95 °C for 10 minutes, followed by 40 cycles of 95 °C for 20 
seconds and 60 °C for 45 seconds. Relative transcript levels were normalized to internal 
reference gene TATA binding protein (TBP) using the 2-ΔΔCt method and are expressed as 
relative ratios to L/F cESC samples. 
Table 2-1. Custom oligonucleotide primer sequences  
Gene Identifier Sequence (5’ to 3’) Amplicon Size (bp) 
STAT3 F - CTGGGCATCAATCCTGTGGT 
R - CTCAGTCCTCGCTTTGTGGT 
144 
KLF4 F - CCATGGGCCAAACTACCCAC 
R - TGGGGTCAACACCATTCCGT 
154 
REX1 F - CGCCGACACCGTCCTCATCG 
R - GTTCCGCAGGGAGCGGCGGGC 
161 
GBX2 F - GCCTCTCCCGAGCGCGTCTA 
R - AGACGAAATGGCCGGGGCTG 
140 
TBX3 F - AGACAGCCCTGCTACGGGGG 
R - CCCCTGCCACGTTGCGTGAT 
133 
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PECAM1 F - GCACCCCCAGCCAACTTCACC 
R - TCCCACTGTCCGTCGCAGAGG 
94 
LIN28 F - GGCGGTGGAGTTCACCTTTA 
R - CCTTTGATCTGCGCTTCTGC 
134 
T/BRA F - TGCAGTACCGAGTGGACCACCT 
R - GCCGTTCTTGGTCACGATCATC 
167 
CER1 F - ACCTGGGACCCATGCCCTCAC 
R - GATCGTCTGGCCGAAGGGCAC 
196 
FGF5 F - AGCCACCTGATCCTCAGCGCC 
R - CGGGTCCGGGTTGCCCTTTG 
70 
OTX2 F - CTGCGAAGCAGTAAACCAGC 
R - GAACCCAGCCAGAAGGTCTC 
129 
SOCS3 F - CCCGCTTCGACTGCGTGCTC 
R - GAAGGCGGCTGCTCCGACAC 
115 
ACVR2B F - TTCTGGATGTACCGCATCG 
R - TCATGAGCTGTGCCTTCCAG 
163 
LAMB1 F - ATGGTTCACGGACACTGCAT 
R - ATGTCGAAGTGGCACGAACT 
167 
GATA6 F - AGTGCGTGAACTGCGGCTCC 
R - ACGCGCTTCTGCGGCTTGAT 
136 
SNAI1 F - GTTTACCTTCCAGCAGCCCT 
R - AGAGAGTCCCAGATGAGCGT 
108 
ELF5 F - CTCCAGTCACCACACGTCG 
R - CCTGGGTTAGCAAGGCCC 
132 
HAND1 F - AGCTGCAACAACACACTTGG 
R - AAGCATAGGGGCTTCGAAAT 
218 
FLK1 F - GTTGGGAGAGGAGAGAGGGT 
R - CAGTGCACCACAAAGACACG 
112 
TBP F - GAGCTCTGGGATCGTGCCGC 
R - TCAGTGCAGTGGTTCGGGGC 
169 
 
2.2.4 Indirect Immunofluorescence Microscopy 
Cells in multiwell dishes or Lab-Tek Chamber Slides (Thermo Fisher Scientific) formats 
were rinsed with PBS and fixed with 4% formaldehyde for 15 minutes. Cells were 
permeabilized with 0.1% Triton X-100 for 20 minutes. Epitope blocking was performed 
with 10% normal goat, donkey, or rabbit serum (Sigma-Aldrich) for 1 hour. The 
following primary antibodies were diluted to the indicated concentrations and incubated 
overnight at 4 °C: anti-OCT4, anti-OTX2, anti-GATA2, anti-GATA4, anti-TUJ1, anti-
NES, anti-H3H27Me3 and anti-pSMAD2. For information regarding primary antibodies, 
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see Table 2-2. AlexaFluor 488 and/or AlexaFluor 547 secondary antibodies were diluted 
1:250 in 5% serum and incubated at room temperature for 1 hour. Cells were 
counterstained with NucBlue specialized DAPI formulation. Cells were imaged on a 
Leica DMI 6000B with Orca Flash digital camera (Hamamatsu Photonics) using Leica 
Application Suite Advanced Fluorescence software (Leica Microsystems). H3K27me3-
immunolabeled cells were observed with a Zeiss LSM 510 Duo Vario confocal 
microscope (Zeiss Canada, Inc.). Serial optical sections were taken in a total depth of 50–
80 µM. More than 30 images were assessed per treatment in three independent 
experiments. Nuclei were categorized based on the presence of well-delineated 
H3K27Me3 foci throughout the input stack. For representative images, extended depth of 
field composites was generated using ZProjector on ImageJ (National Institutes of 
Health). The primary antibody was replaced with diluent and incubated with the 
AlexaFluor secondary antibody to control for antibody specificity. Light or laser settings 
were unchanged when detecting the same primary antibody across samples. Brightness or 
contrast was set using secondary-only control and equivalent imaging parameters were 
applied to all other images. 
Table 2-2. Primary antibody information 
Target Protein Isotype 
Species 
Application (Dilution) Supplier (Catalog) 
OCT4 Mouse WB (1:1000); IF (1:150) Santa Cruz (sc-5729) 
SOX2 Rabbit WB (1:1000) Cell Signaling (3579) 
NANOG Rabbit  WB (1:500) Santa Cruz (sc-33759) 
OTX2 Rabbit WB (1:1000); IF (1:200) Millipore (AB9566) 
GATA2 Rabbit IF (1:200) Santa Cruz (sc-9008) 
GATA4 Rabbit IF (1:200) Abcam (AB84593) 
TUJ1 Mouse IF (1:300) BioLegend (MMS-
435P) 
NESTIN Rat IF (1:150) DSHB (Rat-401) 
STAT3 Rabbit WB (1:1000) Santa Cruz (sc-482) 
p-STAT3 (T705) Rabbit WB (1:1500) Santa Cruz (sc-7993-R) 
ERK1/2 Rabbit WB (1:2000) Cell Signaling (4695) 
p-ERK1/2 
(T202/204) 
Rabbit WB (1:2000) Cell Signaling (4377) 
SMAD2/3 Rabbit WB (1:1000) Cell Signaling (3102) 
p-SMAD2 
(S465/467) 
Rabbit WB (1:1000); IF (1:150) Cell Signaling (3101) 
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SMAD4 Rabbit WB (1:1000) Santa Cruz (sc-7154) 
Histone H3 Rabbit WB (1:1000) Cell Signaling (9715) 
Histone H3Ac Rabbit WB (1:1000) Millipore (06-599) 
H3K27me3 Rabbit WB (1:1000); IF (1:250) Millipore (07-449) 
β-actin Mouse WB (1:30000) Sigma (A3854) 
 
2.2.5 Protein Extraction, SDS-PAGE and Western Blotting 
Cells were rinsed in ice-cold PBS, scraped from 60 mm culture dishes and lysed in 200 
µL RIPA buffer (150 mM sodium chloride, 1% NP-40, 0.5% sodium deoxycholate, 0.1% 
sodium dodecyl sulfate, 50 mM Tris pH 8.0) with a protease and phosphatase inhibitor 
cocktail (EMD Millipore). Total protein concentration was determined by DC Protein 
Assay (BIO-RAD Technologies). Protein lysates were resolved on 4%–12% SDS-PAGE 
gels and transferred onto Immobilon polyvinylidene difluoride membranes. Epitope 
blocking was achieved by incubation with 5% skim milk powder/TBS/0.1% Tween-20 
for 1 hour. The following primary antibodies at the indicated dilution were used: anti-
OCT4, anti-SOX2, anti-NANOG, anti-OTX2, anti-pSTAT3, anti-STAT3, anti-pERK1/2, 
anti-ERK1/2, anti-pSmad2, anti-Smad2/3, anti-Smad4, anti-histone H3 lysine 27 
trimethylated, anti-histone H3 acetylated, anti-histone H3, and β-actin horseradish 
peroxidase (HRP) conjugate. After 16 hours of primary antibody incubation, membranes 
were washed with TBS/0.1% Tween-20. Horseradish peroxidase (HRP)-coupled 
secondary anti-rabbit or anti-mouse IgG antibodies (Jackson Laboratories) were diluted 
in TBS/0.1% Tween-20 and applied to membranes for 1 hour at room temperature. 
Immune reactive protein epitopes were visualized by chemiluminescence on Molecular 
Imager VersaDoc System (BIO-RAD) and Quantity One software (BIO-RAD 
Technologies). Densitometry was performed using ImageLab 3.0 software (BIO-RAD 
Technologies). 
2.2.6 Embryoid Body Formation and Directed Differentiation of 
Outgrowths 
Cells were mechanically isolated and briefly triturated in basal culture media lacking 2iL. 
Disaggregated cESCs were transferred to suspension culture in non-adherent dishes to 
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form embryoid bodies (EBs). Basal media were exchanged daily for 7 days by allowing 
EBs to settle at the bottom of a conical tube and aspirating the supernatant. To promote 
neuroectoderm differentiation, 2iL-derived embryoid aggregates were gently dissociated 
and seeded onto laminin- and poly-L-ornithine-coated dishes in the presence of 
Activin/NODAL signaling antagonist 1 µM SB431542 (SB431542) and 20 ng/mL 
Noggin (Sigma-Aldrich). Mesodermal fate was induced using 10 ng/mL BMP4 and 10 
ng/mL FGF2 on a gelatin substratum. Endoderm differentiation was induced by chemical 
stimulation of WNT signaling using 1 µM CHIR99021 and co-supplemented with 20 
ng/mL Activin A on Geltrex-coated dishes. After 7 days under differentiation conditions, 
each experimental group were fixed with formaldehyde for immunocytochemistry. 
2.2.7 Neural Progenitor Cell Formation Assay 
Cells were mechanically isolated and disaggregated into small clumps by gentle 
pipetting. Cells were resuspended in basal culture medium lacking self-renewal 
supplements (e.g. LIF and FGF2, 2i and LIF) and transferred to suspension culture in 
non-adherent dishes to form EBs. Basal media were exchanged every other day for 5 
days. The resultant EBs from L/F or 2iL cESCs were gently dissociated by pipetting and 
allowed to adhere to multiwell dishes coated with laminin and poly-L-ornithine. EB 
outgrowths were allowed to differentiate in basal media (i.e. spontaneous differentiation) 
or in basal media supplemented with 20 ng/mL Noggin (i.e. directed differentiation). 
After four days under adherent differentiation conditions, cells were fixed with 4% 
formaldehyde and prepared for indirect immunofluorescence microscopy. Primary and 
secondary antibody staining was performed with anti-NES antibody and AlexaFluor 488 
secondary antibody. The number of EB outgrowths exhibiting positive NES staining were 
enumerated for each condition. 
2.2.8 Manipulation of TGFβ Signaling 
For the BMP4 differentiation assay, LIF-FGF2 and 2iL cESCs were exposed to 20 ng/mL 
recombinant human BMP4 in addition to their standard culture media preparation for a 
period of 96 hours. Cells were harvested from multiwell dishes using TRIzol reagent for 
RNA isolation. RNA purification and first-strand cDNA synthesis were performed for 
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RT-qPCR. Transcript abundances indicative of mesoderm and extraembryonic lineages 
(e.g. CDX2, HAND1, GATA6, FLK1) were assessed. To examine LIF-FGF2 cESC 
responsiveness to SMAD2/3 signaling, cultures were supplemented with either 10 µM 
activin receptor-like kinase (ALK) inhibitor SB431542 or 20 ng/mL Activin A for 96 
hours before protein lysate harvest for western blotting. 
2.2.9 Single-cell Cloning Efficiency Assay 
To examine clonogenic potential, individual L/F or 2iL cESC colonies were mechanically 
isolated and incubated in 0.05% Trypsin to dissociate into single cells. Cells were 
resuspended in culture media containing LIF only, FGF2 only, L/F, or 2iL and passed 
through a 40-µM cell strainer. Media with no growth factor or chemical inhibitor 
supplementation were applied for negative controls. Five hundred cells were seeded per 
well of a 24-well plate (n = 6). After 7 days, cells were washed in PBS and stained with 
AlexaFluor 488 anti-SSEA4 antibody (eBioscience) diluted 1:150 in cESC culture media. 
Following a 60 minutes incubation in a humidified incubator, cells were washed with 
PBS and direct immunofluorescence was visualized. Colony-forming efficiency was 
calculated as a percentage of SSEA4+ colonies per number of cells seeded. 
2.2.10 Cell Counting and Population Doubling Time Calculation 
For linear phase population doubling, 50,000 cESCs were seeded onto MEF-coated 
multiwell dishes in triplicate. Cells were detached at 96 and 144 hour timepoints using 
0.05% trypsin to achieve a single-cell suspension. The total live cell number was 
determined using a hemocytometer. Population doubling time was calculated using the 
following formula: 𝑃𝐷 = 48 𝑋 [𝑙𝑜𝑔 2 ÷ 𝑙𝑜𝑔(
# 𝑐𝑒𝑙𝑙𝑠 𝑑𝑎𝑦 6
# 𝑐𝑒𝑙𝑙𝑠 𝑑𝑎𝑦 4
)]. 
2.2.11 5-methylcytosine Enzyme-linked Immunosorbent Assay 
(ELISA) 
L/F or 2iL cESCs were dissected from culture dishes, pelleted by centrifugation and 
rinsed with PBS. Genomic DNA was purified using PureLink Genomic DNA kit. Global 
5-methylcytosine (5-mC) levels were determined using the 5-mC DNA ELISA kit (Zymo 
Research Corp.) according to the manufacturer’s instructions. A standard curve was 
82 
 
generated using E. coli control samples provided with the kit and raw data were 
calculated as percent 5-mC per 150 ng genomic DNA. Output values were corrected by 
the CpG density specific to canine genomic assembly and expressed as a relative ratio to 
L/F cESC samples. 
2.2.12 Immunodeficient Mouse Xenograft Assay 
1.2 x 106 LIF-FGF2 or 2iL cESCs (n = 3) were transplanted into Non-Obese Diabetic 
Severe Combined Immunodeficient (NOD/SCID) interleukin-2 receptor -chain null 
(IL2R-/-) mice (Jackson Laboratory). HES2 hESC lines were injected as positive controls 
(n = 2). Cells were suspended in 50 mL Geltrex and kept on ice (<20 min) before 
intramuscular injection in rear hind leg. Injection sites were monitored every other day by 
palpation. Between 6 weeks and 10 weeks post-injection, mice were anesthetized with 
isofluorane and sacrificed by cervical dislocation, and the area of muscle around the 
injection site was excised. Samples were rinsed in PBS before overnight fixation in 4% 
paraformaldehyde. Fixed tissues were processed for embedding and sectioning. 
Hematoxylin and eosin staining were performed on sections. Animal experiments were 
approved by the Animal Use Subcommittee, AUP #2018–033 (Appendix C). 
2.2.13 Statistical Analysis 
Experiments were performed a minimum of three times with sample sizes indicated in 
figure legends. Data were analyzed using GraphPad Prism 6 by two-sample t-test or one-
way analysis of variance (ANOVA) followed by Tukey's honestly squared difference 
multiple comparison method as appropriate. P < 0.05 was considered statistically 
significant. Data were visualized using GraphPad Prism 6 and presented as mean ± 
standard error of the mean (SEM). 
2.3 Results 
2.3.1 PD0325901, CHIR99021 and LIF (2iL) induce compact 
cESC colony morphology 
OVC.EX cESCs were expanded on MEFs by mechanical dissociation and expansion in 
LIF-FGF2 (L/F) medium. L/F cESCs were grown to high confluency (~80%) prior to 
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switching to 2iL supplemented medium due to strong negative selection associated with 
coercing pluripotent state transitions by kinase inhibitors (Fig. 2-1A). Consistent with 
earlier work on the same cESC lines (Wilcox et al., 2009), L/F cESCs exhibited planar 
morphology akin to hESCs/EpiSCs (Fig. 2-1B) and did not survive passaging regimens 
involving enzymatic dissociation reagents or mechanical dispersion to single-cells. 2iL 
culture was initially associated with observable cell death for a period of 72 hours. 
Within 4 to 5 days, three-dimensional cell clusters emerged from a proportion of cESC 
colonies. By 10 to 14 days, hemispherical colonies with compact borders were observed 
(Fig. 2-1B). Confocal microscopy and z-stack reconstruction of DAPI-stained colonies 
verified that 2iL treated cells formed multilayer stacks of cells, as opposed to L/F cESCs 
that invariably grew as monolayer colonies (Fig. 2-1C). Mature 2iL cESC colonies were 
maintained in the same medium applied for their induction and reproduced a canine 78 
XY karyotype of the originating L/F cESC population (Fig. 2-2A).  
When 2i is removed from the growth media, cESCs rapidly lose dome-like colony 
morphology (Fig. 2-2B). Before enzymatic dissociation could be employed, 2iL cESCs 
initially had to be enriched by sequential pick-passaging, to reduce the carry-over of 
neural progenitor-like cells that arose during the induction of 2iL cESCs (Fig 2-2C-D). 
As genetic background has been shown to influence the ability to derive naïve PSCs, the 
procedure was repeated in three independent OVC.EX cESC lines (Ohtsuka and Niwa, 
2015; Wilcox et al., 2009) (OVC.EX.IO3, OVC.EX.IO7, and OVC.EX.BE5) with 
preliminary characterization of morphology and SSEA4 immunostaining (Fig. 2-3).  
OVC.EX.BE5 cESC that readily differentiate into each of the three germ layers in vitro 
(Wilcox et al., 2009) were selected for extended passaging and subsequent analysis in 
L/F and 2iL conditions. These findings suggest that removal of FGF2 and replacement 
with 2i permits the expansion of a scarce ESC-like population, which can be 
subsequently enriched based on compact colony architecture. 
2.3.2 2iL cESCs are pluripotent and up-regulate transcript markers 
of an earlier developmental identity 
To ensure 2iL-expanded canine cells retained pluripotent characteristics, we performed 
immunoblotting and immunofluorescence of pluripotency-associated transcription  
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Figure 2-1. PD0325901, CHIR99021 and LIF (2iL) induce compact cESC colony 
morphology. 
(A) Timeline schematic of induction, isolation and analysis of 2iL cESCs. (B) 
Representative phase-contrast micrographs of BE5 cESCs in (I) LIF and FGF2 (L/F) or 
(II) 2iL cESCs. Scale bar unit length is 200 µm. (C) Representative cross-section of 
reconstructed Z-stack image for DAPI-stained (I) L/F (monolayer) and (II) 2iL (multi-
layer) cESC colonies. Dashed white line approximates the culture surface. Scale bar unit 
length is 50 µm.  
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Figure 2-2. 2iL cESCs are dependent on the 2i molecules for compact morphology.  
(A) Representative diploid karyotype (2n = 78 XY) from the BE5 2iL cESC line. (B) 
Representative phase-contrast micrograph of (I) steady-state 2iL cESC or (II) 
differentiating 2iL cESC colony 48 hours after 2i removal. Scale bar unit length is 100 
μm. (C) Representative phase-contrast micrograph of neural progenitor-like cells derived 
from LIF-FGF2 (L/F) cESCs that proliferate in 2iL culture. Scale bar is 200 μm. (D) 
Indirect immunofluorescence image for class III neuronal beta-tubulin (TUJ1) antibody 
stain and DAPI nuclear counterstain. Scale bar unit length is is 150 μm. 
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Figure 2-3. Establishment of 2iL cultures in the IO3 cESC line and preliminary 
characterization by stage-specific embryonic antigen 4 (SSEA4) staining.  
(A) Representative phase-contrast micrographs of IO3 cESCs in (I) LIF and FGF2 (L/F) 
or (II) 2iL cESCs. Scale bar is 200 µm. (B) Direct immunofluorescence image for stage-
specific embryonic antigen 4 (SSEA4) antibody stain. Scale bar unit length is 50 µm. 
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factors. There was no difference in OCT4 or SOX2 protein abundance between L/F and 
2iL cESCs (Fig. 2-4A-B, P = 0.76 & P = 0.36). Both L/F and 2iL cESCs exhibited 
nuclear OCT4 staining (Fig. 2-4C). However, there was a significant induction of 
NANOG in 2iL cESC lysates compared to L/F cESC samples (Fig. 2-5A, P = 9.0 x 10-4). 
Further, OTX2 was significantly decreased in 2iL cESCs compared to L/F cESCs. (Fig. 
2-5B, P = 3.5 x 10-3). OTX2 immunostaining was localized to the nucleus and perinuclear 
region of L/F cESC colonies, whereas specific intracellular OTX2 staining was not 
observed in 2iL cESCs (Fig. 2-5C). 2iL cESCs formed embryoid body (EB) aggregates in 
suspension culture to assess cESC pluripotency in vitro (Fig. 2-6A). 2iL cESCs formed 
EBs that could be directed to form putative early progenitors of endoderm, mesoderm, 
and ectoderm as assessed by fluorescent immunocytochemistry for expression of 
GATA4, GATA2, and neuronal beta-III tubulin (TUJ1), respectively (Fig. 2-6B-D). 
We next investigated the gene expression signatures of several orthologous markers of 
naïve and primed pluripotency in L/F or 2iL cESCs to determine whether these cells bear 
transcriptional similarities to naïve mESC or primed mEpiSC/hESC. RT-qPCR analysis 
revealed that naïve-like cESCs stabilized in 2iL exhibit significant reductions in the 
relative transcript abundance of late epiblast markers, including FGF5, ACVR2B and 
OTX2 (Fig. 2-7A, P < 0.039). Conversely, a significant induction of naïve pluripotency 
markers REX1, TBX3, GBX2, PECAM1, and STAT3 (Fig. 2-7B, P < 0.035) was 
observed in 2iL cESCs. The relative abundance of KLF4 and LIN28 transcripts did not 
differ between L/F and 2iL cESCs (Fig. 2-7B). The down-regulation of naïve 
pluripotency-associated transcripts following 2i removal is consistent with destabilization 
of a naïve-like pluripotency program (Fig. 2-7B). These results suggest that 2iL promotes 
a pluripotent phenotype with altered transcriptional profile resembling the ICM/early 
epiblast, which is dependent on persistent repression of GSK3β and MEK1/2 signaling. 
2.3.3 STAT3 phosphorylation but not SMAD2/3 signaling are 
influenced by 2iL culture 
To examine signaling pathways associated with maintenance of undifferentiated L/F and 
2iL cESCs, we assessed the phosphorylation status of FGF-ERK, Activin-SMAD2/3, and 
LIF-STAT3 signal transduction proteins. The fraction of phosphorylated ERK1/2 
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Figure 2-4. 2iL cESCs express SOX2 and OCT4 with nuclear localization. 
Representative western blot images from whole cell lysates and quantification by 
densitometry for (A) OCT4 and (B) SOX2. Means are normalized to internal standard β-
actin and expressed as a relative ratio to LIF-FGF2 (L/F) cESC samples. Bars represent 
standard error of the mean (SEM), n = 3. Means followed by the same letter are not 
significantly different, P < 0.05. (C) Representative indirect immunofluorescence image 
of OCT4 antibody stain and DAPI nuclear counterstain in (I) L/F cESCs and (II) 2iL 
cESC colonies. Scale bar unit length is 150 μm.   
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Figure 2-5. 2iL cESCs accumulate NANOG and down-regulate OTX2 compared to 
L/F cESCs. 
(A). Representative western blot images from whole cell lysates and quantification by 
densitometry for (A) NANOG and (B) OTX2. Means are normalized to internal standard 
β-actin and expressed as a relative ratio to L/F cESC samples. Bars represent standard 
error of the mean (SEM), n =3. Means followed by the same letter are not significantly 
different P < 0.05. (C) Representative indirect immunofluorescence image of OTX2 
antibody stain and DAPI nuclear counterstain in (I) L/F cESCs and (II) 2iL cESC 
colonies. Scale bar unit length is 150 μm.  
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Figure 2-6. Canine ESCs expanded in 2iL retain tri-lineage differentiation capacity 
in vitro. 
(A) Isolated 2iL cESCs form embryoid bodies (EBs) in suspension culture. EB 
outgrowths undergo directed differentiation to embryonic lineages in the presence of 
specific chemical inhibitors and growth factors. Scale bar unit length is 300 μm. (B) 
GATA4-positive cells form in the presence of Activin A and GSK3β inhibitor CHIR. (C) 
Neuronal βIII tubulin (TUJ1)-positive cells form in the presence of BMP inhibitor 
Noggin and ALK inhibitor SB431542. (D) GATA2-positive cells form in the presence of 
FGF2 and BMP4. Scale bar unit length is 75 μm and applies to panels B, C and D.  
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Figure 2-7. 2iL cESCs up-regulate several known naïve pluripotency-associated 
transcripts but not primed pluripotency-related markers. 
(A) Abundance of discriminatory transcripts of mammalian primed pluripotency within 
L/F cESCs and cESCs cultured in 2iL. (B) Abundance of discriminatory transcripts of 
mammalian naïve pluripotency in L/F cESCs, 2iL cESCs and the cell population formed 
96 hours after 2i removal (LIF Only). Means are normalized to internal standard TATA-
binding protein (TBP) and expressed as relative ratios to L/F cESC samples. Bars 
represent standard error of the mean (SEM), n=3. Means followed by the same letter are 
not significantly different, P < 0.05. 
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(T202/204) was not significantly different between L/F and 2iL cESCs (Fig. 2-8A, P = 
0.20). However, there was a significant increase in the ratio of phospho-STAT3 (Y705) 
to total STAT3 in 2iL cESC lysates compared to L/F cESCs (Fig. 2-8B, P = 1.2 x 10-3). 
Whereas the ratio of phospho-SMAD2 (S465/467) to total SMAD2/3 was unchanged 
between cESCs populations (Fig. 2-8C, P = 0.74). Fluorescence immunocytochemistry 
revealed no obvious difference in phospho-SMAD2 staining intensity, but unexpectedly 
revealed a clear pattern of nuclear exclusion under both conditions (Fig. 2-9A-B).  
We further assessed the integrity of the SMAD2/3 signaling pathway in L/F cESCs, as 
well as the acute dependence on this pathway in steady-state culture. We quantified the 
relative abundance of phospho-SMAD2 and SMAD4 in the presence of exogenous 
Activin A or ALK inhibitor (SB431542). L/F cESCs were responsive to Activin A 
supplementation, inferred from elevated SMAD2 phosphorylation after 96 hours of 
treatment (Fig. 2-9C, P = 1.8 x 10-3). However, L/F cESCs also tolerated 10 µM 
SB431542 with no overt differentiation over the same time course. Furthermore, 
SB431542 treatment did not significantly alter the ratio of phospho-SMAD2 to total 
SMAD2/3 protein levels compared to steady-state L/F cESCs (Fig. 2-9C, P = 0.17). 
Collectively these results suggest that 2iL cESCs have more pronounced STAT3 
signaling with no change in SMAD2 phosphorylation. Furthermore, L/F cESCs have 
intact Activin-SMAD2/3 signal transduction machinery and need only low basal levels of 
SMAD2/3 phosphorylation for proliferation in vitro. 
2.3.4 L/F cESCs exhibit a greater lineage-specific bias for 
neurectoderm and mesoderm differentiation 
To investigate whether 2iL culture alters the inherent neural lineage bias of L/F cESCs, 
the ability of either cESC population to form NESTIN (NES) positive neural 
stem/progenitor cells under spontaneous and directed differentiation conditions were 
compared. Intriguingly, 2iL cESCs exhibited a lower efficiency of neural differentiation 
under spontaneous differentiation conditions (P = 2.7 x 10-3), but not under directed 
differentiation culture (P = 0.402), compared with L/F cESCs (Fig. 2-10A-B). Given the 
context-dependent role of BMP4 signaling in promoting mESC maintenance or inducing 
non-ectodermal differentiation of mEpiSC (Bernardo et al., 2011; Ying et al., 2003), 
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Figure 2-8. Enhanced STAT3 phosphorylation in 2iL-enriched cESCs. 
Representative western blot membrane images and quantification by densitometry for 
phosphorylated (p) and total (A) ERK1/2, (B) STAT3 and (C) SMAD2 Means are 
normalized to internal standard β-actin and expressed as relative ratios to L/F cESC 
samples. Bars represent standard error of the mean (SEM), n = 3. Means followed by the 
same letter are not significantly different P < 0.05. 
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Figure 2-9. Steady-state L/F cESCs exhibit cytosolic phospho-SMAD2 and tolerate 
acute inhibition Activin-like kinase (ALK) activity. 
Representative indirect immunofluorescence image for phosphorylated SMAD2 
(pSMAD2) in (A) LIF-FGF2 cESCs and (B) 2iL cESCs. Nuclei were counterstained 
DAPI and the scale bar unit length is 200 μm. (C) Representative immunoblot and 
densitometric quantification of phosphorylated and total SMAD2 as well as SMAD4 in 
L/F cESCs treated with 10 µm SB431542 (ALKi) or 20 ng/mL Activin A (AcvA) for 96 
hours. Bars represent standard error of the mean (SEM), n = 3. Means followed by the 
same letter are not significantly different, P < 0.05.  
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Figure 2-10. L/F cESCs exhibit a greater sensitivity for spontaneous neural 
differentiation and BMP4-induced mesendoderm differentiation. 
(A) Representative indirect immunofluorescence image of neural intermediate filament 
protein Nestin (NES) antibody stain and DAPI nuclear counterstain. Scale bar unit length 
is 150 μm. (B) Enumeration of NES+ embryoid body outgrowths L/F cESCs or 2iL 
cESCs in the presence of minimal media (spontaneous), or Noggin and SB431542 
(directed). (C) Representative phase-contrast micrographs resultant L/F cESC or 2iL 
cESC cultures following 20 ng/mL BMP4 treatment for 96 hours. Scale bar unit length is 
150 μm. (D) Relative quantity of early differentiation transcripts associated with non-
ectodermal lineages in L/F and 2iL cESC cultures in the presence and absence of 20 
ng/mL BMP4. Bars represent standard error of the mean (SEM), n=3. Means followed by 
the same letter are not significantly different, P < 0.05. 
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we assessed the sensitivity of 2iL and L/F cESCs to differentiation in the presence of 
BMP4. L/F cESCs supplemented with 20 ng/mL BMP4 for 96 hours lost planar 
epithelium-like morphology and formed a heterogeneous mixture of narrow fibroblastic 
and broader vacuolated derivatives (Fig. 2-10C). In contrast, 2iL cESCs exhibited no 
observable morphological differentiation in a parallel BMP4 treatment (Fig. 2-10C). The 
expression of mesodermal markers Snail family transcriptional repressor (SNAI1), fetal 
liver kinase 1 (FLK1) and heat and neural crest derivatives expressed 1 (HAND1) were 
significantly upregulated following BMP4 addition to L/F cESCs (P < 0.032), but not for 
2iL cESCs (Fig. 2-10D). Transcripts for pan-endodermal markers (SOX17, FOXA2) and 
visceral endoderm marker hepatocyte nuclear factor 4A (HNF4A) were not detected in 
BMP4-treated cESCs by RT-qPCR. In summary, 2iL cESCs exhibit a lesser intrinsic 
neural differentiation bias and a lower sensitivity to BMP-induced mesodermal 
differentiation. These results indicate that 2iL cESCs exhibit different regulative 
characteristics than L/F cESCs. 
2.3.5 DNA methylation and H3K27me3 modifications are depleted 
in 2iL cESCs 
To investigate whether 2iL enriched cESCs contain a lower abundance epigenetic 
modifications associated with development, we probed genomic DNA and protein 
samples from cESCs using antibodies that selectively recognize epitopes containing these 
covalent modifications. Culture of cESCs in 2iL induced a significant decrease in relative 
genome-wide DNA methylation compared with L/F cESCs (Fig. 2-11A, P = 0.048). In 
addition, the ratio of H3K27me3 to total histone H3 was increased in L/F cESCs 
compared to 2iL cESCs (Fig. 2-11B-C, P = 0.031). Pan histone H3 acetylation (H3Ac) 
did not significantly differ between L/F and 2iL cESCs (Fig. 2-11D, P = 0.92). Subtle 
differences in the pattern of nuclear H3K27me3 localization was also observed between 
cESC populations. L/F cESCs displayed non-uniform condensations of H3K27me3, 
whereas H3K27me3 immunofluorescence showed diffuse patterns in 2iL cESCs (Fig. 2-
12A-C, P < 6.5 x 10-3). Collectively, our results suggest that epigenetic modifications 
associated with developmental gene silencing are less prominent in 2iL cESCs. 
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Figure 2-11. DNA methylation and H3K27me3 modifications are depleted in 2iL 
cESCs. 
(A) Percent of 5-methylcytosine (5-mC) per 100 ng of purified genomic DNA, quantified 
in L/F cESCs and 2iL cESCs by 5-mC DNA ELISA. (B) Representative western blot 
images for total acetylated histone H3 (H3Ac), histone H3 lysine 27 trimethylation 
(H3K27Me3) and total histone H3. Densitometric quantification of (C) H3Ac and (D) 
H3K27Me3 normalized to total histone H3. Mean are expressed as relative ratios to 
canine dermal fibroblasts (cDFs) samples. Bars represent standard error of the mean 
(SEM), n=3. Means followed by the same letter are not significantly different, P < 0.05. 
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Figure 2-12. Decreased nuclear condensations of H3K27me3 antibody stain are 
observed in 2iL cESCs. 
(A) Representative indirect immunofluorescence image of H3K27Me3 antibody staining 
in (I) L/F cESCs and (II) 2iL cESC colonies. The scale bar unit length is 100 μm (B) 
Barplot depicting the percentage of H3K27Me3+ nuclei that meet staining pattern criteria. 
Bars represent standard error of the mean, n=4. Means followed by the same letter are not 
significantly different, P < 0.05. (C) Digital zoom of merged image of L/F cESC in panel 
A with a scale bar unit length of 25 μm. The asterisks symbol (*) denotes a nucleus with 
a single focus, the dagger symbol (†) represents a nucleus with multiple H3K27Me3 
clouds and the hash symbol (#) indicates a nucleus without observable condensations.  
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2.3.6 Enhanced colony-forming efficiency but not tumorigenicity of 
2iL cESCs 
Population doubling time and colony-forming efficiency were quantified to compare 
growth kinetics of cESCs populations, which is relevant for gene-targeting applications. 
Culture with 2iL significantly prolonged the calculated linear-phase population doubling 
time from approximately 33 hours in L/F cESCs to 52 hours in 2iL cESC cultures (Fig. 2-
13A, P = 3.0 x 10-3). Moreover, the population doubling interval of both L/F and 2iL 
cESCs were significantly greater than that of conventional mESC and hESC lines (Fig. 2-
13A, P < 0.035). Upon single-cell dissociation, the ability of L/F cESCs to re-establish 
pluripotent SSEA4+ colonies (~ 0.03% efficiency) was not significantly different from 
control media lacking LIF and/or FGF2 (Fig. 2-13B-C). In contrast, singularized 2iL 
cESCs re-seeded into 2i medium without LIF formed SSEA4+ colonies at a significantly 
lower efficiency (0.25%) compared with 2iL cESCs (3.18%) (Fig. 2-13D, P < 0.0001). 
The cloning efficiency achieved with 2i alone was significantly greater than medium 
containing only LIF or control basal medium (Fig. 2-13D, P = 0.045). Individualized 2iL 
cESCs have greater viability in single-cell suspensions compared to L/F cESCs following 
enzymatic dissociation (Fig. 2-13E, P = 0.039). Our findings suggest that 2iL culture 
compromises the rate of cESC proliferation but improves the ability of cESCs to form 
clonal populations, in part by reducing cell death when colonies are disaggregated.  
Intramuscular xenograft assays were performed in NOD/SCID/IL2R-/- immune deficient 
mice to examine whether 2iL and L/F cESCs differ in their capacity for proliferation and 
differentiation in vivo. Control mice injected with hESCs (n = 2/2) generated well-formed 
teratomas by 6 weeks (Fig. 2-14A), composed of mature derivatives of mesoderm 
(hyaline cartilage), endoderm (villus epithelium), and ectoderm (melanocytes). However, 
no overt tumor growth was observed 10 weeks following transplantation of either L/F (n 
= 0/3) or 2iL (n = 0/3) cESCs.  
Prolonged culture of independent 2iL cESC derivations (>20 passages) revealed that 
cESCs in 2iL media have a limited replication capacity in the undifferentiated state. It 
remains possible that karyotypically abnormal cells accumulate within extended cESC  
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Figure 2-13. Altered growth kinetics and colony-forming efficiency between L/F and 
2iL cESCs. 
(A) Calculated population doubling time (hours) from cell counts in steady-state growth 
conditions for L/F cESCs, 2iL cESCs, human ESC line HES2 and mouse ESC line R1. 
(B) Representative images of SSEA4+ colonies from (I) L/F cESC or (II) 2iL cESC 
cultures, five-days post dissociation and seeding at clonal density. Scale bar unit length is 
150 µm. SSEA4+colonies from (C) L/F cESC or (D) 2iL cESC cultures were counted, 
and single-cell cloning efficiency was calculated as a percentage of cells seeded. (E) 
Percentage of viability cESCs following enzymatic dissociation to single-cells of 
individual cESCs was identified by Trypan Blue exclusion. Bars represent standard error 
of the mean, n=3-6. Means followed by the same letter are not significantly different, P < 
0.05. 
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Figure 2-14. In vivo tumorigenicity and differentiation potential of typical human 
ESC line is not recapitulated by either L/F or 2iL cESCs. 
(A) Representative hematoxylin and eosin stained sections of tumour derived from 
human ESC xenografts. Cell types and lineages represented include (I) villus gut 
epithelium (endoderm), (II) hyaline cartilage (mesoderm) and (III) pigmented epithelium 
(ectoderm). (B) Representative metaphase spreads of normal diploid (I) and abnormal 
polyploid (II) canine karyotypes. 
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culture by genetic drift. Metaphase spreads and Giemsa staining revealed detectable 
polyploid cell populations alongside karyotypically normal (2n = 78 XY) cESCs (Fig. 2-
14B). Therefore, disruptions in cESC self-renewal long-term are associated with the 
emergence of karyotypic abnormalities in prolonged cESC culture. 
2.4 Discussion 
cESC lines with differing morphological and cell surface glycoproteins have been 
derived from canine preimplantation embryos (Vaags et al., 2009; Wilcox et al., 2009). 
However, heterogeneous features ascribed to these cESC cultures may be explained by 
the unique genetic backgrounds between individual embryo outgrowths. Previous cESC 
studies have limited the scope of investigation to core pluripotency-associated factors, 
rather than discriminatory markers of naïve versus primed pluripotency. Our data indicate 
that culture in 2iL enriches for a morphologically and molecularly distinct cESC 
population from originating L/F cESCs, which shares several features to other 
mammalian naïve PSCs. This naïve pluripotency-like phenotype was associated with 
elevated STAT3 phosphorylation, induction of several RNA transcripts characteristic of 
the mammalian epiblast and fewer epigenomic modifications associated with gene 
silencing. These findings provide the first evidence that partial repression of MEK1/2 and 
GSK3β in the absence of exogenous FGF2 may support an earlier developmental state in 
cESCs.  
After initial comparisons of the dog and human genome assembly revealed a high degree 
of genomic synteny (Ostrander and Wayne, 2005), the stem cell community was 
optimistic that cESC would exhibit greater similarly to hESC than mESC (Tecirlioglu 
and Trounson, 2007). In the absence of small molecule inhibitors, cESCs require 
exogenous FGF2 co-supplementation for in vitro proliferation (Vaags et al., 2009; 
Wilcox et al., 2009), which is reminiscent of primed mEpiSC/hESC. Conventional hESC 
lines are insensitive to LIF and refractory to nuclear reprogramming towards naïve-like 
pluripotency with 2i alone (Dahéron et al., 2004; Hanna et al., 2010). In contrast, 
mEpiSCs may be reverted to naïve pluripotent state in LIF-containing media and this 
process may accelerated through the application of 2i (Adachi et al., 2018; Han et al., 
2010; Onishi et al., 2012). In this respect, L/F cESCs more closely resemble the 
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developmental plasticity exhibited by mEpiSCs, which may be conferred to a subset of 
cESCs by pre-existing STAT3 signaling pathway activity. Accumulating evidence 
suggest that stabilization of naïve-like pluripotent state in primates requires a more 
comprehensive selection of inhibitors and growth factors (Gafni et al., 2013; Takashima 
et al., 2014; Theunissen et al., 2014; Ware et al., 2014). Hyperactivity of JAK/STAT3 
signaling can drive reprogramming towards a naïve-like pluripotent state despite the 
presence of other antagonistic cues in both mice and humans (Chen et al., 2015; Van 
Oosten et al., 2012), lending support to a conserved role of STAT3 transcriptional 
activity in promoting a naïve pluripotency transcriptional network 
Evolutionary variation to the wiring of pluripotency-associated transcription factors and 
their relationships to developmental signaling pathways may result in species-specific 
GRN memberships, hierarchical relationships, or characteristics of permissive niche 
microenvironments (Barakat et al., 2018; Glinsky, 2015; Kojima et al., 2017). We show 
that OCT4 and SOX2 are detected at similar levels in L/F and 2iL cESCs. Furthermore, 
we observe reciprocal changes in the abundance of NANOG and OTX2, which are 
expressed in the murine ICM/early epiblast or the late epiblast/anterior primitive streak, 
respectively (Acampora et al., 2012; Aizawa et al., 2004; Chambers et al., 2007). These 
findings indicate that changes to core pluripotency GRN topology in cESC during 
transitions between pluripotent states may share greater similarity to mESC/mEpiSC than 
human primed and naïve PSCs. With respect to the functional relevance of extrinsic 
factors promoting canine pluripotency, Luo et al. stipulated that LIF and FGF2 have anti-
apoptotic and pro-proliferation roles in canine iPSC lines, respectively (Luo et al., 2011). 
In a follow up study, the same LIF and FGF2-dependent canine iPSC lines rely on 
paracrine Activin A signaling from MEF feeders (Luo and Cibelli, 2016). Conversely, 
L/F cESCs described in the present study appear to have adopted a self-renewal program 
largely unaided by Activin-SMAD2/3 signaling. We have not yet extended SB431542 
treatments beyond a single passage of L/F cESCs to directly investigate the fundamental 
importance of ALK-SMAD2/3 signaling to long-term maintenance of primed-like cESCs. 
In our culture microenvironment, we provide exogenous ligands for the phosphoinositide 
3 kinase-protein kinase B pathway (e.g. IGF, FGF2) that has been shown to modulate 
104 
 
SMAD2/3 signaling in hESC and in other cell types promote the cytosolic sequestration 
of SMAD2/3 (Conery et al., 2004; Remy et al., 2004; Singh et al., 2012).  
Naïve and primed PSCs correspond to distinct spatiotemporal iterations of the developing 
embryo, and hence may be differentially responsive to lineage specifying cues in ways 
that reflect their in vivo approximate. BMP4 has a role in both naïve pluripotency 
maintenance and lineage restriction in the gastrulating embryo, the latter of which shares 
transcriptomic similarity to primed PSCs (Bernardo et al., 2011; Kojima et al., 2014; 
Ying et al., 2003). Induction of definitive mesoderm markers following BMP4 exposure 
in L/F cESCs but not in 2iL cESCs suggest the former is characteristic of precursors 
undergoing epithelial-to-mesenchymal transition. This response is consistent with the role 
of BMP4 in murine gastrulation in the formation primitive streak mesoderm (Winnier et 
al., 1995). We note that cell fate trajectories of BMP4-treated primed PSCs are highly 
contextual, and relative activities of the FGF or WNT signaling pathways may influence 
the predominant cell fate by crosstalk mechanisms (Bernardo et al., 2011; Bhushan et al., 
2012). mEpiSCs share a transcriptome signature with the anterior primitive streak and 
appear to be poised for neural specification primed PSC (Iwafuchi-Doi et al., 2012; 
Kojima et al., 2014). Our L/F cESCs share a similar lineage bias towards neural lineages 
(Wilcox et al., 2011). We found that 2iL cESCs exhibit a less pronounced neural lineage 
bias under spontaneous differentiation conditions but not when differentiation is directed 
with Noggin. These findings indicate that 2iL cESC are likely not a direct precursor to 
the neural lineage and have a similar capacity for neural differentiation when 
appropriately specified.   
2iL cESC colonies are induced over a prolonged time course (1-2 weeks), which is 
consistent with a selection or epigenetic reprogramming event rather than an adaptive 
response to a unique microenvironment. The difference in global DNA methylation 
between 2iL enriched cESCs compared to L/F cESCs is indicative of an epigenetic 
barrier that prevents the resetting of the most parental cESCs. Similar magnitudes of 
DNA demethylation are observed upon treatment of S/L mESC with 2i and has been 
mechanistically linked altered DNMT and TET enzyme activity (Hackett et al., 2013; 
Leitch et al., 2013). Consistent with the notion that 2iL cESCs adopt an earlier 
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developmental identity, we observed a decline in global H3K27me3. The H3K27me3 
modification is a hallmark of polycomb repressive complex activity that establishes 
facultative heterochromatin during differentiation and the naïve to primed transition 
(Gifford et al., 2013; Tosolini et al., 2018). Histone H3 acetylation was maintained in 2iL 
culture compared to LIF-FGF2 cESCs, which may reflect generalized chromatin 
plasticity of the pluripotent state (Melcer et al., 2012; Meshorer et al., 2006). Further 
experimentation in genetically female cESC lines may shed light on the dynamics of X-
chromosome inactivation in canine development. Interestingly, Whitworth et al. detected 
two active X-chromosomes in female canine iPSC lines and multipotent stromal cells, 
which may indicate species-specific regulation of X-chromosome activation status 
(Whitworth et al., 2014). Otherwise a lack of X-chromosome dosage compensation in 
canine iPSC-derived somatic cells could result from incomplete silencing of the six 
reprogramming transgenes (Whitworth et al., 2014). 
Low clonogenicity related to slow growth kinetics and sensitivity to enzyme-induced 
apoptosis is generally understood as a property of primed PSCs (Hanna et al., 2010). 
Improvements in cloning efficiency with 2iL cESCs (~ 3%) are consistent to what other 
groups have reported in naïve porcine cell lines (~12%), but far below cloning 
efficiencies achieved in hESC and mESC lines (~40%) (Gafni et al., 2013; Gu et al., 
2014). Furthermore, expansion of cESCs in 2iL did not grant teratoma-forming ability in 
immunodeficient mouse xenografts. Canine PSCs have had low success and poor 
reproducibility with these traditional in vivo assays of self-renewal and differentiation 
into mature lineages. The lack of any tumor mass following transplantation suggests that 
apoptosis or senescence within the in vivo niche may be a barrier to successful teratoma 
assay outcomes. Whereas the finite proliferation of 2iL cESCs is similar to what has been 
described for naïve ESC lines independent of ectopic transfactors (Hanna et al., 2010) 
and may reflect the inability of the culture conditions to sustain the naïve transcriptional 
circuitry long-term.  
In summary, the described work represents the first evidence for population-level 
metastability in canine PSCs and reveals an opportunity to alter pluripotent 
characteristics of cESCs using small-molecule kinase inhibitors. This study lends 
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additional support to a conserved role for 2iL in promoting a naïve-like pluripotent state 
in mammals. However, the 2iL culture medium appears to be unable to fully support the 
self-renewal of reset cESCs long term. Given the recent success of empirically 
consolidated kinase inhibitor combinations in primate ESCs, we suspect that subtle 
modifications to the 2iL culture system, alone or in combination with genetic 
modification, may support a stable naïve pluripotency phenotype. Although the growth 
kinetics and bioprocessing characteristics of cESC are suboptimal for applications in 
transplantation medicine, our results demonstrate that the binary L/F and 2iL cESC 
cultures can yield new insights into canine preimplantation development and conserved 
features of mammalian pluripotency. 
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Chapter 3  
3 Pluripotent state influences metabolic activity and 
mitochondrial structure in canine embryonic stem cells 
A version of this chapter has been published:  
Tobias, I.C., Isaac, R.R., Dierolf, J.G., Khazaee, R., Cumming, RC, and Betts, D.H. 
(2018). Metabolic plasticity during transition to naïve-like pluripotency in canine 
embryo-derived stem cells. Stem Cell Research 30, 22-33. 
Reproduced here with permission from Elsevier publishers (Appendix B). 
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3.1 Introduction 
Naïve and primed PSCs are metastable and occasionally interconvertible cell lines, which 
represent different temporal cellular compartments within the pre-implantation embryo 
(Brons et al., 2007; Nichols and Smith, 2009; Tesar et al., 2007). The naïve pluripotent 
state may be established directly from cells of the inner cell mass (ICM) or induced by 
pharmacological manipulation of primed PSCs, with or without the assistance of 
transgenes favouring naïve pluripotency (Bao et al., 2009; Guo et al., 2009; Nichols et al., 
2009). The molecular and functional characteristics that distinguish naïve pluripotency 
are tolerance to partial repression of mitogen-activated protein kinase kinase (MEK) 
signaling and abrogation of T-cell factor 3 (TCF3) signaling (Meek et al., 2013; Wray et 
al., 2011; Zhou et al., 2015), global epigenomic de-repression (Ficz et al., 2013; Leitch et 
al., 2013), reactivation of the silent X-chromosome in female cells (Gafni et al., 2013; 
Ware et al., 2014), ease of clonogenic selection and contribution to embryonic lineages of 
pre-gastrulation embryos (Buecker et al., 2010; Gafni et al., 2013).   
Both naïve and primed PSCs exhibit high rates of glycolysis in hyperoxic environments, 
resembling the aerobic glycolysis phenotype observed in certain transformed cells 
(Racker, 1972; Vander Heiden et al., 2009; Zhang et al., 2012a). The diversion of 
metabolic intermediates from complete mitochondrial oxidation supplies intermediates to 
anabolic pathways, while mitigating the production of reactive oxygen species (ROS) 
(Folmes et al., 2011; Panopoulos et al., 2012; Varum et al., 2009). This metabolic state 
differs from specialized post-natal cell types, which prioritize efficient adenosine 
triphosphate (ATP) synthesis by oxidative phosphorylation (OXPHOS) (Chung et al., 
2007). Interestingly, naïve PSCs have greater rates of respiration despite housing less 
mature mitochondria compared to their primed counterparts (Sperber et al., 2015; Zhou et 
al., 2012). Mitochondrial function is restrained in primed PSCs by uncoupling the 
oxidation of glycolysis-derived pyruvate (Samudio et al., 2009; Zhou et al., 2012). 
Mitochondrial homeostasis and energy production may be linked to pluripotency and 
self-renewal via the metabolic sensor AMP-activated protein kinase (AMPK) (Liu Y et 
al., 2019). However, it remains unclear whether the AMPK pathway is differentially 
regulated in a pluripotent state-specific manner.  
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The existence of a de facto naïve pluripotent state in non-rodent species is controversial. 
However, naïve-like PSC lines have been characterized in various mammalian species 
including porcine (Nakano et al., 2013), rabbit (Osteil et al., 2013), equine (Whitworth et 
al., 2014) and bovine (Verma et al., 2013). Canine ESCs (cESCs) can be derived and 
expanded on mouse embryonic fibroblast (MEF) feeder layers in the presence of 
leukemia inhibitory factor and fibroblast growth factor 2 (L/F) (Tobias et al., 2013). 
These LIF-FGF2 dependent cESCs exhibit features of primed pluripotency such as 
sensitivity to enzymatic passaging regimes, expression of primed pluripotency markers 
(e.g. OTX2, FGF5) and a neural lineage bias in minimal media (Wilcox et al., 2011, 
2009). In the previous chapter, I showed that dual inhibition of MEK and GSK3β along 
with LIF (2iL) conditionally stabilizes cESCs in a pluripotent state that shares several 
properties with canonical naïve PSCs (Chapter 2). Interestingly, our 2iL cESCs show 
markedly slower in vitro growth compared to initiating LIF-FGF2 cESC populations 
(Tobias et al., 2016). Nevertheless, the fundamentals of pluripotent state progression 
appear to be conserved in placental mammals, making it a priority to define the divergent 
attributes and culture requirements of non-rodent equivalents to naïve and primed PSCs. 
PSC metabolism is inherently flexible, permitting the maintenance of proliferation and 
differentiation capacity within a dynamic physicochemical environment (Harvey et al., 
2016), but the persistence of suboptimal conditions would be expected to negatively 
impact PSC physiology. All canine ESC/iPSC lines established to date are maintained in 
media formulations previously optimized for the growth of human or mouse PSCs (Betts 
and Tobias, 2015). Furthermore, imprecise definition of the extrinsic requirements for 
canine PSC self-renewal may hinder the ability of these lines to proliferate extensively in 
vitro or demonstrate pluripotency in vivo through teratoma formation. The goal of this 
work is to assess mitochondrial function and the contribution of bioenergetic pathways to 
proliferation in the undifferentiated state for primed-like LIF-FGF2 cESCs and naïve-like 
2iL cESC populations. We propose that different metabolic pathway activities support 
ATP generation and biomass accumulation necessary for proliferation of cESCs. 
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3.2 Materials and Methods 
3.2.1 Feeder Layer and Embryonic Stem Cell Culture 
MEF monolayer preparation and culture of cESCs were conducted as previously 
described (Tobias et al., 2016). Briefly, E12.5 DR4 MEFs were mitotically arrested and 
seeded at 1.5 x 104 cells/cm2 for ESC co-culture. Canine ESC lines (BE5, IO3) derived at 
the Ontario Veterinary College from embryo explants (OVC.EX) (Wilcox et al., 2009) 
were seeded onto growth-arrested MEFs and cultured in base media: KnockOut 
DMEM/F12, 15% KnockOut Serum Replacement (KOSR), 1X GlutaMAX, 1X non-
essential amino acids, 10 ng/mL recombinant insulin-like growth factor (R3IGF1; Sigma 
Aldrich) and 0.1 mM 2-mercaptoethanol. Base medium was supplemented with 10 
ng/mL human LIF and 4 ng/mL human FGF2 for maintenance of control L/F cESCs; or 
10 ng/mL human LIF, 0.5 μM MEK inhibitor PD0325901 and 3 μM GSK3β inhibitor 
CHIR99021 for establishment and culture of 2iL cESCs (Tobias et al., 2016). To deplete 
MEF contamination prior to experiments, cESCs were transferred to Geltrex-coated 
dishes and cultured with 70% MEF-conditioned medium balanced with non-conditioned 
base media. Control human ESC line HES-2 (Reubinoff et al., 2000) and murine ESC 
line R1 (Nagy et al., 1993) were adapted and maintained in base medium containing 15% 
KOSR for at least three passages prior to analyses to standardize nutrient availability 
(Zhang et al., 2016). Incubators were maintained at 37°C, 5% CO2 and ambient oxygen. 
Unless otherwise stated, all cell culture reagents were obtained from Thermo Fisher 
Scientific (MA, USA). Inhibitors of metabolic enzymes were from Sigma Aldrich (MO, 
USA). 
3.2.2 Oxygen Consumption Rate and Extracellular Acidification 
Rate 
Cells were seeded onto Geltrex-coated XFe24 Seahorse plates (Agilent Technologies) at 3 
× 104 or 6 × 104 cells per well. Culture media were exchanged for unbuffered media 
supplemented with either 1 mM sodium pyruvate and 10 mM glucose (Mitochondrial 
assay); or 2 mM glutamine (Glycolysis assay) one hour before the assay. After basal 
metabolic readings were recorded, substrates and selective inhibitors were injected to 
achieve final concentrations of: glucose (2.5 mM), 4-(trifluoromethoxy) phenylhydrazone 
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(FCCP, 1 μM), oligomycin (1 μM), 2-deoxyglucose, (2-DG, 50 mM) antimycin A (2.5 
μM) and rotenone (2.5 μM). Changes in oxygen consumption rate (OCR) and 
extracellular acidification rate (ECAR) in response to the addition of substrates/inhibitors 
were described as the mean change after injection compared with the average OCR or 
ECAR before the injection. The OCR and ECAR values were normalized to the total 
quantity of protein isolated from each well. 
3.2.3 Protein Extraction, SDS-PAGE and Western Blotting 
Cells were lysed in 100 μL RIPA buffer (150 mM sodium chloride, 1% NP-40, 0.5% 
sodium deoxycholate, 0.1% sodium dodecyl sulfate, 50 mM Tris, pH 8.0) with a protease 
and phosphatase inhibitor cocktail (EMD Millipore) for 15 minutes on ice. Supernatant 
protein concentration was determined by DC™ Protein Assay (BIO-RAD Technologies). 
Protein lysates were resolved on 4-12% SDS-PAGE gels (Thermo Fisher Scientific), 
transferred onto Immobilon polyvinylidene difluoride membranes followed by incubation 
with 5% skim milk powder/TBS/0.1% Tween-20 for 1 hour. Antibodies used in the work 
are summarized in Table 3-1. After 16 hours of primary antibody incubation, membranes 
were incubated with HRP-coupled secondary antibodies for 1 hour at room temperature. 
Immune-reactive proteins were visualized by chemiluminescence on Molecular Imager® 
VersaDoc™ System and Quantity One software (BIO-RAD Technologies). Densitometry 
was performed using ImageLab 3.0 software (BIO-RAD Technologies). 
Table 3-1. Primary antibody information 
Target Protein Isotype Species Application 
(Dilution) 
Supplier (Catalog) 
ACC1 Rabbit WB (1:1000) Cell Signaling (3662) 
p-ACC (S79) Rabbit WB (1:1000) Cell Signaling (3661) 
AMPKα Rabbit WB (1:500) Cell Signaling (2603) 
p-AMPKα (T172) Rabbit WB (1:500) Cell Signaling (2535) 
ATP5A Mouse WB (1:1000) Abcam (AB14748) 
FASN Mouse WB (1:1000) Santa Cruz (sc-48357) 
GLUT1 Rabbit WB (1:500) Santa Cruz (sc-7903) 
HXK2 Mouse WB (1:2000) Novus (NBP2-02272) 
LDHA Rabbit WB (1:1000) Cell Signaling (2012) 
MIC60 Rabbit WB (1:2000) Novus (NB100-1919) 
PDH (E1α) Mouse WB (1:2000) Abcam (AB110334) 
p-PDH (S232) Rabbit WB (1:2000) Millipore (AP1063) 
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PKM1 Rabbit WB (1:1000) Proteintech (15821-1AP) 
PKM2 Rabbit WB (1:1000) Proteintech (15822-1AP) 
PDHK1 Rabbit WB (1:1000) Enzo (ADI-KAP-
PK112) 
SDHB Mouse WB (1:1000) Abcam (AB14745) 
TOMM2 Rabbit WB (1:1000) Proteintech (11802-1AP) 
UQCRC2 Mouse WB (1:1000) Abcam (AB14714) 
 
3.2.4 Flow Cytometric Analysis of cESC-MEF Co-cultures 
To discriminate cESCs from feeder cells, the plasma membrane of MEFs were stained 
with lipophilic dialkylcarbocyanine dyes (Nakayama et al., 1992) in either the green (SP-
DiOC18) or far red (Di-D) fluorescent spectrum. Adherent MEFs were stained with 5 
μg/mL of Di-D or SP-DiOC18 diluted in culture media for two hours at 37°C. MEFs were 
washed twice with PBS prior to seeding L/F or 2iL cESCs. Events were recorded using 
the Accuri C6 platform (BD Bioscience) using standard laser configuration, a flow rate of 
35 μL/minute and the following optical filters: 533/30 (FL-1), 585/40 (FL-2), 670 LP 
(FL-3) and 675/25 (FL-4). Single colour or fluorescence minus one control samples 
containing an equivalent volume of diluent were included to set analyses gates and to 
threshold background autofluorescence. Briefly, the single-cell population was gated by 
pulse processing (pulse height vs. pulse area) to remove cell dublets and obvious debris. 
Markers were applied to FL-1A and FL-4A cytograms to exclude SP-DiOC18 or Di-D 
stained MEFs from further interrogation. Average fluorescence intensity values from are 
presented as the geometric mean. 
3.2.5 Chemifluorescence and Flow Cytometry 
JC-1 green fluorescence reflects JC-1 monomers and the formation of J+-aggregates in 
the mitochondrial matrix leads to orange fluorescence. The dual-colour properties of JC-1 
allows a ratiometric comparison of relative mitochondrial polarization states (Cossarizza 
et al., 1993; Smiley et al., 1991). Tetramethylrodamine methyl ester (TMRM) is a 
yellow-red fluorescent stain, which is highly sensitive to changes in the mitochondrial 
electrochemical gradient (Scaduto and Grotyohann, 1999). However, MitoTracker Green 
FM has been reported to stain mitochondria regardless of chemical ablation of the ΔΨm 
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(Buckman et al., 2001). For mitochondrial labelling, single live cells in suspension were 
adjusted to a density of approximately 1 x 106 cells/mL in flow staining buffer and 
incubated with 200 nM MitoTracker Green or 5 μg/mL JC-1 for 30 minutes protected 
from light. Alternatively, single live cells were incubated with 150 nM TMRM for 15 
minutes. 30,000 total events were recorded at a flow rate of 35 μL/minute. In JC-1 
experiments, spectral compensation was performed by subtracting 12% of FL-1A from 
FL-2A. In TMRM experiments, spectral compensation was performed by subtracting 9% 
of FL-1A from FL-2A. Relative ΔΨm was calculated as geometric mean of FL-2A 
fluorescence intensity (for TMRM) or the ratio of FL2-A: FL1-A geometric mean 
fluorescence intensity (J+-aggregate: JC-1 monomer). 
3.2.6 Chemifluorescence and Live Cell Imaging 
Cells were stained for 1 hour with 1 μM Calcein Green AM and then 15 minutes with 25 
nM TMRM diluted in Live Cell Imaging Solution (Thermo Fisher Scientific). Cells were 
imaged within a 5% CO2 live cell imaging chamber mounted on the stage of a Leica DMI 
6000B microscope. Digital images were captured with an Orca Flash camera 
(Hamamatsu Photonics) and Application Suite X software (Leica Microsystems). 
Exposure time, illumination intensity and experimental duration were minimized to 
preserve mitochondrial integrity and avoid artefactual changes in fluorescence intensity 
(Iannetti et al., 2016; Mitra and Lippincott-Schwartz, 2010).  Brightness and contrast 
were standardized to unstained control samples and the equivalent imaging parameters 
were applied to all other images using ImageJ. Membrane potential was calculated as the 
change in fluorescence intensity of TMRM in redistribution (non-quenching) mode after 
FCCP-induced mitochondrial depolarization. Calcein fluorescence was recorded to 
control for plasma membrane integrity. Fluorescent intensity was monitored for five 
minutes to establish baseline values (set to 100%) and an additional fifteen minutes after 
treatment with 250 nM FCCP or vehicle (DMSO). The mean fluorescent intensity of 
cytoplasmic foci corresponding to mitochondria in cESCs was measured using ImageJ 
(National Institutes of Health, MD). 
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3.2.7 Mitochondrial and Genomic DNA Isolation and Quantitative 
PCR 
Mitochondrial DNA (mtDNA) and genomic DNA were purified from cESC pellets using 
GenElute Mammalian Genomic DNA Miniprep Kit (Sigma Aldrich), according to 
manufacturer's instructions. Quality and quantity of DNA was determined through 
spectrometry using a NanoDrop ND-2000 (NanoDrop Technologies). Oligonucleotide 
primers targeting cytochrome oxidase II (MTCOII) were designed from published canine 
mtDNA sequences (Kim et al., 1998) using accession number U96639.2. Polycystin-1 
(PKD1) was selected as a single copy genomic reference gene in the domestic dog 
(Dackowski et al., 2002). Primer sequences and amplicon sizes are summarized in Table 
3-2. Specificity of each primer set was determined by gel electrophoresis, band excision 
and sequencing of the resultant amplicon using the Applied Biosystems 3730 DNA 
Analyzer (London Regional Genomics Center). Quantitative PCR was performed using 6 
ng of template DNA and SensiFAST ™ SYBR (Bioline Reagents, MA). Thermal cycling 
conditions included 2 minutes at 95°C followed by 39 cycles of 95°C for 5 seconds, 62°C 
for 10 seconds and 72°C for 20 seconds. Reaction data were corrected for individual 
primer amplification efficiencies, calculated from a standard dilution series. Relative 
transcript abundance was determined using CFX384 Real-time system on a C1000 
Thermal Cycler (BIO-RAD Technologies) CFX software and calculated using 2-ΔΔCt 
method. 
Table 3-2. Custom oligonucleotide primer sequences. 
Gene Identifier Sequence (5’ to 3’) Size (bp) 
MTCO2 F – ATCGCTCTACCTTCCCTCCG 
R – ACAGTCCTGGTCGTATGGCT 
349 
PKD1 F – AGCTGCATAACTGGATCGACAAC 
R – ATGTAACGCATGGGGAACCG 
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3.2.8 Sample Preparation for Transmission Electron Microscopy 
Briefly, cells were washed with PBS and fixed directly on the plate with a pre-warmed 
1:1 mixture of media and Karnovsky’s fixative (2% Paraformaldehyde, 2.5% 
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Glutaraldehyde, 0.1 M Sodium Cacodylate, pH 7.4) for 10 minutes. Cells were gently 
scraped into a 1.5 mL microcentrifuge tube and gently pelleted at a very low speed (200 
RCF with no centrifuge braking). Cells were resuspended in pure Karnovsky’s fixative 
(10-20X the pellet volume) for 15 minutes, then gently pelleted and resuspended in fresh 
Karnovsky’s fixative. Primary fixation continued for 2 hours, then cells were washed four 
times in 0.1 M Sodium Cacodylate buffer, pH 7.4 for 5 minutes each. Samples were 
encapsulated 2% agarose, cut into 1 mm cubes using a razor and soaked for one hour in 
0.5% Osmium Tetroxide in foil-wrapped glass tubes on crushed ice. Samples were rinsed 
three times in 0.1 M Cacodylate buffer for 10 minutes each, followed by another three 
washes in water for 40 minutes each. Samples were soaked for eight hours in a half-
saturated Uranyl Acetate solution, and then rinsed six times in water for 30 minutes each. 
Agarose pieces were transferred through a graded series of acetone at: 20%, 50%, 70%, 
95%, and finally three times at 100% for 15 minutes each. Samples were placed on a 
rotary mixer will be embedded with graded mixtures of Epon-Araldite resin and acetone 
at 1:2 overnight, 1:1 for eight hours, 2:1 overnight and finally pure resin for five hours. 
Molds of samples were prepared and baked at 60 °C for 96 hours. Ultra-thin sections (70 
nm) were retrieved from cell-containing areas of the resin blocks and placed on 200 mesh 
nickel grids. Post-staining of grids was carried out with 2% Uranyl Acetate for 15 
minutes and Reynold’s Lead Citrate for 1 minute, rinsing with water between stains. 
Grids were air-dried and imaged within 48 hours. 
3.2.9 Mitochondrial Morphometric Image Analysis 
At least 60 images containing 18 distinct cells were taken from coded L/F and 2iL cESC 
samples using a Philips CM10 transmission electron microscope at 34,000X 
magnification for observation of 380 total mitochondria. Mitochondrial counts, 
dimensions and cristae orientation were assessed by blinded investigators using ImageJ. 
The aspect ratio was calculated as the ratio between the unit length of major and minor 
axes for mitochondrial ellipsoids. The cristae density was calculated from the cristae 
number normalized to calculated mitochondrial surface area. To evaluate the degree of 
cristae alignment within mitochondria, cristae angles were recorded to calculate the mean 
incident angle between cristae. 
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3.2.10 Metabolic Inhibitor Treatment and Cell Counting  
20,000 cESCs were seeded into multiwell plates and total cell counts were performed 
every 24 hours for 4 days using a hemocytometer. For inhibitor treatments, cells adhered 
overnight in the absence of inhibitors and growth in the presence of inhibitors was scored 
after 48 hours. Data are presented as the fold change in total cell number relative to the 
initial cell number at the 0-hour time point. 2-deoxy-D-glucose (2-DG) and Rotenone 
(RTN) were diluted into culture media to final concentrations of 1.25 mM and 250 nM, 
respectively. Concentrations used in our assays were determined by single inhibitor dose-
titrations to find the minimum concentration affecting cell proliferation.  
3.2.11 Cellular ATP Detection Assay 
L/F and 2iL cESCs were treated with 2-DG, RTN or vehicle and diluted to 100,000 
cells/mL in cESC culture media. Cell suspensions were transferred to an opaque white 
96-well microplate (10,000 cells/well) and ATP content was determined using the 
Luminescent ATP Detection Assay Kit (Abcam). Luminescence was quantified with the 
SpectroMax M5 (Molecular Devices, CA) instrument and ATP content (pM/cell) was 
interpolated from an eight-point standard curve. 
3.2.12 Cell Death and Apoptosis Assay 
The incidence of cell death and apoptosis during steady-state growth and inhibitor assays 
was assessed by measuring the percentage of 7-aminoactinomycin D (7-AAD)/Annexin-
V positive cells. Briefly, single cells suspended in Annexin binding buffer (10 mM 
HEPES, 140 mM Sodium Chloride, 2.5 mM Calcium Chloride, pH 7.4) were stained with 
fluorescein isothiocyanate (FITC) Annexin-V conjugate (Thermo Fisher Scientific) for 
20 minutes and 7-AAD Viability staining solution (eBioscience) for 5 minutes. 20,000 
total events were recorded using an Accuri C6 flow cytometer (BD Biosciences). Spectral 
compensation was performed by subtracting 2% of FL1 from FL3 to adjust for minor 
FITC overlap into FL-3. Changes in cell viability was assessed as the mean proportion of 
Annexin-V-FITC-/7-AAD- (viable), Annexin-V-FITC+/7-AAD- (apoptotic) or Annexin-
V-FITC+/7-AAD+ (dead) cells. 
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3.2.13 Statistical Analysis 
Data were analyzed using R (version 3.2.3) by two-sample composite t-test or one-way 
analysis of variance (ANOVA) followed by Tukey’s HSD multiple comparison method 
as appropriate. P < 0.05 was considered statistically significant. Data were visualized 
using GraphPad Prism 6 and presented as mean +/- standard error of the mean (SEM). 
3.3 Results 
3.3.1 Enhanced glucose oxidation and respiratory capacity in 2iL 
cESC 
Glycolytic and oxidative metabolism in ESCs were assessed by measuring the 
extracellular acidification rate (ECAR) and oxygen consumption rate (OCR), respectively 
(Zhang et al., 2012b). To explore if activation of mitochondrial respiration is a feature 
conserved in naïve-like cESCs, we compared the metabolic rate measurements of BE5 
cESCs maintained in L/F or 2iL, HES-2 human (h)ESCs and R1 murine (m)ESCs. OCR 
was monitored after cells were successively exposed to oligomycin (OLIGO), 4-
(trifluoromethoxy)-phenylhydrazone (FCCP) and antimycin A/rotenone (Fig. 3-1A).  
In the presence of glucose, both R1 mESCs (P=1.03 x 10-4) and 2iL cESCs (P=0.025) 
have greater OCR: ECAR ratio compared to primed-like L/F cESCs and hESCs (Fig. 3-
1B). The respiration attributable to ATP-synthase activity did not differ between hESCs, 
LIF-FGF2 or 2iL cESCs (P=0.25) but was markedly greater in mESCs (P=6.8 x 10-6) 
(Fig. 3-1C). The fold change in OCR following FCCP-stimulated maximal respiration (a 
measure of mitochondrial spare capacity) is significantly elevated in 2iL cESCs (P=1.40 
x 10-3) and R1 mESCs (P=7.2 x 10-6) in comparison to primed human ESCs and L/F 
cESCs (Fig. 3-1D). However, rate measurements correlating to basal oxygen 
consumption (P=0.024), ATP synthase-linked respiration and mitochondrial spare 
capacity (P=0.013) in 2iL cESCs all remain below naïve mESCs.  
To assess if enhanced 2iL cESC respiration is reproducible in a different genetic 
background, we examined OCR responses to chemical manipulation of mitochondrial 
function in IO3 cESCs (Fig. 3-2A). Like BE5 cESCs, we observed a statistically  
123 
 
  
Figure 3-1. Culture in 2iL enhances glucose oxidation and respiratory capacity of 
BE5 cESCs. 
(A) Oxygen consumption rate (OCR) tracing of BE5 LIF-FGF2 cESCs, BE5 2iL cESCs, 
HES-2 hESCs and R1 mESCs. Addition of oligomycin reduces OCR and reflects 
respiration independent of oxidative phosphorylation. Addition of FCCP stimulates 
electron transport chain activity and maximal OCR. Addition of Antimycin A/Rotenone 
(mitochondrial chain complex inhibitors) shows OCR independent of mitochondrial 
metabolism. (B) Basal OCR with respect to ECAR in glucose-containing media (C) 
Relative decreases in OCR after oligomycin injection. (D) Relative increases in OCR 
after FCCP injection. Rate measurements were normalized to total protein quantified by 
Lowry assay. Bars represent standard error of the mean (SEM), n = 5. Means followed by 
the same letter are not significantly different, P < 0.05. 
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Figure 3-2. 2iL-induced respiration is reproducible in IO3 cESC line. 
(A) Oxygen consumption rate tracing of IO3 LIF-FGF2 cESCs, IO3 2iL cESCs, R1-
derived epiblast-like stem cells and R1 mESCs. (B) Basal OCR with respect to ECAR in 
glucose-containing media (C) Relative decreases in OCR after oligomycin injection. (D) 
Relative increases in OCR after FCCP injection. Rate measurements were normalized to 
total protein quantified by Lowry assay. Bars represent standard error of the mean (SEM), 
n = 5. Means followed by the same letter are not significantly different, P < 0.05. 
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significant increase in basal OCR: ECAR ratio (P=1.94 x 10-5) and mitochondrial spare 
capacity (P=0.042), but not ATP-coupled respiration (P=0.30) in IO3 2iL cESCs 
compared to L/F cESCs (Fig. 3-2B-D).   
3.3.2 Altered mitochondrial ultrastructure but not mitochondrial 
biomass in 2iL cESC 
We next sought to quantify mitochondrial content to determine if altered mitochondrial 
biomass contributed to cESC metabolic function. Lipophilic dialkylcarbocyanine dyes 
were applied to co-cultured MEFs to discriminate cESC-specific signals by flow 
cytometry (Fig. 3-3A-B). The geometric mean of MitoTracker Green FM fluorescence 
intensity was significantly lower in the 2iL cESC population (Fig. 3-3C-D, P=4.40 x 10-
3). Whereas, the geometric mean of forward scatter (FSC) intensity, an estimate of cell 
size, was not different between L/F and 2iL cESCs (Fig. 3-3E-F, P=0.97). Therefore, it is 
unlikely that altered cell volume contributed to the observed change in MitoTracker 
Green FM accumulation in cESCs. We probed cESC lysates for TOMM20, an integral 
component of the outer mitochondrial membrane (Rassow and Pfanner, 2000), as a 
surrogate measure of mitochondrial content. TOMM20 abundance was not different in 
2iL cESCs compared to originating L/F cESCs (Fig. 3-4A, P=0.21). Similarly, we 
observed no change in the relative mitochondrial DNA (mtDNA) quantity between L/F 
and 2iL cESCs (Fig. 3-4B, P=0.53). The level of Mitofilin (MIC60), an inner 
mitochondrial membrane protein associated with tubular cristae formation (Hessenberger 
et al., 2017), was significantly reduced in 2iL cESCs compared to L/F cESCs (Fig. 3-4C, 
P=9.0 x 10-4). 
Alterations to 2iL cESC mitochondrial ultrastructure may affect MitoTracker Green FM 
accumulation despite indications that overall mitochondrial biomass are unchanged. 
Using transmission electron microscopy, we observed that mitochondria of both L/F and 
2iL cESCs were typically arranged in perinuclear clusters (Fig. 3-5A). Furthermore, the 
internal structure of L/F and 2iL mitochondria exhibited several contrast features selected 
for detailed morphometric analysis (Fig. 3-5B-C). Mitochondria visualized in L/F cESCs 
tended to have lower overall abundance and larger surface area compared to 
mitochondria within 2iL cESCs, but these metrics were not considered statistically 
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Figure 3-3. 2iL cESCs show lower MitoTracker Green FM accumulation 
independent of cell size. 
Representative inclusion gating of (A) Di-D labelled MEFs and (B) unstained cESCs in 
co-culture on SSC-A vs. FL4-A cytograms to exclude contaminating MEFs from flow 
cytometric analysis. (C) Overlay FL1-A histogram and (D) quantification of geometric 
mean MitoTracker Green FM intensity as an estimate of mitochondrial mass in 
singularized L/F and 2iL cESCs. (E) Overlay histogram of forward light scatter area 
(FSC-A) and (F) quantification of change in FSC-A as an estimate of relative L/F or 2iL 
cESC size. Bars represent standard error of the mean (SEM), n = 3. Means followed by 
the same letter are not significantly different, P < 0.05. 
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significant (Fig. 3-5D, P=0.1403 and P=0.1866). 2iL cESCs contained shorter and more 
rounded mitochondria with respect to mean aspect ratio compared to mitochondria within 
L/F cESCs (Fig. 3-6A, P=0.003). Mitochondria from L/F and 2iL cESCs exhibit a similar 
density of cristae membranes (Fig. 3-6B, P=0.861). Interestingly, the mitochondria in 2iL 
cESCs exhibited poorer pairwise alignment of crista membranes (i.e.  0° represents 
parallel membrane orientation), with a mean incident cristae angle of 58.02° compared to 
38.07° in L/F cESCs (Fig. 3-6C, P=0.019). 
3.3.3 Increased mitochondrial membrane potential and ATP level 
in 2iL cESC 
Cellular ATP production is regulated by mitochondrial membrane potential (ΔΨm), 
which is established by electron transport and the coincident transport of protons to the 
intermembrane space (Ehrenberg et al., 1988; Kamo et al., 1979). We assessed 
mitochondrial polarization state using the ΔΨm-sensitive dyes tetramethylrhodamine, 
methyl ester (TMRM) and JC-1 to explore the relationship between mitochondrial 
respiration and proton-motive force in cESCs. 
Contrary to the anticipated result, quantification of cells stained with JC-1 (Fig. 3-7A, 
P=4.60 x 10-3) or TMRM (Fig. 3-7B, P=1.30 x 10-3) by flow cytometry showed 
significant reductions in the relative ΔΨm of 2iL cESCs compared to those expanded in 
L/F. However, quantification of fluorescent intensity per cell may not be a reliable 
comparison if ultrastructural changes in mitochondria affect probe uptake and retention 
kinetics between L/F and 2iL cESCs. Rather than performing a static comparison 
between whole cell mitochondrial polarization states, we sought to quantify the dynamic 
re-distribution of TMRM upon selective depolarization of ΔΨm by live cell fluorescent 
microscopy (Fig. 3-7C). 2iL cESCs exhibited a significantly greater decrease in TMRM 
fluorescence intensity following FCCP-mediated depolarization compared to L/F cESCs 
(Fig. 3-7D, P=0.0106). Calcein Green AM fluorescence intensity was maintained after 
FCCP treatment (Fig. 3-8), suggesting that viability or plasma membrane integrity do not 
confound TMRM re-distribution.  
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Figure 3-7. Dynamic redistribution but not static accumulation of mitochondrial 
polarization-sensitive dyes correlates with respiratory activity in cESCs. 
(A) Geometric mean J-aggregate intensity to JC-1 monomer intensity ratio (FL2-A : FL1-
A) in singularized L/F and 2iL cESCs. (B) Geometric mean tetramethylrhodamine, 
methyl ester (TMRM) fluorescence intensity (FL2-A) in singularized L/F and 2iL cESCs. 
(C) Time course of TMRM mean fluorescence intensity before (baseline) and after 
selective depolarization FCCP. Calcein Green AM mean fluorescence intensity was also 
recorded as an indicator of plasma membrane integrity. (D) Magnitude of FCCP-
mediated reduction in TMRM staining in redistribution conditions. Bars represent 
standard error of the mean, n = 4-6. Means followed by the same letter are not 
significantly different, P < 0.05. 
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Figure 3-8. Selective decrease in mitochondrial but not cytosolic staining with FCCP 
treatment. 
L/F and 2iL cESCs were monitored for TMRM (red) or Calcein Green AM (blue) 
fluorescence for a duration of 20 minutes. Initial readings establish baseline fluorescence 
intensity (0-5 minutes) and afterwards the change in fluorescence intensity after FCCP 
(250 nM) or vehicle treatment (6-20 minutes) was monitored. Representative 
micrographs are shown, and scale bar unit length is 50 µm. 
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We next investigated the abundance of mitochondrial chain complex subunits by 
immunoblot analysis. 2iL cESCs exhibited a significant increase (P=1.5 x 10-3) in 
succinate dehydrogenase iron sulfur subunit B (SDHB; complex II) and lower (P=0.026) 
F1-ATP synthase subunit 5 alpha (ATP5A; complex V) (Fig. 3-9A-C) abundance 
compared to L/F cESCs. Ubiquitinol-cytochrome c reductase core protein 2 (UQCRC2; 
complex III) did not significantly differ between L/F and 2iL cESCs (Fig. 3-9D, P=0.53). 
Furthermore, steady-state ATP levels were greater in 2iL cESCs compared to L/F cESCs 
(Fig. 3-10A, P=1.0 x 10-5). This result is corroborated by enhanced phosphorylation of 
AMP-activated protein kinase (AMPK) at Thr172 (Fig. 3-10B-C, P=0.044) as well as 
increased Ser79 phosphorylation of acetyl-CoA carboxylase (ACC1), a canonical AMPK 
target enzyme, in L/F cESCs compared to 2iL cESCs (Fig. 3-10D, P=0.020). Reliable 
signals could not be obtained for antibodies directed against human cytochrome C 
oxidase 2 (MTCOX2; complex IV) and NADH: ubiquinone oxidoreductase subunit B8 
(NDUFB8; complex I) due to poor amino acid conservation in the canine homologs 
(<85% similarity by blastp algorithm).   
3.3.4 Differentiation regulation of pyruvate metabolizing enzymes 
is associated with altered lipid accumulation 
Multiple enzymes responsible for pyruvate flux into the TCA cycle are differentially 
regulated in naïve versus primed PSC populations (Zhang et al., 2011; Zhou et al., 2012). 
Therefore, we assessed the levels of proteins involved in pyruvate handling by 
immunoblot analysis. L/F cESCs exhibited increased levels of lactate dehydrogenase 
isoform A (LDHA), a key enzyme in maintaining high glycolytic flux, compared to 2iL 
cESCs (Fig. 3-11A-B, P=0.01). Whereas levels of M2 isoform of pyruvate kinase 
(PKM2), an isoenzyme associated with elevated aerobic glycolysis in transformed cells, 
exhibited similar levels in L/F and 2iL cESCs (Fig. 3-11C, P=0.65). However, the M1 
isoform of pyruvate kinase (PKM1), which is suggested to promote mitochondrial 
pyruvate oxidation (Taniguchi et al., 2016), was significantly enriched in 2iL cESCs (Fig. 
3-11D, P=0.013). Surprisingly, levels of pyruvate dehydrogenase (PDH) kinase 1 (Fig. 3-
11E-F, P=0.045) and the ratio phosphorylated PDH to total PDH (Fig. 3-11G, P=7.0 x 10-
3) were both elevated in 2iL cESCs. 
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Figure 3-9. Altered respiratory chain complex subunit abundances between L/F 
and 2iL cESCs. 
Representative western blot membrane images of L/F and 2iL cESC whole lysates 
probed for F1 ATP synthase alpha subunit (ATP5A), succinate dehydrogenase beta 
(SDHB), ubiquinol-cytochrome c reductase core protein 2 (UQCRC2) and reference 
protein beta-actin. Densitometric quantification of protein levels for (B) SDHB, (C) 
ATP5A, and (D) UQCRC2. Means are normalized to internal standard beta-actin and 
expressed as relative ratios to L/F cESC samples. Bars represent standard error of the 
mean, n = 4. Means followed by the same letter are not significantly different, P < 
0.05.  
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Figure 3-10. 2iL cESCs display elevated ATP content and AMPK signaling. 
(A). Calculation of cellular ATP by interpolating standard curve values in a 
luminescent microplate assay and normalized to cell number. (B) Representative 
western blot membrane image for phosphorylated and total AMP-activated protein 
kinase (AMPK) or acetyl-CoA carboxylase (ACC). Protein quantification by 
densitometry for (C) AMPK phosphorylation (D) ACC phosphorylation. Means are 
normalized to internal standard beta-actin and expressed as relative ratios to L/F 
cESC samples. Bars represent standard error of the mean (SEM), n= 4-7. Means 
followed by the same letter are not significantly different, P < 0.05. 
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Incomplete oxidation of glucose may favour the redirection of intermediate metabolites 
towards anabolic processes, such as lipogenesis (Tohyama et al., 2016). We therefore 
investigated the level of neutral lipids within L/F and 2iL cESCs using Nile Red. Flow 
cytometric analysis revealed greater mean fluorescence intensity associated with neutral 
lipids in L/F cESCs compared to 2iL cESCs (Fig. 3-12A-B, P=3.0 x 10-4). Nile Red 
fluorescence attributable to polar lipids, such as phospholipids, did not significantly differ 
between L/F and 2iL cESCs (Fig. 3-12C, P=0.78). Indeed, fatty acid synthase (FASN), a 
key enzyme in de novo lipogenesis, was significantly more abundant in L/F cESC than 
2iL cESC protein lysates (Fig. 3-12D, P=0.015). 
3.3.5 HXK2 level and glycolytic capacity are correlated among 
mammalian ESC lines 
To examine glycolytic activity in PSC lines, ECAR was monitored after the sequential 
addition of glucose, oligomycin and 2-deoxy-D-glucose (2-DG) (Fig. 3-13A). ECAR 
measurements in the absence of glucose, or after 2-DG exposure, did not differ between 
all lines tested, implying that non-glycolytic acidification mechanisms did not 
substantially contribute to ECAR observations. Glucose-induced ECAR (i.e. glycolytic 
acidification) in L/F cESCs were equivalent to those recorded from naïve-like R1 mESCs 
or 2iL cESCs (P=0.88) and lower than HES2 hESCs (P=0.046) (Fig. 3-13B). 
Oligomycin-stimulated ECAR (i.e. maximum glycolytic capacity) was equivalent 
between L/F and 2iL cESCs (P=0.98), but significantly lower than R1 mESC (P=6.3 x 
10-3) and HES2 hESC lines (P=9.25 x 10-3) (Fig. 3-13C). However, the quotient of 
oligomycin and glucose stimulated ECAR (i.e. glycolytic reserve capacity) was 
augmented in 2iL cESCs (P=0.017), HES2 hESCs (P=4.59 x 10-3) and R1 mESCs (P=1.0 
x 10-7) compared to LIF-FGF2 cESCs (Fig. 3-13D). Interestingly, L/F cESCs, 2iL cESCs, 
HES2 hESC and R1 mESC did not show any difference in constitutive glucose uniporter 
GLUT1 quantity (Fig. 3-14A, F=0.20456, P=0.89). However, rate-limiting glycolytic 
enzyme Hexokinase-2 (HXK2) (Bissonnette et al., 1996) differed among ESC 
populations (Fig. 3-14B, F=11.38, P = 3.0 x 10-4). HXK2 level was significantly greater 
in HES2 (P=3.02 x 10-2) and R1 (P=2.0 x 10-4) compared to L/F cESCs, which exhibited 
similar HXK2 levels to 2iL cESCs (P=0.68). 
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Figure 3-13. Both L/F and 2iL cESC exhibit lower glycolytic capacities than human 
or mouse ESC. 
(A) Extracellular acidification rate tracing of LIF-FGF2 cESCs, 2iL cESCs, HES-2 
hESCs and R1 mESCs measured by Seahorse extracellular flux analyzer. Addition of 
glucose to cells equilibrated in glucose-free media establishes the basal glycolytic rate. 
Addition of oligomycin stimulates glycolytic flux in response to a deficiency in 
mitochondrial ATP production resulting in maximum ECAR. The difference between 
baseline ECAR and rate measurements after injection of 2-DG is non-glycolytic 
acidification. (B) Relative changes in ECAR after glucose injection. (C) Relative changes 
in ECAR after oligomycin injection. (D) Difference between oligomycin and glucose 
stimulated ECAR. Rate measurements were normalized to total protein quantified by 
Lowry assay. Bars represent standard error of the mean (SEM), n = 5. Means followed by 
the same letter are no significantly different, P < 0.05.  
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Figure 3-14. Both L/F and 2iL cESCs exhibit lower HXK2 abundance compared to 
human or murine ESC. 
(A) Representative western blot membrane image of hexokinase 2 (HXK2), constitutive 
glucose uniporter (GLUT1) and reference protein beta-actin in L/F cESC, 2iL cESC, 
HES2 hESC and R1 mESC. Protein quantification by densitometry for (B) GLUT1 and 
(C) HXK2. Bars represent standard error of the mean (SEM), n = 3. Means followed by 
the same letter are not significantly different, P < 0.05. 
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3.3.6 Bioenergetic pathway inhibition differentially affects L/F and 
2iL cESCs 
We used inhibitors of the electron transport chain (ETC) and glycolysis to dissect the 
contributions of these metabolic pathways to acute L/F and 2iL cESC proliferation. 
Given that 2iL cESCs have greater respiratory and glycolytic reserve capacities than L/F 
cESCs, we posited that 2iL cESC expansion would be less sensitive to bioenergetic 
pathway antagonism. Expansion of L/F cESCs was impaired by 2-DG, a competitive 
inhibitor of HXK (Fig. 3-15A, P=2.24 x 10-3), without altering the proportion of live cells 
(Fig. 3-16B, P=0.58). In contrast, the mitochondrial complex I inhibitor RTN did not 
alter L/F cESC proliferation (Fig. 3-15A, P=0.67) or viability (Fig. 3-15B, P=0.89). 2iL 
cESC expansion was unaffected by the presence 2-DG (Fig. 3-15C, P=0.92), however, 
RTN exposure decreased acute proliferation 2iL cESC expansion (Fig. 3-15C, P=6.30 x 
10-3) without a change in cell viability (Fig. 3-15D, P=0.67).  
Exposure of L/F cESCs to 2-DG and RTN during steady-state growth did not 
significantly affect the ATP content (Fig. 3-16A, F=3.185, P=0.065). Whereas, ATP 
levels within 2iL cESCs were sensitive to the presence of partial blockade of bioenergetic 
pathways (Fig. 3-16B, F=61.439, P=9.08 x 10-9). Interestingly, treatment of 2iL cESCs 
with RTN (P=1.0 x 10-7), but not with 2-DG (P=0.93), significantly decreased ATP 
concentrations. No significant changes in the proportion of apoptotic or dead cells were 
detected in either cESC population for the duration of 2-DG exposure (Fig. 3-17A-C, 
P=0.84 & P=0.20) or RTN treatment (Fig. 3-17D-F, P=0.80 and P=0.74). 
3.4 Discussion 
Our data indicate that 2iL-enriched cESCs display enhanced mitochondrial respiration, 
increased mitochondrial intermembrane potential, remodeling of mitochondrial 
ultrastructure, and changes in the abundance of enzymes involved in pyruvate handling, 
electron transport and lipid synthesis. Pluripotent state-associated changes in cESC 
metabolic pathway activity and enzyme abundance have a functionally relevant impact 
on cESC ATP synthesis and proliferation. Our study provides the first evidence for 
suboptimal glycolytic flux in cESCs lines as well as extensive remodeling of the cristae  
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Figure 3-16. Selective metabolic pathway inhibition affects ATP level of 2iL cESCs 
but not L/F cESCs.  
Quantification of cellular ATP level in (A) L/F cESCs or (B) 2iL cESCs following acute 
exposure to 2-deoxy-D-glucose (2-DG) or rotenone (RTN). Bars represent standard error 
of the mean (SEM) n = 5. Means followed by the same letter are not significantly 
different, P < 0.05. 
 
144 
 
  
Figure 3-17. Titrated metabolic pathway inhibitors do not increase apoptotic or 
dead cESCs.  
(A) Representative dotplots of Annexin V-FITC and 7-aminoactinomycin D (7-AAD) 
stained cESCs treated with 2-deoxyglucose (2-DG) or vehicle. Quantification of (B) 
apoptotic and (C) dead cells following treatment with 2-DG or vehicle. (D) 
Representative dotplots of Annexin V-FITC and 7-AAD stained cESCs treated with 
rotenone (RTN) or vehicle. Quantification of (E) apoptotic and (F) dead cells following 
treatment with RTN or vehicle. Bars represent standard error of the mean (SEM) n = 3. 
Means followed by the same letter are not significantly different, P < 0.05. 
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membranes associated with a metabolic switch towards mitochondrial metabolism with 
naïve-like pluripotency induction.  
We found that 2iL subculture enriches for a cESC population with greater respiratory 
spare capacity and a preference for mitochondrial glucose oxidation under steady-state 
conditions compared to L/F cESCs. Augmented cellular respiration has also been 
reported upon induction of naïve-like hESCs (Takashima et al., 2014) and may represent 
a conserved attribute of naïve pluripotency in placental mammals. We found that elevated 
respiratory capacity 2iL cESCs is not associated with any difference in overall 
mitochondrial biomass with respect to L/F cESCs. However, 2iL cESCs predominantly 
contain smaller, rounded mitochondria that morphologically similar to those within 
mouse ESC and chemically induced naïve-like human ESC (Sperber et al., 2015; Zhou et 
al., 2012). We investigated glycolytic enzymes upstream of mitochondrial substrate 
provision and identified increased levels PKM isoform 1 and a lower LDH isoform A 
level in 2iL cESCs. These observations are suggestive of increased mitochondrial 
pyruvate and NADH availability at the expense of LDH-mediated NAD+ regeneration 
(Fantin et al., 2006). Elevated phosphorylation of PDH would be expected to limit 
pyruvate conversion to acetyl-CoA in 2iL cESCs, implicating reductive carboxylation of 
pyruvate as an alternative mechanism of TCA cycle replenishment. As a plausible 
consequence of greater pyruvate oxidation, fewer metabolic intermediates may be 
available for anabolic pathways such as de novo lipogenesis (Tohyama et al., 2016). We 
found that L/F cESCs exhibited greater FASN abundance and accumulated more 
intracellular neutral lipids than 2iL cESCs.  
In contrast to previous reports that mitochondria within naïve-like ESCs are qualitatively 
cristae-poor (Ware et al., 2014; Zhou et al., 2012), we observed that mitochondrial cristae 
density is preserved in 2iL cESCs. Furthermore, we quantified previously unrecognized 
changes to the degree of cristae organization between different states of pluripotency in 
vitro. 2iL cESCs contained mitochondria with disorganized cristae that project along the 
periphery of the organelle rather than assuming a lamellar, axis-spanning orientation. The 
arch-like inner mitochondrial membranes within 2iL cESCs are similar to those described 
in early preimplantation embryos (Baharvand and Matthaei, 2003; Sathananthan and 
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Trounson, 2000), suggesting that immature mitochondrial morphology is not an artifact 
of in vitro culture. Altered cristae architecture is associated with changes to the 
abundance of Mitofilin/MIC60, a component of the mitochondrial contact site and cristae 
organizing system (Hessenberger et al., 2017). We also observed, but did not directly 
quantify, the widening of cristae, particularly at the tips and the cristae junctions. 
Conceivably, lower abundance of catalytic ATP synthase subunits in 2iL cESCs could 
limit the pool of oligomerized ATP synthase complexes, which induce membrane 
curvature and restrict the circumference of cristae rims and tips (Davies et al., 2012). 
Structural changes to the cristae inflate the intracristal space, increasing the diffusion 
distance needed to traverse the outer mitochondrial membrane and plausibly function as a 
proton or ROS reservoir (Plecitá-Hlavatá and Ježek, 2016).  
The transition from OXPHOS to aerobic glycolysis in human and mouse ESCs is 
accompanied by coordinated changes in mitochondrial chain complex subunit expression 
(Zhou et al., 2012), electron transport chain (ETC) activity and ATP synthesis by 
OXPHOS. However, reconfiguration of membrane composition or chain complex 
stoichiometry can have a less obvious influence on mitochondrial function through the 
formation of supercomplexes that channel substrates and electron carriers (Dudek et al., 
2013; Lapuente-Brun et al., 2013). We identified an enrichment of SDHB subunit (i.e. 
complex II) and a reduction of ATP5A subunit (i.e. complex V). The observed changes in 
respiratory chain subunits implicate both altered OXPHOS kinetics or efficiency and 
expedited conversion of succinate to fumarate in the TCA cycle. Our data also suggest 
that increased cellular ATP level may promote global changes in 2iL cESCs through 
retrograde signaling via the energy-sensing AMPK pathway (Herzig and Shaw, 2018), or 
speculatively ATP-dependent chromatin remodeling enzymes (Zhang et al., 2018). 
We find that L/F cESCs do not exhibit the mitochondrial reserve capacity to oxidize 
pyruvate thereby rendering L/F cESCs dependent on glycolysis for in vitro growth. 
Indeed, inhibition of electron transport had no effect on the acute expansion of L/F cESC, 
whereas blockade of glycolysis was observed to reduce L/F cESC proliferation 
independent of ATP. This is consistent with respirometry experiments with hESCs 
(Sperber et al., 2015) and reports that ETC activity is dispensable for maintenance of 
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primed pluripotency (Varum et al., 2009). In contrast, 2iL cESCs showed both elevated 
respiratory and glycolytic reserve capacity and were tolerant to partial inhibition of 
glycolysis by 2-DG, implicating that divergent metabolic programs support proliferation 
in L/F and 2iL cESCs with regards to glucose utilization. Comparative experiments 
including hESC/mEpiLC, mESC, L/F and 2iL cESC lines indicate that glycolytic 
capacity is not influenced by pluripotent state. However, there appears to be a canine-
specific reduction in glycolytic capacity that coincides with prolonged population 
doubling intervals observed cESC lines. Glucose uptake and metabolism are typically co-
regulated by transcriptional programs controlling cell growth and proliferation (e.g. 
MYC), however we observe a selective decrease in HXK2 in cESCs compared to mESC 
or hESC (Dang et al., 2008). Indeed, several tumor-suppressor pathways involving 
micro-RNA species or autophagic clearance have been implicated in selective HXK2 
repression (Jiao et al., 2018; Liu et al., 2017; Peschiaroli et al., 2013).  
Enhanced glycolytic reserve capacity observed in oxidative 2iL cESCs suggests a degree 
metabolic pathway flexibility that resembles the ‘bivalent’ metabolic responses observed 
with naïve R1 mESCs than primed HES-2 hESCs. However, 2iL cESC proliferation and 
ATP generation was sensitive to RTN exposure, which is dissimilar to experiments 
performed in naïve mESC (Vlaski-Lafarge et al., 2019). Lower ATP content of RTN-
treated 2iL cESCs could signify that glycolysis alone cannot meet the bioenergetic 
demand for steady state growth of 2iL cESCs. Conversely, RTN treatment may be 
associated with ROS production (Li et al., 2003) and indirectly affecting cellular ATP 
through retrograde ROS signaling mechanisms. We have not yet followed up on the 
potential contributions of redox-sensitive retrograde signaling pathways such as nuclear 
respiratory factor (NRF), p53 and p21 that are understood to influence the cell cycle and 
mitochondrial metabolism (Chandel et al., 2000; Khacho et al., 2016; Passos et al., 2010).  
The described work represents the first evidence of suboptimal glycolytic flux in cESCs 
lines as well as extensive remodeling of the cristae membranes associated with a 
metabolic switch towards mitochondrial metabolism with naïve-like pluripotency 
induction in the dog. Our data demonstrate that L/F cESCs exhibit a preferentially 
glycolytic and anabolic phenotype. Whereas 2iL cESCs acquire both glycolytic and 
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respiratory reserve capacities but remain less bioenergetic and metabolically flexible than 
naïve mESC. This study lends additional support to the notion that cellular metabolism is 
a conserved discriminatory readout of pluripotent states in placental mammals. However, 
species-specific attributes appear to constrain glycolytic flux in cESCs and metabolic 
bivalency achievable through a 2iL-supported naïve pluripotent state. 
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Chapter 4  
4 Bioactive metabolite supplementation promotes 
mesenchymal-to-epithelial transition in early canine 
reprogramming 
4.1 Introduction 
Domestic dogs are susceptible to a spectrum of inherited and acquired diseases with 
analogy to humans (Ostrander et al., 2000; Sutter and Ostrander, 2004). Exposure to 
environmental mutagens during human-canine coexistence (Backer et al., 2008) as well 
as similarities in immune system anatomy and development (Storb and Thomas, 1985) 
have likely contributed to these shared pathologies. Approximately 94% of the canine 
genome is syntenic to the human assembly and considered conserved ancestral sequence 
(Lindblad-Toh et al., 2005; Ostrander and Wayne, 2005). Modeling the effect of disease-
associated loci in a variety of cell types has been made feasible by the ectopic expression 
of a defined set of factors to generate induced pluripotent stem cells (iPSCs) (Takahashi 
and Yamanaka, 2006). However, the routine use of canine iPSCs has been limited by 
protocol inconsistency (Betts and Tobias, 2015), low number of clonal iPSC lines 
established (Chow et al., 2017; Luo et al., 2011) and a lack of quantitative evidence of 
long-term self-renewal. Despite a high degree of synteny through evolution, studies of 
several putative canine iPSC lines have revealed unique features compared to human 
iPSC including the requirement of LIF/STAT3 signaling for prolonged self-renewal 
(Chow et al., 2017; Koh et al., 2013; Luo et al., 2011).  
Global analyses of epigenetic modifications in reprogramming intermediates suggest that 
progress towards a pluripotent state is constrained by repressive modifications on 
chromatin (Apostolou and Hochedlinger, 2013; De Carvalho et al., 2010). Focal DNA 
demethylation during iPSC generation and maintenance of hypomethylated chromatin in 
pluripotent cells are mediated by the ten-eleven translocation (TET) family of 
methylcytosine dioxygenase (Bagci and Fisher, 2013; Wu and Zhang, 2017). TET 
enzymes mediate active-active and active-passive mechanisms of DNA demethylation, 
through the oxidation of 5-methylcytosine (5-mC) into a variety of cytosine substituents 
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that may be recognized by base-excision repair machinery (He et al., 2011; Ito et al., 
2011). Functional genomics and computational modelling of iPSC derivation indicate 
that engagement of reprogramming transfactors with previously silent regulatory 
sequences facilitates local epigenetic remodeling and elevated transcriptional output at 
critical pluripotency regulators (Koche et al., 2011; Soufi et al., 2012). Recently, it was 
demonstrated that TET recruitment and active demethylation at pluripotency-associated 
enhancers and promoters, occurs prior to chromatin opening and stable transcriptional 
activation (Sardina et al., 2018).  
The density of CpG islands (CGIs) is the highest in the domestic canine genome 
assembly among completely sequenced placental mammals, despite no genome-wide 
difference in the parameters used to define CGIs (Han et al., 2008). Mammalian genomes 
contain subgroups of high CpG (HCP), intermediate CpG (ICP) and low CpG promoters 
(LCP), each with a distinct relationship between DNA methylation and transcriptional 
activity (Meissner et al., 2008). HCPs contain at least one de facto CGI (Fouse et al., 
2008) and are generally not transcriptionally active when methylated (Antequera et al., 
1990; Deaton and Bird, 2011; Weber et al., 2007). TET binding is elevated at CpG-rich 
sequences such as CGIs, owing to its CXXC domain (Williams et al., 2011; Xu et al., 
2011). TET enzymes lacking the CXXC domain exhibit similar genomic localization, 
albeit with lower enrichment, suggesting that protein-protein interactions also contribute 
to TET recruitment (Zhang et al., 2016). 5-hydroxymethylcytosine (5-hmC), a stable 
product of TET-catalysis (Bachman et al., 2014), is critical to the maintenance of active 
cis-regulatory modules (CRMs). The demethylated state of pluripotency-associated 
enhancers and promoters are dependent on TET because these regions gain the greatest 
de novo methylation in TET1-3 triple knockout mESCs (Lu et al., 2014).  At least one 
competent TET paralog is required for successful acquisition of pluripotency by somatic 
cell reprogramming (Hu et al., 2014). 
Reprogramming canine fibroblasts with integrating vectors is reported to be highly 
protracted process (30-40 days) (Koh and Piedrahita, 2015), and the molecular events 
during canine reprogramming have not been characterized or time-resolved. An 
understanding of the bottlenecks in canine somatic cell reprogramming is vital to increase 
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the probability of successful reprogramming and map the molecular events in canine 
pluripotency acquisition. The temporary use of small molecules to enhance the 
endogenous DNA demethylation machinery is a promising strategy to improve the 
efficiency and kinetics of reprogramming in challenging cell populations. Kinetics are 
critical for non-integrating gene delivery systems, such as Sendai virus (SeV) vectors, 
with a limited timeframe for cells to achieve transgene-independence. 
Several physiological metabolites have been demonstrated to regulate TET abundance, 
catalytic activity or recruitment including alpha-ketoglutarate, L-ascorbic acid (Vitamin 
C) and retinoic acid (a derivative of Vitamin A) (Blaschke et al., 2013; Carey et al., 2014; 
Hore et al., 2016; Yin et al., 2013). TET enzymes have affinity for CpG-rich sequences 
that are frequent in a canine genome, as well as other regulatory elements when recruited 
by pluripotency transcription factors in a reprogramming context. It is conceivable that 
TET proteins might have an important role in active DNA demethylation, or otherwise 
enable more permissive histone modifications by indirect cross-talk mechanisms, at 
endogenous DNA- and chromatin-binding pluripotency regulators in the uniquely CpG 
island-rich canine genome. However, the soluble factors controlling TET abundance and 
activity in a somatic nuclear environment, and how they could be leveraged in 
reprogramming canine cells has yet to be explored.  
Taking advantage of the efficient, non-integrating CytoTune SeV gene-delivery system, 
which is designed as self-limiting and non-transmissible (Ban et al., 2011; Fusaki et al., 
2009), we investigated whether modifiers of DNA methylation could promote early 
canine de-differentiation. We highlight that initiation of canine fetal fibroblast 
reprogramming features a mesenchymal-to-epithelial transition within the first week, 
which is bolstered by physiological metabolites that enhance TET-mediated 5-hmC 
generation. 
4.2 Materials and Methods 
4.2.1 Genomic Sequence Retrieval and Processing 
Genomic sequence and gene features were retrieved from the Ensembl genome browser 
(Release 92) using the biomaRt/Bioconductor package. The 5’-flanking sequences of 1-1-
159 
 
1 orthologous genes from the canine (CanFam3.1), human (GRCh38.p12) and mouse 
(GRCm38.p6) genomic assemblies were accessed using biomaRt (Drost and Paszkowski, 
2017). For hierarchical cluster analysis, the common orthologs of three additional 
Eutherian species were included: rabbit (OryCun2.0), porcine (Sscrofa11.1) and bovine 
(UMD3.1). See Table 4-1 for specific details regarding the retrieval of differentially 
expressed gene sets accessed in this work.  Our analysis included regions 2 kilobases 
upstream and 500 bases downstream of each transcription start site, as defined by track 
RefSeq genes (O’Leary et al., 2016). Retrieved sequences with large gaps (ambiguous 
bases [N] > 250) were excluded from further analyses, whereas smaller gaps were 
accounted for in DNA string length calculations. 
Table 4-1. Summary of conserved reprogramming-associated gene products.  
Study Information Data Accessed Resultant Gene List 
Mouse Fibroblast 
Reprogramming 
(Nefzger et al., 2017)  
Accessed list of highly correlated 
genes (fibroblast versus 
neutrophil/keratinocyte) with 
correlation coefficient cut-off of 0.9 
and a minimum of 4-fold change 
POU5F1, PRDM14, 
DNMT3B, TET1, SALL4, 
EZH2, NANOG, DPPA4, 
SOX2, JARID2, LIN28A, 
OTX2, NR5A2, NR0B1, 
ZFP42, TRIM71, TET2, 
FOXH1, WDR5, MYBL2, 
KDM2B. 
Human Fibroblast 
Reprogramming 
(Tanaka et al., 2015)  
Accessed list of Type III/ESC 
genes (Table S3). Identified by 
factor loadings in principle 
components. 
 
4.2.2 Identification of CpG Islands and Calculation of CpG 
Sequence Metrics 
Promoter sequence bioinformatics were performed using applications from the European 
Molecular Biology Open Software Suite (EMBOSS 6.6.0) (Rice et al., 2000). Putative 
CGIs were revealed with the “newcpgreport” EMBOSS tool, using the default application 
parameters. Promoters were further characterized as High CpG Promoters (HCP), 
Intermediate CpG Promoters (lCP) or Low CpG Promoters (LCP) according to 
established criteria (Fouse et al., 2008; Weber et al., 2007): Briefly, HCP must contain at 
minimum a 500-bp window where fractional GC-content  is greater than 0.55 and 
CpGobs/CpGexp ratio is greater than 0.6; whereas ICP include any regions falling 
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between LCP and HCP; finally LCP must lack a CpG rich 500 bp window but exhibit a 
CpGobs/CpGexp ratio is >0.4. 
We identified and scored focal CpG-rich regions using the “newcpgseek” EMBOSS tool, 
which computes a running sum of clustered CpG dinucleotides from all positions in the 
sequence. Additionally, for each retrieved promoter the whole sequence CpGobs/CpGexp 
ratio was calculated: 
𝐶𝑝𝐺 𝑅𝑎𝑡𝑖𝑜 =
(𝐶𝑜𝑢𝑛𝑡𝐶𝑝𝐺  ×  𝐿𝑒𝑛𝑔𝑡ℎ𝑏𝑝)
(𝐶𝑜𝑢𝑛𝑡𝐶  ×  𝐶𝑜𝑢𝑛𝑡𝐺)
 
 
4.2.3 Sequence Alignment and Motif Discovery 
In the obtained promoters, pairwise alignment and identification of conserved non-coding 
sequence was performed using mVISTA (http://genome.lbl.gov/vista/index.shtml). 
Position weight matrices were accessed from the JASPAR 2018 database. Transcription 
factor binding motif discovery was performed with “jaspscan” EMBOSS tool using the 
default parameters. Consensus motifs were visualized as a sequence logo graphic 
(http://weblogo.threeplusone.com/). 
4.2.4 Primary Cell Culture 
Primary canine adult dermal fibroblast was purchased from National Institute of General 
Medical Science Repository (Coriell Institute, Camden, NJ). Additionally, canine fetal 
fibroblasts amendable to somatic cell nuclear transfer-mediated reprogramming (Jeong et 
al., 2012) were a gift from Dr. Jeong Yeon-Woo of Sooam Biotech Research Foundation 
(Seoul, South Korea). Somatic cells maintained in DMEM high glucose supplemented 
with 10% FBS, 2 mM GlutaMax, 1X non-essential amino acids and 0.5 mM 2-
mercaptoethanol. 
4.2.5 Somatic Cell Reprogramming 
Two days prior to transduction, canine fibroblasts were seeded at 5 x 104 cells/well of a 
six-well plate. Using the CytoTune 2.0 Reprogramming Kit, Sendai viral vectors (SeV) 
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encoding human KOS (KLF4/OCT4/SOX2), c-MYC and KLF4 were added to individual 
wells containing 2 x 105 cells according to manufacturer’s protocol with some 
modifications. The KOS and c-MYC SeV vectors were applied at a multiplicity of 
infection (MOI) of 6, based on transduction efficiencies achieved using CytoTune 
emGFP reporter (Thermo Fisher Scientific). The KLF4-SeV vector MOI was increased 
from 3 to 5 to improve the transcriptional output of the reprogramming vectors (personal 
communication with Thermo Fisher Scientific).  
Two days post-infection (DPI), fibroblast medium was supplemented with either 0.1 nM 
Retinoic Acid/100 µM Ascorbic Acid (RA/AA) or an equivalent volume of diluent 
(vehicle). Treatments were applied with daily medium exchanges for four days. At 6 DPI, 
the transduced cells were bulk passaged and transferred (3 x 104 cells) to 10 cm culture 
dishes containing 2 x 104/cm2 γ-irradiated CF1 strain MEFs (Applied Stem Cell). For 
analysis of 6 DPI intermediates, 0.8 x 106 cells were pelleted, submerged in 300 µL 
RNAlater (Sigma Aldrich) and stored at -80°C until nucleic acid extraction. Presumptive 
canine iPSCs were maintained in basal medium containing Knockout DMEM/F12, 20% 
KSR (Tobias et al., 2016; Yoshida et al., 2009) or DMEM with 10% FBS. Co-cultures of 
transduced canine fibroblasts and arrested MEFs were monitored for epithelialization and 
the emergence of primary colonies. For clonal isolation (10-20 DPI), primary colonies 
were mechanically isolated with a pipet tip and transferred into a Geltrex- and MEF-
coated 48-well plate.    
4.2.6 Reverse Transcription and Quantitative PCR 
Total RNA from cultured cells was isolated using PureLink RNA kit (Thermo Fisher) 
and quantified using a NanoDrop spectrophotometer. 500 ng of total RNA was treated 
with RQ1 DNase (Promega) and used to synthesize cDNA using the Superscript III 
Reverse Transcription kit (Thermo Fisher) with 1.25 µM each of oligo dT and random 
hexamers. Aliquots of cDNA were diluted 1:20 in nuclease-free water for use as template 
in qPCR reaction mixtures containing: 5 µL SensiFast SYBR (BioLine Reagents), 1 µL 
primer mixture (500 nm final), 2 µL nuclease-free water and 2 µL template. PCR assays 
were run on using the CFX384 Real-Time System (BIO-RAD). Thermal cycling 
conditions included 2 minutes at 95°C followed by 39 cycles of 95°C for 15 seconds and 
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60°C for 30 seconds. Annealing temperatures were optimized for the amplification of a 
single product of expected size, excised and sequenced at the London Regional Genomics 
Center (Robarts Research Institute, ON) to confirm specificity. All custom primer 
sequences and amplicon sizes can be found in Table 4-2. Reaction data were corrected 
for individual primer amplification efficiencies, calculated from a standard dilution 
series. The expression ratio for genes of interest were normalized to two reference genes 
(TBP and RPS5) and calculated using the 2-ΔΔCt method.  
Table 4-2. Custom oligonucleotide primer sequences.  
Gene Identifier Sequence (5’ to 3’) Amplicon Size 
TET1 F – CCAGTTAACCCGACCTGTCC 
R – CGGCCGAGAGCCATTAGAAA  
124 
TET2 F – AGCACATTGGTATGCACCCT 
R – TGTCGGCATGTCTTGACTGG  
224 
TET3 F – GCCCCCTACTCAGGAAATGA 
R – GGTAGAAAAAGGGCTCTCGGG  
223 
CDH1 F – AGGCTAACGTCGAAATCGCT  
R – GAGGATGACCTCAAACGGGG  
236 
CDH2 F – ACGGACCCAAACAGCAATGA  
R – ACAGACACAGTTGCCGTTGA  
155 
DSP F – AATCCTCTGGCCGTAGACCT  
R – CCTGACGCATCGTTTTCAGC  
175 
KRT19 F – AGCTCACCATGCAGAACCTC  
R – GACGGGCATTGTCAATCTGC  
237 
SMAD2 F – AAGTGGTGTGAGAAAGCGGT  
R – GGCCTGTTGTATCCCACTGA  
187 
SNAI2 F – GAACTGGACACGCACACAGT  
R – CACACGGTAATGGGGCTGTA  
116 
VIM F – TTCAGAGAGAGGAAGCCGAGA  
R – AGGTCAGGCTTGGAAACATCC  
214 
TBP F – GAGCTCTGGGATCGTGCCGC 
R – TCAGTGCAGTGGTTCGGGGC   
167 
RPS5 F – TCACTGGTGAGAACCCCCT  
R – CCTGATTCACACGGCGTAG  
141 
 
4.2.7 Targeted Bisulfite PCR 
Genomic DNA (gDNA) from cultured cells was isolated using GenElute Mammalian 
Genomic DNA Miniprep kit (Sigma Aldrich). Genomic DNA was eluted in 30 µL of 
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sterile TE buffer pH 8.0 and determine concentration using NanoDrop 2000 spectroscopy 
(Thermo Fisher Scientific). Bisulfite modification and purification was performed using 
the EZ DNA Methylation Gold kit (Zymo Research) with 400 ng of gDNA. Eluted 
bisulfite-converted DNA was used immediately for PCR using Platinum Taq Polymerase 
and primer pairs designed to target the 5’-flanking sequences close to the transcriptional 
start site of canine OCT4 and NANOG (Luo et al., 2011). See Table 4-3 for primer 
sequences and amplicon sizes. To account for stochastic amplification, three parallel 25 
µL reactions for each template and primer combination were performed, pooled and re-
aliquoted for future steps. Nested re-PCR was performed with 3 µL of the resultant 
bisulfite-PCR reaction mixture. PCR amplifications used variations of the following 
thermal cycling protocol: 3 minutes at 94°C; 35 cycles of 94°C for 20 seconds, 59-64°C 
gradient for 15 seconds, 72°C for 15 seconds; 72°C for 5 minutes final extension. In 
nested re-PCR reactions a touchdown annealing range of 70-64°C was added before 
amplification cycles. 
Table 4-3. NANOG and OCT4 primer sequences for bisulfite PCR.  
Primer Set Sequence (5’ to 3’) Amplicon Size 
NANOG_OUT F – GTATTTTTGATTTTAAAGGATGGA 
R – AAAACCTCCACATATAAAAAATAAA  
359 
NANOG_IN F – TAGAAATATTTAATTGTGGGGTT 
R – CATATAAAAAATAAAAAAAAAACAAAAT 
312 
OCT4_OUT F – AGGTTAGTGGGTGGGATTGG  
R – CCTTAAAACAACAACCCCACTC  
362 
OCT4_IN F – AGGTGTTGAGTAGTTTTTAGGAGA  
R – ACTCCCACCTAAAATCCACAATA  
314 
 
4.2.8 Clone Sequencing and Methylation Analysis 
Fresh PCR amplicons were ligated into pCR2.1 vectors and transformed into TOP10 
competent E. coli using TA cloning kit (Thermo Fisher). Bacteria were plated onto LB 
agar with ampicillin and streaked with X-gal. No more than 10 white bacterial colonies 
were picked for each biological replicate and transferred into 3-mL of LB medium with 
antibiotic. Clones were grown for 16 hours in a 37°C bacterial incubator. The plasmid 
DNA were purified with Presto Mini Plasmid kit (Frogga Bio) and sequenced with 3730 
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DNA Analyzer System (Applied Biosciences) using M13 forward and reverse primers 
(London Regional Genomics Centre, Robarts Research Institute). Base calls, quality 
trimming, vector clipping and contig assembly was performed using the pre-Gap and 
Gap4 tools (Staden Package) (Staden, 1996). To determine accurate methylation patterns 
on target regions, at least 18 total processed clone sequences were aligned to the 
reference genomic sequence using methVisual R/Bioconductor package (Bioconductor 
release 3.6) (Zackay and Steinhoff, 2010). Alignment and quality control functions were 
used to compute bisulfite conversion rate and percentage sequence identity. The 
methylation state for each CpG site was exported from the quality-checked aligned 
sample sequences. For each acceptable clone, we adjusted cytosine methylation level to 
the bisulfite conversion rate (Biscon): 
𝐴𝑑𝑗𝑢𝑠𝑡𝑒𝑑 𝐶𝑦𝑡𝑜𝑠𝑖𝑛𝑒 𝑀𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑖𝑜𝑛 𝐿𝑒𝑣𝑒𝑙 =
(
𝐶𝑚𝑒𝑡ℎ
𝐵𝑖𝑠𝑐𝑜𝑛
⁄ )
𝐶𝑡𝑜𝑡𝑎𝑙
 
4.2.9 DNA Enzyme-linked Immunosorbant Assay (ELISA) 
Genomic DNA was isolated as described above (see Section 2.4), aliquoted and diluted to 
10 ng/µL. Global 5-methylcytosine or 5-hydroxymethylcytosine level were assessed from 
100 ng of total gDNA using 5-mC DNA ELISA Kit or Quest 5-hmC DNA ELISA Kit 
(Zymo Research), according to the manufacturers’ recommendations. Briefly, percent 5-
mC or 5-hmC was interpolated from a five-point standard curve and adjusted based on 
the CpG dinucleotide density of the reference genome assembly for the species under 
investigation.   
4.2.10 RT2 Profiler PCR Array Analysis 
Total RNA from cultured cells was isolated using PureLink RNA kit (Thermo Fisher) 
and quantified using a NanoDrop spectrophotometer. Genomic DNA digestion was 
performed using the RNase-free DNase Set (Qiagen). For the RT2 Profiler PCR array, 
400 ng of RNA was reverse transcribed to cDNA using the RT2 First Strand Kit (Qiagen). 
Quantitative PCR was performed using the Canine Epithelial-Mesenchymal Transcription 
RT2 Profiler PCR Array (Qiagen) according to manufacturer’s guidelines. Data generated 
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from the PCR Array was analyzed as expression ratios using five reference genes 
(ACTB, B2M, GAPDH, HPRT1, RPLP1) and calculated using the 2-ΔΔCt method. 
Differentially expressed transcripts targets were validated using custom oligonucleotide 
primers and qPCR analysis (see section 4.2.6).  
4.2.11 Statistical Analysis 
Experiments were not randomized, and the investigators were not blinded to allocation 
during experiments and outcome assessment. No statistical method was used to 
predetermine sample size. Sample sizes specific to each figure are denoted in figure 
legends. A p-value < 0.05 was considered significant. When two groups were compared, 
an unpaired t-test or, if assumptions of normality and equal variance were violated, a 
Wilcoxon rank sum test was performed. For multiple group comparisons, either one-way 
analyses of variance (ANOVA) or the non-parametric Welch’s ANOVA was applied. A 
two-way ANOVA was performed in instances of two grouping variables. Where 
significance existed for a grouping factor, Tukey or Games-Howell post-hoc methods 
were carried out to determine differences between groups. Permutation tests were applied 
to determine if promoter class assignments and CpG richness scores are independent. For 
correlation analyses, the linear association was assessed using Spearman’s rho statistic.  
All statistical analyses and plotting were carried out using R 3.5.0 statistical computing 
environment. 
4.3 Results 
4.3.1 A subset of reprogramming-associated orthologues is CpG-
rich in the canine genome assembly. 
We first sought to assess the conservation of CpG-rich sequences and CGIs, which are 
targets of cytosine modification enzymes, in the promoter sequences of shared 
orthologous genes between canine, human and mouse. To this end, we compiled a gene 
set from the intersection of differentially expressed genes between day 0 of 
reprogramming and the iPSC state in humans and mice (Nefzger et al., 2017; Tanaka et 
al., 2015). The gene set filtered based on Gene Ontology terms “DNA binding” or 
“Chromatin binding” and limited to those with a RefSeq annotated canine ortholog. 
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STRING protein association network construction showed the resultant gene set form 
two interconnected clusters of conventional pluripotency transcription factors (e.g. 
NANOG, ZFP42) and epigenetic modifying enzymes (e.g. JARID2, DNMT3B) (Fig. 4-
1A). Peripheral components of the set consist of general regulators of proliferation with 
complex contributions to reprogramming (e.g. MYBL2, TRIM71) (Chang et al., 2012; 
Ward et al., 2018).  
The promoter class assignments in 22 qualifying regions associated with reprogramming 
are distinct from the class allocations in 40 randomly selected background loci filtered 
based on gene Ontology Terms “DNA binding” (GO:0003677) or “Chromatin binding” 
(GO:0003682) (P = 0.039, Permutation Test).  We observe marginally greater numbers of 
HCPs in the canine promoter set, however this distribution of promoter classes was not 
significantly different from human or mouse (Fig. 4-1B, P = 0.587 & P = 0.575, 
Permutation Test). It remained plausible that canine promoter sequences are more CpG-
rich but fall below the threshold of CGIs. We performed pairwise comparisons between 
CpG richness scores from each species, using permutational percentile tests which 
account for subsets of promoter sequences contributing to data asymmetry within groups 
(Mangiafico, 2015). The median was not significantly different among canine-human (P 
= 0.156), canine-mouse (P = 0.08) or mouse-human (P =1) pairs. However, the 75th 
percentile was significantly different between canine and mouse (P = 0.038), but not 
canine-human (P = 0.107) or human-mouse (P = 0.526) pairs (Fig. 4-1C).  
To determine if the CpG sequence features among canine promoters diverge from other 
placental mammals (human, mouse, rabbit, porcine, bovine), we assessed paired 
association of whole promoter CpG ratio. Hierarchical cluster analysis of species grouped 
canine with murine promoter sets away from a porcine, human, bovine and rabbit cluster 
(Fig. 4-2). This analysis also highlighted that, among the mammalian promoters 
collected, canine sequences exhibit the greatest dissimilarity aside from rabbit. Whereas, 
clustering of promoters revealed four groups: 1) high CpG ratio in all species (SOX2,  
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Figure 4-1. Class assignments and CpG-rich sequence score among promoters of 
genes associated with somatic cell reprogramming. 
(A) STRING network visualization of putative protein-protein interactions between 
common differentially expressed genes in human and mouse reprogramming time course 
transcriptome experiments. K-means clustering (k=2) of networks demarcates DNA-
binding and chromatin modifying enzymes. (B) Proportion of sequences assigned to high 
CpG promoter (HCP), intermediate CpG promoter (ICP) and low CpG promoter (LCP) 
classifications. (C) CpG richness score of promoter sequences from canine, human and 
mouse genome assemblies. Permutational percentile tests (PPT) were used to determine if 
the distribution of samples were significantly different between species at different 
quartiles (median = PPT50, Q3/upper quartile = PPT75). The indicated quartiles of 
sample distributions that are followed by the same letter are not significantly different.  
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Figure 4-2. A subset of promoters associated with reprogramming is exclusively 
CpG-rich in the canine genome. 
Comparison of CpG ratio by hierarchical cluster analysis between collected promoters 
from different mammalian superorders: Euarchontoglires (Human, Mouse, Rabbit) and 
Laurasiatheria (Canine, Porcine, Bovine). A CpG ratio approaching 0 indicates few 
cytosine and guanine bases are arranged in CpG dinucleotides, whereas a CpG ratio 
approaching 1 indicates that more cytosine and guanine bases are found in a CpG context 
than expected by randomization. Dendrograms represent Euclidean distance. 
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PRDM14), 2) high CpG ratio in rabbit (OTX2, ZFP42), 3) low CpG ratio in all species 
(NANOG, POU5F1) and 4) high CpG ratio in dog (TET2, NR5A2, JARID2). Pairwise 
association analysis revealed that canine promoter sets are significantly correlated with 
other species, except rabbit (rho= 0.314, P=0.241) and human (rho= 0.499, P=0.054). 
Collectively, these results suggest that the promoters of genes involved in mammalian 
iPSC generation are not enriched for CGIs in dogs, however a subset of canine promoters 
are composed of more CpG-rich compared to the murine promoter set. 
4.3.2 OCT4 and NANOG promoters are methylated in canine 
fibroblasts and partially reprogrammed cells 
Manipulation of genomic DNA methylation is an effective means of increasing the 
probability of complete reprogramming, but only when applied at the appropriate point in 
the workflow (Mikkelsen et al., 2008). Indeed, we observe that global DNA 
demethylation is significantly reduced in canine adult fibroblast (cAF) after four (P = 
0.015) or seven (Fig. 4-3A, P = 0.024) days of exposure to 5-µM 5azaC. We established 
three partially reprogrammed cell lines, cPR-L6, cPR-D7 and cPR-F9, in our attempt to 
reprogram adult dermal fibroblast with CytoTune 2.0 Sendai reprogramming vectors and 
transient DNMT inhibition. They produce heterogeneous cultures consisting of colonies 
with compact centres consisting of cells positive for SSEA4, a marker of cESCs, 
surrounded by cells with bipolar morphology (Fig. 4-3B). RT-qPCR analyses show 
incomplete expression of the triad of core pluripotency markers in cPR clones (Fig. 4-
3C).  
To investigate the extent of pluripotency gene silencing in cPR cells and parental 
fibroblasts compared to pluripotent cESCs we assessed the methylation status of regions 
within the canine NANOG or POU5F1/OCT4 promoter. Differing methylation profiles 
are evident in the OCT4 promoter region (Fig. 4-4A) and the NANOG promoter region 
(Fig. 4-4B) between cDF, cPR and cESCs. Methylation of the POU5F1 promoter region 
is lower in cESC compared to cDF (P = 0.032), but not cPR (Fig 4-4C, P = 0.082). 
Methylation of the NANOG promoter region is lower in cESC compared to both cDF 
(P=1.25 x 10-3) and cPR (P= 6.36 x 10-4) (Fig. 4-4D). In summary, DNMT inhibition 
elicits global DNA demethylation in cDF but is limited as a reprogramming supplement  
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Figure 4-3. Canine dermal fibroblasts exposed transiently to 5-azacytidine (5-AzaC) 
generate partially reprogrammed cell lines. 
(A) 5-mC level in canine dermal fibroblasts exposed to 5-µM 5-azacytidine (5-AzaC), a 
DNMT inhibitor, for four or seven days. (B) Representative phase-contrast and direct 
immunofluorescence image for stage-specific embryonic antigen 4 (SSEA4) antibody 
stain of a partially reprogrammed clonal cell population (cPR-L6). (C) Transcript 
abundance of core pluripotency factors (OCT4, SOX2, NANOG) and tri-lineage markers 
(BRACHYURY, GATA6, NESTIN) in partially reprogrammed cell lines and parental 
fibroblast (cDF). Transcript levels are normalized to internal reference gene TATA-
binding protein (TBP) and expressed as relative ratios to cDF samples. Bars represent 
standard error of the mean, n =3. Means followed by the same letter are not significantly 
different, P < 0.05. 
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in canines because only partially reprogrammed clones with methylated NANOG 
promoters could be attained. 
4.3.3 5-hmC level varies among species and cell type 
TET activity is thought to have a conserved role in a variety nuclear reprogramming 
systems by facilitating conversion of methylcytosine (5-mC) to 5-hydroxymethylcytosine 
(5-hmC) (Gao et al., 2013; Hill et al., 2014). To determine if the degree of global 
cytosine methylation (catalyzed by DNMTs) or cytosine hydroxymethylation (catalyzed 
by TET) differs among mammalian somatic genomes, we performed a comparative 
analysis of 5-mC and 5-hmC level in primary fibroblasts from canine, human and mouse. 
Total genome methylation was significantly lower in canine fibroblasts, compared to 
human neonatal BJ1 fibroblasts (Fig. 4-5A, P = 3.67 x 10-2) or embryonic fibroblast from 
CF1 mice (Fig. 4-5A, P = 2.60 x 10-3). The degree of cytosine hydroxymethylation was 
significantly greater in murine fibroblasts compared to human fibroblasts and canine 
fibroblasts (Fig. 4-5B, P = 3.7 x 10-6 & P = 1.0 x 10-7). Furthermore, 5-hmC level was 
also greater in human fibroblasts compared to canine fibroblasts. (Fig. 4-5B, P = 6.83 x 
10-3). We compared canine adult (cAF) and fetal fibroblasts (cFF) to discern the impact 
of donor tissue maturity on global cytosine modification level. Basal 5-mC and 5-hmC 
were not significantly different between cFF and cAF (Fig. 4-5C-D, P = 0.22). Both 
fibroblast cell populations exhibit lower 5-hmC compared to pluripotent cESCs (P < 1 x 
10-7) and transitional cPR cells (Fig. 4-5C-D, P < 1 x 10-7). These results suggest that 
steady-state cytosine modification levels, particularly 5-hmC, are detectably influenced 
by covariates such as the species and age of the donor tissue and may impact the ability 
of a given cell population to generate iPSCs. 
4.3.4 Identification of L-ascorbic acid and retinoic acid 
concentrations that increase TET activity 
Before proceeding to a modified reprogramming study, we sought to profile pan-TET 
activity and TET paralog expression in canine somatic cells upon exposure to 
combinations of RA and AA at levels used for iPSC generation. In murine and human 
ESCs or reprogramming cells, TET2 expression is responsive to a conserved retinoic  
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Figure 4-5. 5-hydroxymethylcytosine level varies with species and cell type.  
(A) Percent 5-methylcytosine (5-mC) in cultures of primary fibroblast derived from 
canine, human and mouse. (B) Percent 5-hydroxymethylcytosine (5-hmC) in cultures of 
primary fibroblast derived from canine, human and mouse. (C) Relative 5-mC level 
levels in canine adult fibroblast (cAF), canine fetal fibroblast (cFF), canine partially 
reprogrammed (cPR) and canine embryonic stem (cES) cells. (D) Relative 5-hmC level 
in cAF, cFF, cPR and cES cells. The percentage of each modified base is corrected for 
the CpG dinucleotide density for each specific genome assembly. Bars represent standard 
error of the mean (SEM), n = 4-5. Means followed by the same letter are not significantly 
different, P < 0.05. 
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acid (RA) signaling element, distinct from the enzyme cofactor function of L-ascorbic 
acid (AA) (Hore et al., 2016). Using the ratio of genome-wide 5-hmC to 5-mC as an 
index of the overall catalytic output of TET enzymes (Ficz et al., 2011), we observed 
both AA (Fig. 4-6A, F = 4.08, P = 2.83 x 10-2) and RA (Fig. 4-6A, F = 6.73, P = 4.26 x 
10-3) have a significant independent influence on 5-hmC:5-mC ratio. Only the 
combinations of 100 µM AA (Fig. 4-6A, P= 0.033) and 0.1 nM or 1 nM RA (Fig. 4-6A, 
P= 0.035) significantly elevated 5-hmC:5-mC ratio compared to vehicle controls.  
Analysis of endogenous TET expression levels revealed basal levels of TET transcript in 
canine fibroblast ranging from 0.57% of reference gene expression for TET1, 8.30% for 
TET2 and 1.58% for TET3 transcripts. Interestingly, exposure of canine fibroblast to 
various RA concentrations did not alter TET paralog expression (Fig. 4-6B - 4-6D). 
Significant changes in cTET1 (Fig. 4-6B, P= 0.0171) and cTET3 (Fig. 4-6D, P= 6.29 x 
10-3) abundance were only detected in 250 µM AA compared to vehicle control. The 
observation that cTET paralog expression is not sensitive to RA in canine fibroblast may 
indicate that the reprogramming OKSM factors are required co-factors. Indeed, we have 
identified a putative OCT4:SOX2 composite motif upstream of cTET1 and a partial 
OCT4 motif upstream of cTET2 in conserved non-coding sequence (Fig. 4-6E). 
4.3.5 Physiological oxygen changes the influence of metabolites 
on TET activity 
Physiological oxygen tensions (i.e. < 5% O2) have been shown to improve iPSC 
derivation efficiency (Yoshida et al., 2009) and increased TET paralog expression in 
cultured cells and embryos (Mariani et al., 2014; Skiles et al., 2018). We next sought 
determine whether cTET transcript abundance and catalytic output are similarly 
responsive to AA, a pleiotropic molecule with donor antioxidant activity (Du et al., 
2012), when cultured in a 5% oxygen environment. We observe relative 5-hmC levels 
approximately 1.4-fold higher than at atmospheric oxygen cultures. Surprisingly, in a 
physiological oxygen condition, neither AA (Fig. 4-7A, F = 0.30, P = 0.74) nor RA (Fig. 
4-7A, F= 0.74, P= 0.57) significantly alter the 5-hmC:5-mC ratio compared to vehicle 
controls. We find that all cTET paralogs are generally more abundant (between 1.3 and 
2.5-fold) in 5% oxygen  
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Figure 4-7. L-ascorbic acid suppresses hypoxia-mediated induction of cTET1 and 
cTET3. 
(A) 5-hmC:5-mC ratio in canine dermal fibroblasts cultured in a 5% physiological 
oxygen environment and exposed to various concentrations ascorbic acid (AA) and/or 
retinoic acid (RA). Each data point is calculated from paired aliquots from the same 
purified gDNA sample and analyzed by separate ELISA assay kits. (B) Relative 
transcript abundances for cTET1, cTET2 and cTET3 in canine dermal fibroblasts 
cultured in physiological 5% oxygen and exposed to various concentrations of AA. (C) 
Pairwise alignment of canine, human and mouse TET3 promoter with partially conserved 
HIF-1 motif. (D) Weighted sequence motif logo for HIF-1. Bars represent standard error 
of the mean (SEM), n = 4. Means followed by the same letter are not significantly 
different, P < 0.05. 
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without culture media supplements. (Fig. 4-7B). This hypoxia-mediated induction of 
cTET1 and cTET3 transcripts is abrogated in the presence of AA at 250 µM (Fig. 4-7B, P 
= 2.16 x 10-3 & P = 0.018). The notion that TETs may be a target of the hypoxic response 
is supported by the presence of a partially conserved HIF1 motif in the cTET3 locus (Fig. 
4-7C-D). In summary a negative regulatory effect of AA on the cTET1 and cTET3 
hypoxic response may obscure the role of AA and RA in regulating 5-hmC and 5-mC 
content in canine fibroblasts. 
4.3.6 L-ascorbic acid and retinoic acid promote focal 
epithelialization during early canine reprogramming 
The KOS, KLF4 and c-MYC SeV vectors were applied at a multiplicity of infection 
(MOI) of 5 or 6, based on transduction efficiencies achieved using control emGFP 
control SeV reporter (Fig. 4-8A-B). Increased levels of reprogramming factor expression 
have been shown to improve reprogramming in refractory mouse lacking NANOG 
(Carter et al., 2014; Schwarz et al., 2014). Further, inadequate KLF4 expression has been 
shown to pause the reprogramming process in independent of the remaining Yamanaka 
transfactors (Nishimura et al., 2014). Low passage canine fetal fibroblast (cFF at p1) cells 
were selected as the donor cell population. Throughout the first 48 hours after viral 
transduction, we observed slightly greater levels of cytotoxicity in SeV-transduced cFFs 
versus non-transduced control cells (~8% vs. ~20%, visual record) (Fig. 4-9A). After 24 
hours of treatment with AA/RA or vehicle, transduced cFFs enter a hyperproliferative 
state and reach confluency. Transduced cFFs treated with AA/RA exhibited small 
clusters with epithelial character by 4 DPI which increased in size and frequency by 5 
DPI (Fig. 4-9B). Interestingly, we observe that AA/RA-treated cells form more primary 
colonies upon re-seeding onto MEF feeders (Fig. 4-9C, P = 0.029). 
We next examined the abundance of transcripts associated with mesenchymal-to-
epithelial transition (MET) in 6 DPI reprogramming intermediates by qPCR array. 
Pairwise correlation analysis and clustering revealed that targeted expression profiles of 
biological replicates were highly similar (ρ > 0.94), suggesting that merging data across 
arrays was robust to batch effects (Fig. 4-10A). This analysis also highlighted that 
AA/RA treated intermediates were more dissimilar to non-transduced cFF cells by the  
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Figure 4-8. Optimization of multiplicity of infection (MOI) in canine fibroblast using 
Sendai emGFP control vector. 
(A) Representative phase-contrast and fluorescent micrographs of canine dermal 
fibroblast transduced with emGFP control Sendai vector at various multiplicity of 
infection (MOI). Scale bar unit length is 125 µm. (B) Summarization of the mean percent 
emGFP-positive cells at each MOI. Bars represent standard error of the mean (SEM), n = 
2.  
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Figure 4-10. L-ascorbic acid and retinoic acid enhance a transcriptional response 
resembling mesenchymal-to-epithelial transition. 
(A) Density matrix of Pearson correlation coefficients of transcript panel abundances in 
each sample. (B) Relative abundances of transcripts associated with DNA binding 
proteins. (C) Relative abundances of transcripts associated with secreted ligands or 
extracellular matrix components. (D) Relative abundances of transcripts associated with 
the cytoskeleton or cell adhesion that are down-regulated at 6 DPI. (E) Relative 
abundances of transcripts associated with the cytoskeleton or cell adhesion that are up-
regulated at 6 DPI. Bars represent standard error of the mean (SEM), n = 3. Means 
followed by the same letter are not significantly different, P < 0.05. 
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Euclidean distance than vehicle-treated intermediates at 6 DPI. The transcripts of several 
DNA-binding proteins involved in the repression of epithelial gene expression were 
downregulated in 6 DPI samples (e.g. SNAI2, ZEB1) (Fig. 4-10B, P < 8.63 x 10-3). 
Furthermore, SMAD2 transcript was significantly decreased in AA/RA intermediates 
compared to vehicle control (Fig. 4-10B, P = 1.08 x 10-2). Similarly, 6 DPI intermediates 
exhibited a lower abundance of several mesenchyme-associated transcripts with known 
signaling or structural role in the extracellular space (e.g. FN1, BMP2, SERPINE1) 
compared to parental cFF cells (Fig. 4-10C, P < 1.99 x 10-2). Among different TGFβ 
isoforms, only TGFβ1 was significantly decreased in AA/RA intermediates relative to 
vehicle control (Fig. 4-10C, P = 4.28 x 10-2). Strikingly, several transcripts related to 
cytoskeletal (e.g. MSN, MAP1B, KRT7) and plasma membrane (e.g. F11R, TMEFF2) 
components were differentially abundant in reprogramming intermediates compared to 
donor cFF cells. (Fig. 4-10D-E, P < 1.30 x 10-2). Notably, characteristic mesodermal 
markers CDH2 (P = 4.51 x 10-2) and VIM (P = 3.55 x 10-2) are significantly lower in 
AA/RA-treated intermediates (Fig. 4-10D). Whereas, epithelial hallmark transcripts 
CDH1 (P = 2.31 x 10-3), DSP (P = 6.54 x 10-3), KRT14 (P = 2.43 x 10-3) and KRT19 (P = 
1.72 x 10-2) were significantly elevated in reprogramming intermediates exposed to 
AA/RA (Fig. 4-10D). Custom oligonucleotides were designed to validate several 
differentially abundant transcripts relevant to MET (Fig 4-11A-B).  
Defining the culture conditions that support self-renewal of pluripotent cells from dogs 
remains a challenge. We and others have expanded cESC (Tobias et al., 2016) and ciPSC 
(Luo et al., 2011; Nishimura et al., 2013) in Knockout Serum Replacement (KOSR)-
containing medium optimized for hESC. In the previous chapter, I demonstrated that 
cESCs cultured in this medium exhibit deficiencies in the glycolysis pathway compared 
to human or mouse ESCs (Chapter 3). To propagate presumptive ciPSCs, we attempted 
single- and bulk-colony passaging techniques in different medium and growth factor 
combinations (Fig. 4-12A). We found that cESC-like culture conditions containing 
KOSR could not mature canine iPSC-like cells (Fig. 4-12B). Conversely, standard 
DMEM with 10% FBS media was more effective at stabilizing early reprogramming 
intermediates, which was accentuated with exogenous LIF supplementation (Fig. 4-12C).  
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Figure 4-11. Validation of differentially abundant mesenchymal and epithelial 
transcripts using custom oligonucleotide primers.  
(A) Relative abundances of transcripts associated epithelial cell types quantified by 
reverse-transcription qPCR. (B) Relative abundances of transcripts associated with 
mesenchymal cell types quantified by reverse-transcription qPCR. Bars represent 
standard error of the mean (SEM), n = 3. Means followed by the same letter are not 
significantly different, P < 0.05. 
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However, within three-to-four passages, presumptive ciPSCs progressively lost compact 
border morphology and gradually formed monolayer structures with radial asymmetry 
(Fig. 4-12D). These results suggest that LIF supplementation supports the emergence of 
early reprogramming intermediates, but insufficient to propagate maturing canine iPSCs 
long-term. 
4.4 Discussion 
It is currently unknown if canine reprogramming mirrors the trajectory of human or 
mouse cells towards the iPSC state. Previous studies have focused on the molecular 
characteristics and differentiation potential of a limited number of putative iPSC clones 
derived from a single reprogramming experiment (Luo and Cibelli, 2016). To develop a 
reproducible system to derive and maintain canine iPSCs, it is essential to identify the 
most obstructive mechanisms to the reprogramming of canine cells by forced expression 
of transcription factors. We found that global 5-hmC level varies among primary 
fibroblast cultures from different species commonly used for reprogramming 
experiments. Gene expression and epigenetic assays indicate that partially reprogrammed 
cells exhibit limited pluripotency factor expression, methylation of the NANOG promoter 
and lower 5-hmC levels compared to canine ESC lines. Our study also indicates that a 
transcriptional response resembling MET occurs within the first week of canine 
reprogramming. Morphological and transcriptional indicators of MET can be facilitated 
using bioactive metabolites, which modulate 5-hmC accumulation in canine fibroblasts 
independent of changes in TET paralog expression. 
During iPSC generation thousands of loci gain or lose methylation (Polo et al., 2012) as 
reprogramming factors direct active demethylation (Sardina et al., 2018) and outcompete 
the somatic gene regulatory network allowing de novo methylation of lineage-associated 
genes (Schwarz et al., 2018). Ultimately, genome-wide methylation in the established 
pluripotent cells is estimated to be similar to somatic cells unless small molecular 
inhibitors or activators are added to drive further epigenome erasure (Ficz et al., 2013; 
Leitch et al., 2013). We have previously demonstrated that small molecule inhibitors of 
MEK1/2 and GSK3 enrich for a population of cESCs with lower global 5-mC levels 
(Tobias et al., 2016) and noted a previously recognized over-representation of CGIs in 
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the canine genome assembly (Han et al., 2008).  In addition to prompting targeted 
chromatin remodeling, TET enzymes help to maintain the hypomethylated state of high 
CpG density regions (Williams et al., 2011; Wu et al., 2011). Previous enrichment 
analyses of canine-human homologous genes focused on subsets of loci with a CGI 
present only in the human assembly (Han and Zhao, 2009). Due to a lack of a formal 
gene ontology term affiliated with somatic cell reprogramming, we derived a gene list 
from time-course transcriptome experiments in human and murine cells. Our sequence 
analyses showed that there were no differences in the number of canine promoters with a 
unique CGI among conserved reprogramming genes, but a subset of promoters (~20%) 
consisted of uniquely CpG-rich sequence in the canine genome. A valuable extension of 
this investigation would include collecting CpG-related sequence features from regions 
associated with cis-regulatory modules, particularly distal regulatory elements predicted 
from clustered pluripotency transcription factor motifs.   
Higher reprogramming efficiencies between somatic cell types positively correlate with 
the number hypermethylated tissue-specific genes shared with pluripotent ESCs (Barrero 
et al., 2012). Furthermore, embryonic and fetal cell populations are often more efficiently 
reprogrammed, occasionally with fewer ectopic transfactors, compared to differentiated 
adult cells (Hansel et al., 2014; Kleger et al., 2012). We found no differences in the 
fraction of 5-mC among total genome CpG dinucleotides between adult or fetal canine 
fibroblasts, partially reprogrammed cells or ES cells. However, 5-hmC level was 
associated with cES and cPR cells considered to be more plastic populations than somatic 
fibroblasts. Interestingly, canine fibroblasts appear to be deficient in 5-hmC compared to 
human and mouse fibroblasts. This may be due, in part to lower global levels of 5-mC 
substrate available for oxidation, a species-dependent or time-dependent consequence of 
adaptation to culture (Nestor et al., 2015).   
Comparisons of time-resolved data from the reprogramming of different cell types and/or 
species have identified context specific trajectories and barriers to acquired pluripotency 
(Fu et al., 2018; Nefzger et al., 2017). We observed incomplete demethylation of the 
NANOG promoter region, and as a plausible consequence endogenous NANOG 
transcripts are not upregulated in partially reprogrammed clones. Limited epigenetic 
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remodeling and endogenous pluripotency gene re-activation is also evident in porcine 
reprogramming (Choi et al., 2016), another Laurasiatherian species. We found that 
endogenous POU5F1 expression in cPR lines does not correlate well with the 
methylation status of the -394 to -88 region targeted in this study. One possibility is that 
cytosine residues with gene regulatory activity are present elsewhere in the canine 
POU5F1 promoter. POU5F1 expression in cPR lines suggest that POU5F1 re-expression 
dynamics resemble the human reprogramming time course, wherein POU5F1 is 
reversibly re-expressed during MET, as opposed to during the later maturation phase in 
murine reprogramming (Brambrink et al., 2008; Teshigawara et al., 2016). 
To date, canine reprogramming studies have only applied small molecule inhibitors to 
facilitate reprogramming (Betts and Tobias, 2015). In our hands, transient exposure to 
DNMT inhibitor 5-azaC did not noticeably impact the initiation canine reprogramming 
but enabled the stabilization of partially reprogrammed cell populations. Prolonged 
disruption of DNMT is not desirable due to the potential to activate retrotransposons and 
induce genome instability (Eden et al., 2003; Walsh et al., 1998). Analysis of cells 
apparently trapped in partially reprogrammed states have provided useful information on 
reprogramming obstacles, notably in the maturing iPSCs (Mikkelsen et al., 2008).  
However, the continued emergence of partially reprogrammed cells has diminishing 
value and may confound molecular analyses by misidentification with cells undergoing 
productive reprogramming. 
Experimental manipulations that increase TET abundance or catalytic activity promotes 
5-methycytosine removal and iPSC generation in both human and murine cells (Costa et 
al., 2013; Doege et al., 2012; Gao et al., 2013). L-ascorbic acid directly interacts with the 
TET catalytic domain as a cofactor (Blaschke et al., 2013; Yin et al., 2013) and enhances 
Fe (II) recycling (Hore et al., 2016) to elevate methylcytosine dioxygenase activity. 
Whereas, retinoic acid may synergistically increase TET action via nuclear receptor 
complex-dependent functions such as: up-regulation of TET2/TET3 expression (Hore et 
al., 2016) and focal recruitment of TET1/2 and base-excision repair machinery (Hassan et 
al., 2017). Interestingly, retinoid ligands appear to have TET-independent mechanisms to 
regulate early human and mouse reprogramming via retinoic acid receptor-gamma 
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(RARG) and binding partner NR5A2 (also known as LRH1) (Wang et al., 2011). As the 
reactions catalyzed by TET enzymes are dependent on molecular oxygen, it is not 
surprising that physiological levels of extracellular oxygen promote TET activity (Burr et 
al., 2018). In the present study, we observed an antagonistic effect of L-ascorbic acid on 
the expression of TET1 and TET3 in a 5% oxygen environment. Our result resembles the 
ability of L-ascorbic acid to suppress the HIF-1 transcriptional response in cancer cells by 
stimulating the activity of HIF-degrading prolyl hydroxylase enzymes (Kuiper and 
Vissers, 2014). 
The first phase of cell reprogramming is initiation, which encompasses several of 
transgene-dependent events including hyper-proliferation and loss of somatic identity 
(Stadtfeld et al., 2008). The specific cellular and molecular events that define the 
initiation phase is dependent on cell type (Nefzger et al., 2017) and in fibroblast is 
highlighted by MET (Li et al., 2010; Samavarchi-Tehrani et al., 2010). In our single-
infection reprogramming system, we observed altered expression of a variety of growth 
factors, adhesion molecules, cytoskeletal components and transcriptional regulators on 
day six, which is consistent with the process of MET.  Interestingly, exposure to AA/RA 
enhanced several previously established aspects of MET including a switch from 
neuronal-type to epithelial-type cadherin expression (Araki et al., 2011) and the induction 
of keratin gene expression (Kagawa et al., 2019). Clusters epithelial-like cells are 
observed as early as four days post infection, but only in AA/RA treated reprogramming 
intermediates. Surprisingly, the apparent timing of the initiation phase in canine cells in 
our reprogramming system bears stronger resemblance to mouse reprogramming than 
human reprogramming (Høffding and Hyttel, 2015; Teshigawara et al., 2016). We note 
that other reprogramming vector systems may yield results that differ from our 
observations because the trajectory of cell states towards pluripotency and overall 
kinetics of iPSC generation are influenced by the reprogramming system utilized 
(Chantzoura et al., 2015). Our strategy to stabilize maturing canine iPSC intermediates in 
culture media used for routine culture of canine ESC and putative iPSC was unsuccessful 
beyond days 26-30 of reprogramming. Fundamental questions remain outstanding 
regarding the trophic requirements and regulatory processes that achieve a transgene-
independent pluripotent state in the dog.  
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Our study represents the first investigation to identify phase-specific hurdles to canine 
induced pluripotency. We identified several promoter regions controlling canine genes 
involved in pluripotency regulation with distinctively CpG-rich sequence. Our 
examination of early canine reprogramming suggests that MET initiates four-to-six days 
after canine fibroblast infection, which is consistent with the kinetics of murine 
reprogramming systems.  The notion that the over-representation of clustered CpG 
dinucleotides in the dog may influence the redistribution of DNA methylation during 
canine reprogramming warrants further investigation by untargeted, genome-wide 
approaches. This study also lends support to an evolutionarily conserved TET regulatory 
mechanism controlling the MET program, which has broader implications in the areas of 
developmental and cancer biology. 
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Chapter 5  
5 General Discussion and Conclusions 
5.1 Discussion and Significance of Research 
It has long been understood that manipulation of developmental signaling pathways can 
influence lineage specification from the pluripotent state. A recent extension of this 
paradigm suggest manipulations to the culture environment can affect the range of 
characteristics and differentiation potential of plastic mammalian cell populations. In this 
plateau model, developmental trajectories can be halted by specific extrinsic signals in a 
lineage-primed pluripotent state. Under distinct environmental constraints, this 
progression can even be reversed to stabilize an earlier developmental state on a nearby 
plateau representing a closely-related cell population. In mammals, two discrete 
pluripotency plateaus appear to be obtainable, known as naïve and primed, through direct 
embryonic derivation or reprogramming technologies with developmentally appropriate 
stimuli from culture environments. Direct reprogramming of somatic cells to either 
pluripotent state requires ectopic TF overexpression and/or modulation of epigenome 
modifying enzymes to override the somatic nucleus. In pluripotent stem cells derived 
from large mammals, such as domestic dogs, there is little consensus regarding the 
exogenous requirements for the acquisition or maintenance of stable pluripotency. 
Variation among permissive culture environments may be confounded by the co-
existence of multiple canine pluripotent states with exclusive input requirements and 
discrete cellular and molecular characteristics. 
The overall hypothesis of my thesis is that the culture environment can promote nuclear 
and metabolic reprogramming of canine cell lines towards a more primitive state of 
pluripotency. The main findings of this thesis that support my hypothesis and advance 
this knowledge are:  
1. Manipulation of FGF-ERK and WNT-β-catenin signaling pathways enriched for a 
unique cESC population with ultrastructural, transcriptional and epigenetic 
similarity to the naïve pluripotent state.  
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2. Maintenance of cESCs in discrete culture environments are dependent on 
different metabolic pathways for in vitro proliferation.  
3. Combinatorial exposure to metabolites that influence cell signaling and 
epigenetics facilitate the early de-differentiation of canine somatic cells.  
With my thesis work, I have advanced our understanding of the extrinsic requirements 
and potential intrinsic mediators for the induction and maintenance of phenotypically 
distinct cESC. Furthermore, we illustrated the utility of metabolite supplementation 
targeting epigenetic remodeling processes during de-differentiation to facilitate phase-
specific progression towards a reprogrammed pluripotent state. Taken together, these 
investigations establish a developmental context for cESCs that is dependent on complex 
interactions between gene regulatory mechanisms, metabolic activities and the 
microenvironment (Figure 5-1).  
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5.1.1 Pluripotent state-specific signaling and metabolic pathways 
support cESC maintenance 
Extracellular signals cooperate with transcriptional regulatory machinery to organize 
epigenetic features critical to multi-lineage plasticity and to minimize the loss of 
pluripotent attributes through rapid symmetrical cell divisions. Despite greater than a 
dozen derivation and characterization studies of canine embryo-derived or 
reprogramming factor-induced PSCs (Menon et al., 2019), the similarity of canine 
ESC/iPSC to pluripotent state phenotypes described in rodents and primates remain 
unexplored.     
I propose a model in which blastocyst-derived canine pluripotent stem cells maintained in 
LIF and FGF2 (L/F) represent a metastable lineage-primed state of pluripotency from 
which a developmentally immature subpopulation may be enriched with selective 
disruption of developmental signaling pathways. Application of small molecule inhibitors 
of GSK3 and MEK signaling with LIF supplementation (2iL) support a pluripotent cell 
population with transcriptional, epigenetic and differentiation tendencies suggestive of an 
earlier developmental identity (Chapter 2). The discrete pluripotent cell populations 
supported by L/F or 2iL exhibit morphologically and functionally distinct mitochondria, 
that alter metabolic pathway prioritization for anabolism and ATP generation (Chapter 3) 
(Figure 5-2). 
LIF and FGF2-dependent canine ESCs/iPSCs spontaneously differentiate in vitro in the 
absence of exogenous LIF (Koh et al., 2013; Vaags et al., 2009; Wilcox et al., 2009). We 
show that pre-existing LIF-STAT3 signaling activity in L/F cESCs is enhanced with the 
induction and culture of naïve-like cESCs in 2iL (Chapter 2). The induction of STAT3 
signaling is consistent with an evolutionarily conserved role in the establishment and 
maintenance of naïve pluripotency among rodents, primates and ungulates (Chen et al., 
2015; Meng et al., 2015; Van Oosten et al., 2012; Wu et al., 2019). We also observe that 
2iL cESCs have elevated respiratory capacities compared to L/F cESCs (Chapter 3). 
During primed-to-naïve pluripotency resetting in mice, STAT3 has been shown to 
directly promote respiration by activation of mtDNA transcription (Carbognin et al., 
2016). Reprogramming of mEpiSC to mESC by LIF-STAT3 signaling is halted by  
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Figure 5-2. Different metabolic pathway activities support proliferation of canine 
ESCs approximating primed and naïve pluripotency. 
Conversion of LIF-FGF2 (L/F) cESCs to a naïve-like pluripotent state in 2iL medium is 
associated with enhanced mitochondrial respiration and membrane potential (ΔΨm). 
Incomplete oxidation of glucose in L/F cESCs is accompanied by lower ATP production 
and elevated neutral lipid accumulation. Remodeling of mitochondrial ultrastructure in 
2iL cESCs includes shorter mitochondria and disorganized cristae. Elevated 
mitochondrial activity in 2iL cESCs may have a widespread influence on cellular 
processes by altering retrograde AMPK signaling. Abbreviations: Glucose (GLU), 
Phosphoenolpyruvate (PEP), pyruvate (PYR), lactate (LAC), fatty acid synthase (FASN). 
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respiratory complex I inhibitor rotenone, implying that electron transport chain activity is 
important for rewiring the pluripotency GRN (Carbognin et al., 2016). There is some 
evidence that 2i has a complementary function to LIF by suppressing PGC-1α expression 
to maintain the structural immaturity of mitochondria (Mahato et al., 2014). We 
qualitatively observed the broadening of cristae outlets and tips and detected significant 
decreases in MIC60 and assembled F1 ATP synthase subunits (Chapter 3). A similar 
mitochondrial morphology is apparent in 2i mESC compared to S/L controls, suggesting 
that 2i may directly affect cristae remodeling in naïve PSC (Mahato et al., 2014).  
Activin/Nodal-SMAD2 signaling is believed to have an evolutionarily conserved role in 
mEpiSC/hESC coordinating the primed pluripotency GRN and reducing paracrine BMP 
signaling that drives lineage specification (Bertero et al., 2015; Sakaki-Yumoto et al., 
2013; Senft et al., 2018). We found no difference in SMAD2 phosphorylation between 
L/F and 2iL cESCs indicating that this pathway is not likely to oppose the stabilization of 
naïve or primed pluripotency in canines (Chapter 2). We noted that Activin receptor type 
2B (ACVR2B) transcript abundance is down-regulated in 2iL cESCs, which implies that 
2iL cESCs may be less sensitized to TGFβ ligands (Chapter 2). Additionally, phospho-
SMAD2 level was not significantly different between ALK inhibitor SB431542 treatment 
and steady-state L/F cESC culture suggesting low basal SMAD2 signaling may be 
supported by alternative signaling cascades (Chapter 2). A comparison of independently 
derived metastable porcine iPSC lines with distinct culture requirements (+LIF; +FGF2; 
+LIF+FGF2) demonstrated that OCT4 and NANOG expression and self-renewal is 
improved with Activin A exposure (Yang et al., 2017). Furthermore, exogenous Activin 
A was recently shown to replace FGF2 signaling and induce NANOG expression in LIF 
and FGF2-dependent canine iPSCs (Luo and Cibelli, 2016). Taken together, these studies 
indicate that a more stable primed pluripotent state may be obtained through an 
evolutionarily conserved Activin-SMAD2/3-NANOG axis.    
5.1.2 Intracellular signaling pathways may link bioenergetics to 
self-renewal and tumorigenicity of cESCs 
Quantification of cESC proliferative rates during steady-state growth indicated that 
culture conditions may be suboptimal, and that cell metabolism is influenced by the 
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pluripotent state (Chapter 2). These observations were confirmed with quantifiably lower 
glycolytic capacities and HXK2 abundances in cESCs compared to hESC and mESC 
cultures, despite culture in controlled nutritional environments (Chapter 3). Furthermore, 
2iL cESCs exhibit greater spare respiratory and glycolytic reserve capacities than L/F 
cESCs (Chapter 3). These observations raise fundamental questions regarding the 
regulation of glycolysis and proliferation in ESCs derived from dogs. It should be noted 
that indirect measurements of glycolytic and mitochondrial activities were used in this 
wrk. A direct analysis of metabolic flux and dissection of metabolic pathway dynamics 
could be achieved through stable isotope-assisted metabolomics.  
Glycolytic flux in PSC and embryos are regulated at the level of glucose uptake by 
GLUT transporters as well as glycolytic enzyme abundances or activities. Constitutive 
transporter GLUT1 is expressed in both hESC and mESC, correlates with glucose uptake 
and mediates hypoxic adaptation of PSC to anaerobic glycolysis following HIF 
stabilization (Forristal et al., 2013; Wu et al., 2017). While we found no difference in the 
abundance of GLUT1 (Chapter 3), we cannot formally rule out differential rates of 
glucose consumption underlying significantly different glycolytic capacities between 
cESCs and hESCs or mESCs. We did not investigate the contribution of GLUT3, which 
is developmentally regulated and shows high correspondence with OCT4 expression 
(Carayannopoulos et al., 2014; Christensen et al., 2015). Recently, blunted glycolytic 
rates in iPSC lines derived from aged donors was associated with elevated ROS and 
depleted of TCA cycle phenotype that was rescued by GLUT3 overexpression (Zhang et 
al., 2017). Manipulation of glycolytic flux in cESCs may be required to mitigate the 
incidence of spontaneous differentiation, improve scalable culture as well as promote in 
vivo survival and proliferation following xenotransplantation assays.   
Gene regulatory networks controlled by OCT4 and C-MYC/N-MYC promote high 
glycolytic flux in both mESC and hESC by regulating glycolytic enzyme expressions 
including HXK2, LDHA and PKM2 (Cliff et al., 2017; Gu et al., 2016; Kim et al., 2015). 
C-MYC/N-MYC double knockout studies indicate that growth-arrested mESCs remain 
functionally pluripotent (Scognamiglio et al., 2016). Therefore, regulators of cell growth, 
metabolism and pluripotency are strongly interconnected in PSC but disruption of 
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intracellular signaling networks can functionally uncouple pluripotency and self-renewal. 
In the present work, we did not observe any difference in the abundances of core 
pluripotency factor OCT4 or the level of HXK2 or PKM2 between L/F and 2iL cESCs 
(Chapters 2 and 3). However, we found decreased HXK2 in both L/F and 2iL cESCs 
compared to hESC or mESC (Chapter 3). The low proliferation rate in cESC cultures 
bears a striking resemblance to a novel “paused” pluripotent state induced in mESC by 
inhibition of mechanistic target of rapamycin (mTOR) (Bulut-Karslioglu et al., 2016). 
Notably, progression through the cell cycle is slower in paused pluripotency without 
appreciable apoptosis or differentiation (Bulut-Karslioglu et al., 2016). Inhibition of 
mTOR promotes autophagy and suppresses global transcriptional and translational 
output, all of which characterize paused pluripotent cells (Bulut-Karslioglu et al., 2016; 
Sotthibundhu et al., 2016). Interestingly, selective HXK2 degradation by chaperone-
mediated autophagy is an anti-cancer mechanism employed by non-transformed cells 
(Jiao et al., 2018; Xia et al., 2015).  
Several lines of evidence suggest that cESCs in L/F or 2iL conditions may represent a 
similarly idle pluripotent phenotype where glycolytic capacity is blunted by hyperactive 
autophagy. In addition to mTOR, autophagy may be initiated in mammalian cells by liver 
kinase B1 (LKB1)-AMPK signaling (Kim et al., 2011). We found that increased 
mitochondrial respiration and ATP level in 2iL cESCs was associated with a decrease 
AMPK activity compared to L/F cESC (Chapter 3). These observations provoke 
questions regarding the roles of nutrient and energy sensing pathways in regulating 
autophagy and related catabolic pathways (e.g. mitophagy) in pluripotency maintenance 
and self-renewal. Future investigations should also attempt to disentangle the 
contributions of regulated degradation versus fission-fusion homeostasis to mitochondrial 
networks in pluripotent state transitions and lineage restriction. 
PSC normally maintain low expression of p21 and exclude p53 from the nucleus to 
rapidly progress through G1/S or G2/M cell cycle checkpoints (Calder et al., 2013; 
Suvorova et al., 2016; Zhang et al., 2014). Unsurprising, mammalian PSC traditionally do 
not exhibit contact inhibition in vitro and possess high tumorigenic potential in 
immunocompromised hosts (Ben-David and Benvenisty, 2011). Observations that LIF 
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and FGF2-dependent cESC lines derived in an independent laboratory generate teratomas 
have not been replicated (Vaags et al., 2009). We showed that cESC transplantation from 
either L/F or 2iL conditions do not readily yield tumors compared to hESCs that generate 
mature teratomas (Chapter 2). Cell intrinsic factors that contribute to low tumorigenicity 
of cESCs may resemble some combination of sensitivity to apoptosis, low competitive 
fitness and/or poor transcriptional activation of proto-oncogenic GRNs. Transcriptional 
networks centered around C-MYC/N-MYC typically show considerable overlap between 
steady-state PSCs and cancer cells, which is largely related to a shared role in 
transcriptional amplification (Kim et al., 2010; Lin et al., 2012). There are also species-
specific drivers of tumorigenicity in PSCs such as embryonic ras-like gene (Eras). Eras 
constitutively activates the PI3K-mTOR signaling pathway to augment the proliferation 
and tumorigenicity of mESC but does not contribute to tumorigenic potential of primate 
ESC (Takahashi et al., 2003; Tanaka et al., 2009; Yu and Cui, 2016).   
5.2 Future Studies: Purification and analysis of canine 
reprogramming intermediate cells 
Somatic cell reprogramming is a multi-step process that requires phase-specific 
epigenomic remodeling and transcriptional activity for productive transitions towards 
pluripotency. Initiation of reprogramming in fibroblast populations is characterized by 
silencing the somatic GRN that de-represses epithelial gene expression (Li et al., 2010; 
Samavarchi-Tehrani et al., 2010). Productively reprogramming cells undergo 
mesenchymal-to-epithelial transition (MET) characterized by the induction of gene 
products that form epithelial tight junctions (Høffding and Hyttel, 2015; Shook and 
Keller, 2003). Dose-optimization of the combination of L-ascorbic acid and retinoic acid 
can reproducibly induce the accumulation of oxidized products of methylated DNA 
catalyzed by the TET dioxygenase family enzymes (Chapter 4). Combined and transient 
(2-6 DPI) metabolite treatment correlates positively with a MET transcriptional response 
and increased frequency of reprogramming progression to the maturation phase (Chapter 
4). However, exogenous growth factor/cytokine supplementation alone was not suitable 
to stabilize canine reprogramming intermediates (Chapter 4).   
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Pluripotency maturation is the greatest obstacle to successful reprogramming because it 
depends on the rare and probabilistic activation of previously silent genomic regions. 
Reactivation of pluripotency-associated loci during iPSC maturation is reversible and 
sustained transcriptional output is dependent on the recruitment of chromatin modifying 
enzymes to important CRMs (Teshigawara et al., 2016). The ability of a given region to 
recruit histone or DNA modifying enzymes that support or oppose reprogramming is 
partly dependent on the composition of the local genomic sequence (Behera et al., 2018; 
Carcamo-Orive et al., 2017). We have assessed the conservation of CpG-sequence 
richness among 1:1:1 orthologues that are differentially expressed during primate and 
rodent reprogramming. A subset of promoters with substantial gains in CpG-sequence 
richness were identified as potentially unique to the canine genome assembly (Chapter 4). 
These sequence features are distinct from other Laurasiatherian mammals (e.g. pig, cow) 
and therefore are more likely to be a consequence of canid evolution (Chapter 4). It is 
tempting to speculate that localized gains in CpG-richness would increase the affinity and 
grant regulatory control to specific enzyme classes containing CpG DNA binding 
domains (e.g. CXXC, MDB) domains such as DNMTs, TETs and components of 
polycomb group repressive complexes (Du Q et al., 2015; Risner et al., 2013). However, 
we are limited in the scope of this investigation to shared orthologues selected from 
genome-wide sequencing experiments from a different clade of placental mammals. 
Future studies should prioritize unbiased identification of genes predictive of the 
establishment and maintenance of different canine pluripotent states. In this regard, a 
comparative transcriptomic approach between dissected canine preimplantation embryos 
(e.g. embryonic ICM or epiblast) as well as cESC cultures approximating different 
pluripotent states would identify both divergent and conserved molecular determinants of 
canine pluripotency (Bernardo et al., 2018). 
Complicating the study of iPSC maturation is high biological variation caused by non-
hierarchical gene activation and clonal dominance effects (Kuno et al., 2018; Tanabe et 
al., 2013). To address this challenge, strategies are required to enrich for cells exhibiting 
early pluripotency characteristics. The inclusion of additional transfactors such as LIN28 
and NANOG alongside O-K-S-M has been shown to increase reprogramming efficiency 
or overcome age-related cellular senescence in donor cells (Lapasset et al., 2011; Liao et 
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al., 2008). It is believed that LIN28 and NANOG function independent of cell division 
kinetics by co-targeting pluripotency-associated CRMs and facilitating both 
combinatorial and cooperative TF binding to stably reactivate endogenous pluripotency 
loci (Hanna et al., 2009). Although, this approach increases the probability of 
reprogramming intermediates reaching the maturation phase, it does not guarantee 
deterministic reprogramming. Hence, biological heterogeneity would be expected to 
persist and confound the identification of endogenous gene sets and processes important 
for the completion of iPSC maturation.   
MET-associated transcriptional response in early canine reprogramming implicates 
several gene products localized to the cell surface. Sorting and enrichment of cell 
populations based on epithelial or mesenchymal surface markers using FACS will 
deconvolute the heterogeneity among the mixture of productively reprogramming canine 
cell populations and alternative cell fates. Intermediate subpopulations undergoing a 
productive reprogramming trajectory have been successfully isolated by monitoring the 
loss of somatic surface markers and concomitant gain of epithelial surface markers 
(Nefzger et al., 2015; Polo et al., 2012). This approach will allow us to dissect the 
pathways and processes active in productively reprogramming versus refractory cell 
populations (Fig. 5-3).  
To this end, I have validated canine-reactive antibodies against glycoprotein epitopes 
characteristic of mesenchymal cell types. Canine fibroblast populations are immuno-
reactive to mesenchymal surface markers such as the CD90/THY1 and CD44/ECMR-III 
(Fig. 5-4A). These antigens are uniformly present (>98%) on fibroblast cultures, but only 
CD90/THY1 is absent from control epithelial cell line MDCK-II and hence apparently 
specific to the mesenchymal state (Fig. 5-4B). In contrast, the epithelial adhesion protein 
CD324/CDH1 level is elevated in MDCK-II compared to fibroblasts (Fig. 5-4B). 
CD324/CDH1 was significantly induced by AA/RA treatment at 6 DPI by reverse 
transcription qPCR using commercial and custom oligonucleotide primers (Chapter 4). I 
predict that CD90/THY1 and CD324/CDH1 will serve as selectable markers to 
discriminate between epithelial and mesenchymal cells, among the heterogeneous 
intermediates in early canine reprogramming for detailed molecular analyses. 
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Figure 5-3. Strategy to investigate conserved and divergent reprogramming 
mechanisms in the dog. 
(A) Initiation and maturation phases of reprogramming are reversible and dependent on 
reprogramming factor expression. Stabilization of induced pluripotency relies on 
currently unknown extrinsic signals that are distinct from those involved in pluripotency 
maintenance. (B) Putative canine-reactive antibodies for mesenchymal (e.g. 
CD44/ECMR-III, CD90/THY1) or epithelial (e.g. CD324/CDH1) glycoprotein antigens 
may be applied to enrich for productively reprogramming intermediate cells that have 
undergone mesenchymal-to-epithelial transition. Comparison of productive and 
refractory reprogramming intermediates will identify gene products and processes 
important to canine reprogramming. Interspecies differences may be elucidated by 
comparing these datasets to publicly available human and mouse reprogramming studies 
at matched reprogramming timepoints.  
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Figure 5-4. Validation of canine-reactive surface markers to discriminate 
mesenchymal or epithelial canine cells. 
Representative direct immunofluorescence images in canine fetal fibroblast for 
extracellular matrix receptor III (CD44/ECMR-III) and thymus cell antigen 
(CD90/THY1). Scale bar unit length is 50 µm. (B) Representative overlay histograms of 
canine fetal fibroblast (cFF) and Madin Darby Canine Kidney (MDCK-II) epithelial cell 
line stained with CD44, CD90 or epithelial cadherin (CDH1/CD324).  
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5.3 Summary 
Pluripotency and self-renewal are widely presumed to be conserved features of the inner 
cell mass and epiblast of mammalian embryos. Environmental stimuli change 
dynamically during early development and so these distinct pluripotent cell populations 
rely on variations of core gene regulatory mechanisms and metabolic activities. This 
ensures that pluripotent cells are to undergo robust symmetric self-renewal, while 
remaining poised for embryonic lineage specification. Evolutionary divergence in 
reproductive physiology and early developmental progression lead to species-specific 
pluripotent cell attributes, which will also likely alter the molecular roadmaps to an 
induced pluripotent state. My discovery that cESC may adopt molecularly distinct 
phenotypes with metabolic requirements mirroring primed and naïve pluripotent states 
advances the knowledge of conserved pluripotent state regulators. In summary, this thesis 
expands on the influence of the culture environment on phenotypic plasticity exhibited by 
cESCs and canine reprogramming intermediates.  
5.4 References 
Behera, V., Evans, P., Face, C. J., Hamagami, N., Sankaranarayanan, L., Keller, C. A., … 
Blobel, G. A. (2018). Exploiting genetic variation to uncover rules of 
transcription factor binding and chromatin accessibility. Nature Communications.  
Ben-David, U., & Benvenisty, N. (2011). The tumorigenicity of human embryonic and 
induced pluripotent stem cells. Nature Reviews Cancer.  
Bernardo, A. S., Jouneau, A., Marks, H., Kensche, P., Kobolak, J., Freude, K., … 
Dinnyes, A. (2018). Mammalian embryo comparison identifies novel 
pluripotency genes associated with the naïve or primed state. Biology Open.  
Bertero, A., Madrigal, P., Galli, A., Hubner, N. C., Moreno, I., Burks, D., … Vallier, L. 
(2015). Activin/Nodal signaling and NANOG orchestrate human embryonic stem 
cell fate decisions by controlling the H3K4me3 chromatin mark. Genes and 
Development.  
Bulut-Karslioglu, A., Biechele, S., Jin, H., MacRae, T. A., Hejna, M., Gertsenstein, M., 
… Ramalho-Santos, M. (2016). Inhibition of mTOR induces a paused pluripotent 
state. Nature.  
211 
 
Calder, A., Roth-Albin, I., Bhatia, S., Pilquil, C., Lee, J. H., Bhatia, M., … Draper, J. S. 
(2013). Lengthened G1 Phase Indicates Differentiation Status in Human 
Embryonic Stem Cells. Stem Cells and Development, 22(2), 279–295.  
Carayannopoulos, M. O., Xiong, F., Jensen, P., Rios-Galdamez, Y., Huang, H., Lin, S., & 
Devaskar, S. U. (2014). GLUT3 gene expression is critical for embryonic growth, 
brain development and survival. Molecular Genetics and Metabolism.  
Carbognin, E., Betto, R. M., Soriano, M. E., Smith, A. G., & Martello, G. (2016). Stat3 
promotes mitochondrial transcription and oxidative respiration during 
maintenance and induction of naive pluripotency. The EMBO Journal, 35(6), 
618–34.  
Carcamo-Orive, I., Hoffman, G. E., Cundiff, P., Beckmann, N. D., D’Souza, S. L., 
Knowles, J. W., … Lemischka, I. (2017). Analysis of Transcriptional Variability 
in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants 
of Heterogeneity. Cell Stem Cell.  
Chen, H., Aksoy, I., Gonnot, F., Osteil, P., Aubry, M., Hamela, C., … Savatier, P. (2015). 
Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to 
naive-like pluripotency. Nature Communications.  
Christensen, D. R., Calder, P. C., & Houghton, F. D. (2015). GLUT3 and PKM2 regulate 
OCT4 expression and support the hypoxic culture of human embryonic stem cells. 
Scientific Reports.  
Cliff, T. S., Wu, T., Boward, B. R., Glushka, J. N., Prestegaard, J. H., Dalton, S., … 
Glushka, J. N. (2017). MYC Controls Human Pluripotent Stem Cell Fate MYC 
Controls Human Pluripotent Stem Cell Fate. Cell Stem CellStem Cell, 21(4), 1–
15.  
Du, Q., Luu, P. L., Stirzaker, C., & Clark, S. J. (2015). Methyl-CpG-binding domain 
proteins: Readers of the epigenome. Epigenomics.  
Forristal, C. E., Christensen, D. R., Chinnery, F. E., Petruzzelli, R., Parry, K. L., 
Sanchez-Elsner, T., & Houghton, F. D. (2013). Environmental Oxygen Tension 
Regulates the Energy Metabolism and Self-Renewal of Human Embryonic Stem 
Cells. PLoS ONE.  
Gu, W., Gaeta, X., Sahakyan, A., Chan, A. B., Hong, C. S., Kim, R., … Christofk, H. R. 
(2016). Glycolytic Metabolism Plays a Functional Role in Regulating Human 
Pluripotent Stem Cell State. Cell Stem Cell.  
Hanna, J., Saha, K., Pando, B., Van Zon, J., Lengner, C. J., Creyghton, M. P., … 
Jaenisch, R. (2009). Direct cell reprogramming is a stochastic process amenable 
to acceleration. Nature.  
212 
 
Høffding, M. K., & Hyttel, P. (2015). Ultrastructural visualization of the Mesenchymal-
to-Epithelial Transition during reprogramming of human fibroblasts to induced 
pluripotent stem cells. Stem Cell Research, 14(1), 39–53.  
Jiao, L., Zhang, H. L., Li, D. D., Yang, K. L., Tang, J., Li, X., … Zhu, X. F. (2018). 
Regulation of glycolytic metabolism by autophagy in liver cancer involves 
selective autophagic degradation of HK2 (hexokinase 2). Autophagy.  
Kim, H., Jang, H., Kim, T. W., Kang, B. H., Lee, S. E., Jeon, Y. K., … Youn, H. D. 
(2015). Core Pluripotency Factors Directly Regulate Metabolism in Embryonic 
Stem Cell to Maintain Pluripotency. Stem Cells.  
Kim, J., Woo, A. J., Chu, J., Snow, J. W., Fujiwara, Y., Kim, C. G., … Orkin, S. H. 
(2010). A Myc Network Accounts for Similarities between Embryonic Stem and 
Cancer Cell Transcription Programs. Cell.  
Kim, J., Kundu, M., Viollet, B., & Guan K.L. (2011). AMPK and mTOR regulate 
autophagy through direct phosphorylation of Ulk1. Nat Cell Biol.  
Koh, S., Thomas, R., Tsai, S., Bischoff, S., Lim, J.-H., Breen, M., … Piedrahita, J. A. 
(2013). Growth Requirements and Chromosomal Instability of Induced 
Pluripotent Stem Cells Generated from Adult Canine Fibroblasts. Stem Cells and 
Development.  
Kuno, A., Nishimura, K., & Takahashi, S. (2018). Time-course transcriptome analysis of 
human cellular reprogramming from multiple cell types reveals the drastic change 
occurs between the mid phase and the late phase. BMC Genomics.  
Lapasset, L., Milhavet, O., Prieur, A., Besnard, E., Babled, A., Ät-Hamou, N., … 
Lemaitre, J. M. (2011). Rejuvenating senescent and centenarian human cells by 
reprogramming through the pluripotent state. Genes and Development.  
Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., … Pei, D. (2010). A mesenchymal-to-
Epithelial transition initiates and is required for the nuclear reprogramming of 
mouse fibroblasts. Cell Stem Cell.  
Liao, J., Wu, Z., Wang, Y., Cheng, L., Cui, C., Gao, Y., … Xiao, L. (2008). Enhanced 
efficiency of generating induced pluripotent stem (iPS) cells from human somatic 
cells by a combination of six transcription factors. Cell Research.  
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., … Young, 
R. A. (2012). Transcriptional amplification in tumor cells with elevated c-Myc. 
Cell.  
Luo, J., & Cibelli, J. B. (2016). Conserved Role of bFGF and a Divergent Role of LIF for 
Pluripotency Maintenance and Survival in Canine Pluripotent Stem Cells. Stem 
Cells and Development, 25(21), 1670–1680.  
213 
 
Mahato, B., Home, P., Rajendran, G., Paul, A., Saha, B., Ganguly, A., … Paul, S. (2014). 
Regulation of mitochondrial function and cellular energy metabolism by protein 
kinase C-λ/ι: a novel mode of balancing pluripotency. Stem Cells (Dayton, Ohio), 
32(11), 2880–92.  
Meng, F., Oback, B., Turner, P., Forrester-Gauntlett, B., & Henderson, H. (2015). Signal 
Inhibition Reveals JAK/STAT3 Pathway as Critical for Bovine Inner Cell Mass 
Development1. Biology of Reproduction.  
Menon, D. V., Patel, D., Joshi, C. G., & Kumar, A. (2019). The road less travelled: The 
efficacy of canine pluripotent stem cells. Experimental Cell Research.  
Nefzger, C. M., Alaei, S., & Polo, J. M. (2015). Isolation of reprogramming intermediates 
during generation of induced pluripotent stem cells from mouse embryonic 
fibroblasts. In Methods in Molecular Biology.  
Polo, J. M., Anderssen, E., Walsh, R. M., Schwarz, B. A., Nefzger, C. M., Lim, S. M., … 
Hochedlinger, K. (2012). A molecular roadmap of reprogramming somatic cells 
into iPS cells. Cell, 151(7), 1617–1632.  
Risner, L. E., Kuntimaddi, A., Lokken, A. A., Achille, N. J., Birch, N. W., Schoenfelt, 
K., … Zeleznik-Le, N. J. (2013). Functional specificity of CpG DNA-binding 
CXXC domains in mixed lineage leukemia. Journal of Biological Chemistry.  
Sakaki-Yumoto, M., Liu, J., Ramalho-Santos, M., Yoshida, N., & Derynck, R. (2013). 
Smad2 Is essential for maintenance of the human and mouse primed pluripotent 
stem cell state. Journal of Biological Chemistry.  
Samavarchi-Tehrani, P., Golipour, A., David, L., Sung, H. K., Beyer, T. A., Datti, A., … 
Wrana, J. L. (2010). Functional genomics reveals a BMP-Driven mesenchymal-
to-Epithelial transition in the initiation of somatic cell reprogramming. Cell Stem 
Cell.  
Scognamiglio, R., Cabezas-Wallscheid, N., Thier, M. C. C., Altamura, S., Reyes, A., 
Prendergast, Á. M. M., … Trumpp, A. (2016). Myc Depletion Induces a 
Pluripotent Dormant State Mimicking Diapause. Cell, 164(4), 668–680.  
Senft, A. D., Costello, I., King, H. W., Mould, A. W., Bikoff, E. K., & Robertson, E. J. 
(2018). Combinatorial Smad2/3 Activities Downstream of Nodal Signaling 
Maintain Embryonic/Extra-Embryonic Cell Identities during Lineage Priming. 
Cell Reports.  
Shook, D., & Keller, R. (2003). Mechanisms, mechanics and function of epithelial-
mesenchymal transitions in early development. Mechanisms of Development.  
Sotthibundhu, A., McDonagh, K., Von Kriegsheim, A., Garcia-Munoz, A., Klawiter, A., 
Thompson, K., … Shen, S. (2016). Rapamycin regulates autophagy and cell 
adhesion in induced pluripotent stem cells. Stem Cell Research and Therapy.  
214 
 
Suvorova, I. I., Grigorash, B. B., Chuykin, I. A., Pospelova, T. V., & Pospelov, V. A. 
(2016). G1 checkpoint is compromised in mouse ESCs due to functional 
uncoupling of p53-p21waf1 signaling. Cell Cycle.  
Takahashi, K., Mitsui, K., & Yamanaka, S. (2003). Role of ERas in promoting tumour-
like properties in mouse embryonic stem cells. Nature.  
Tanabe, K., Yamanaka, S., Narita, M., Takahashi, K., & Nakamura, M. (2013). 
Maturation, not initiation, is the major roadblock during reprogramming toward 
pluripotency from human fibroblasts. Proceedings of the National Academy of 
Sciences.  
Tanaka, Y., Ikeda, T., Kishi, Y., Masuda, S., Shibata, H., Takeuchi, K., … Hanazono, Y. 
(2009). ERas is expressed in primate embryonic stem cells but not related to 
tumorigenesis. Cell Transplantation.  
Teshigawara, R., Hirano, K., Nagata, S., Ainscough, J., & Tada, T. (2016). OCT4 activity 
during conversion of human intermediately reprogrammed stem cells to iPSCs 
through mesenchymal-epithelial transition. Development.  
Vaags, A. K., Rosic-Kablar, S., Gartley, C. J., Zheng, Y. Z., Chesney, A., Villagómez, D. 
A. F., … Hough, M. R. (2009). Derivation and Characterization of Canine 
Embryonic Stem Cell Lines with In Vitro and In Vivo Differentiation Potential. 
Stem Cells, 27(2), 329–340.  
Van Oosten, A. L., Costa, Y., Smith, A., & Silva, J. C. R. (2012). JAK/STAT3 signalling 
is sufficient and dominant over antagonistic cues for the establishment of naive 
pluripotency. Nature Communications.  
Wilcox, J. T., Semple, E., Gartley, C., Brisson, B. A., Perrault, S. D., Villagómez, D. A. 
F., … Betts, D. H. (2009). Characterization of Canine Embryonic Stem Cell Lines 
Derived From Different Niche Microenvironments. Stem Cells and Development, 
18(8), 1167–1178.  
Wu, H., Song, C., Zhang, J., Zhao, J., Fu, B., Mao, T., & Zhang, Y. (2017). Melatonin-
mediated upregulation of GLUT1 blocks exit from pluripotency by increasing the 
uptake of oxidized Vitamin C in mouse embryonic stem cells. FASEB Journal.  
Wu, R., Liu, Y., Zhao, Y., Bi, Z., Yao, Y., Liu, Q., … Wang, X. (2019). m6A 
methylation controls pluripotency of porcine induced pluripotent stem cells by 
targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated 
manner. Cell Death & Disease, 10(3), 171.  
Xia, H. guang, Najafov, A., Geng, J., Galan-Acosta, L., Han, X., Guo, Y., … 
Vakifahmetoglu-Norberg, H. (2015). Degradation of HK2 by chaperone-mediated 
autophagy promotes metabolic catastrophe and cell death. Journal of Cell 
Biology.  
215 
 
Yang, F., Wang, N., Wang, Y., Yu, T., & Wang, H. (2017). Activin-SMAD signaling is 
required for maintenance of porcine iPS cell self-renewal through upregulation of 
NANOG and OCT4 expression. Journal of Cellular Physiology.  
Yu, J. S. L., & Cui, W. (2016). Proliferation, survival and metabolism: the role of 
PI3K/AKT/mTOR signalling in pluripotency and cell fate determination. 
Development.  
Zhang, C., Skamagki, M., Liu, Z., Ananthanarayanan, A., Zhao, R., Li, H., & Kim, K. 
(2017). Biological Significance of the Suppression of Oxidative Phosphorylation 
in Induced Pluripotent Stem Cells. Cell Reports.  
Zhang, Z. N., Chung, S. K., Xu, Z., & Xu, Y. (2014). Oct4 maintains the pluripotency of 
human embryonic stem cells by inactivating p53 through sirt1-mediated 
deacetylation. Stem Cells.  
 
   
  
216 
 
Appendix A: Materials and Methods for cell surface marker 
validation 
Immunolabeling for Fluorescence Microscopy 
For fluorescence microscopy, cells were stained for 1 hour with CD44-PE (1:100) or 
CD90-PE (1:50) diluted in a 3% BSA staining solution. Table A-1 contains primary 
antibody information. Cells were imaged on the stage of a Leica DMI 6000B microscope. 
Digital images were captured with an Orca Flash camera (Hamamatsu Photonics) and 
Application Suite X software (Leica Microsystems). Brightness and contrast were 
standardized to isotype stained samples and the equivalent imaging parameters were 
applied to all other images using ImageJ (National Institutes of Health, MD).  
 
Table 0-1. Primary antibody information for flow cytometry. 
Antibody Fluorochrome Supplier (Catalog) 
Anti-CD44 (IM7) PE Thermo Fisher (12-0441-82) 
Anti-CD90 (YKIX337.217) PE Thermo Fisher (12-5900-42) 
Anti-CD324 (DECMA-1) FITC Thermo Fisher (14-3249-82) 
Rat IgG Isotype Control PE Thermo Fisher (12-4031-82) 
Rat IgG Isotype Control FITC Thermo Fisher (11-4321-80) 
 
Immunolabeling for Flow Cytometry 
For flow cytometry, cells were collected by a cell scraper after treating with enzyme-free 
cell dissociation buffer containing EDTA for 5 min at 37 °C, and was treated TrypLE 
enzyme for 6 minutes at 37 °C. Single live cells in suspension were filtered through a 70-
μm strainer adjusted to a density of approximately 1 x106 cells/mL in staining buffer (1% 
bovine serum albumin, 0.075% Sodium Azide) and incubated with CD90-PE (1:50) or 
CD44-PE (1:100) and CD324 (1:25) for 1 hour protected from light. Cells were washed 
twice with staining buffer, transferred to a polystyrene tube and stained with 7-AAD 
reagent to exclude dead cells. Events were recorded using the Accuri C6 platform (BD 
Bioscience) using standard laser configuration, a flow rate of 35 μL/minute and the 
following optical filters: 533/30 (FL-1), 585/40 (FL-2), 670 LP (FL-3) and 675/25 (FL-
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4). Single colour or fluorescence minus one control samples containing an equivalent 
volume of diluent were included to set analyses gates and to threshold background 
autofluorescence. Briefly, the single-cell population was isolated by pulse processing 
(pulse height vs. pulse area) for further interrogation. Samples stained with the 
appropriate isotype control were used to determine non-specific antibody binding. 
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